data_2lvc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lvc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.884 0.373 . . . . 71.540000000000006 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.329999999999998 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 74.040000000000006 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 72.310000000000002 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.519999999999996 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 75.349999999999994 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 73.430000000000007 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.349999999999994 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 74.510000000000005 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 74.140000000000001 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 71.530000000000001 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 73.200000000000003 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.150000000000006 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.598 HG23 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 74.200000000000003 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 73.340000000000003 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 72.450000000000003 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.239999999999995 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 72.040000000000006 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.625 ' HG3' HG23 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.25 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 72.129999999999995 110.685 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 73.200000000000003 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.030000000000001 109.746 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.420000000000002 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.049999999999997 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.200000000000003 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 75.230000000000004 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.439999999999998 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.129999999999995 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.140000000000001 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 73.209999999999994 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 55.43 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.450000000000003 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.109999999999999 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.329999999999998 108.273 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.409999999999997 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.310000000000002 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.450000000000003 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.310000000000002 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.150000000000006 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 73.019999999999996 110.889 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 74.219999999999999 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 72.420000000000002 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 73.120000000000005 109.283 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.340000000000003 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.310000000000002 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 72.319999999999993 111.378 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.549999999999997 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 62.229999999999997 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.420000000000002 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.689 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.129999999999995 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.230000000000004 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 74.310000000000002 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 74.129999999999995 107.666 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.140000000000001 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.510000000000005 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 73.540000000000006 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 74.409999999999997 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.239999999999995 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.230000000000004 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.611 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 74.140000000000001 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 74.129999999999995 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 74.120000000000005 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.010000000000005 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.530000000000001 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.109999999999999 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.200000000000003 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.669 ' SG ' ' HB1' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.400000000000006 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.439999999999998 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 52.340000000000003 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.129999999999995 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.209999999999994 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 75.129999999999995 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.430000000000007 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.510000000000005 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 75.040000000000006 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 72.349999999999994 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.549999999999997 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.340000000000003 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.120000000000005 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.58 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.430000000000007 111.656 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.420000000000002 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 72.420000000000002 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 74.319999999999993 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 74.239999999999995 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 75.150000000000006 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.019999999999996 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 74.150000000000006 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 72.400000000000006 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.420000000000002 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.209999999999994 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.400000000000006 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' THR . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.319999999999993 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.219999999999999 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.329999999999998 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 73.219999999999999 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.219999999999999 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.5 ' HG3' HG21 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.439999999999998 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 52.049999999999997 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 73.329999999999998 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.230000000000004 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.099999999999994 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 73.140000000000001 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.430000000000007 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.129999999999995 110.647 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.420000000000002 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.219999999999999 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.150000000000006 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 60' ' ' ARG . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 74.310000000000002 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.409999999999997 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.439999999999998 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 75.540000000000006 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB2' HG21 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.019999999999996 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.099999999999994 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 74.129999999999995 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 72.230000000000004 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 70.409999999999997 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.25 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 63.329999999999998 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.444 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 70.140000000000001 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.129999999999995 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.411 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.519999999999996 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 70.510000000000005 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG21 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.439999999999998 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 74.540000000000006 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.340000000000003 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.439999999999998 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 71.040000000000006 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.329999999999998 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG23 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.099999999999994 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 74.340000000000003 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.230000000000004 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 73.530000000000001 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.340000000000003 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 72.549999999999997 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.409999999999997 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 HG22 HD12 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.150000000000006 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 75.25 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' HG21 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 71.540000000000006 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.409999999999997 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.240000000000002 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 71.140000000000001 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.450000000000003 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.642 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.430000000000007 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.109999999999999 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.510000000000005 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 62.25 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.453 ' H ' HG11 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.439999999999998 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.439999999999998 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.409999999999997 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 73.319999999999993 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 75.129999999999995 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 60.020000000000003 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 75.329999999999998 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 75.140000000000001 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 64.140000000000001 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.445 HG23 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p . . . . . 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.319999999999993 110.462 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.219999999999999 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 74.040000000000006 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 74.319999999999993 110.312 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.149999999999999 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 75.430000000000007 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 72.439999999999998 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.409999999999997 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 72.450000000000003 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.439999999999998 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 74.450000000000003 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.439999999999998 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 73.209999999999994 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 75.420000000000002 109.235 168.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 71.430000000000007 113.339 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.439999999999998 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.546 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.209999999999994 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 75.340000000000003 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.340000000000003 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.230000000000004 111.189 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 73.239999999999995 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.030000000000001 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.030000000000001 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.430000000000007 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 74.019999999999996 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.349999999999994 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 74.430000000000007 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 64.530000000000001 110.823 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.400000000000006 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 74.319999999999993 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.209999999999994 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HZ2' ' HB2' ' A' ' 40' ' ' LYS . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.200000000000003 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.240000000000002 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.239999999999995 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 70.120000000000005 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 75.120000000000005 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.530000000000001 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 74.239999999999995 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.120000000000005 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.319999999999993 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 75.010000000000005 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 HD22 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 65.420000000000002 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 72.409999999999997 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.310000000000002 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.439999999999998 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 65.450000000000003 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.230000000000004 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 74.409999999999997 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.543 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.329999999999998 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.439999999999998 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 72.120000000000005 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 75.420000000000002 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.319999999999993 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 75.230000000000004 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.439999999999998 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.230000000000004 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.41 ' HB ' HD12 ' A' ' 90' ' ' ILE . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.439999999999998 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.230000000000004 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.420000000000002 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 71.239999999999995 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.310000000000002 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.350000000000001 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 73.230000000000004 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 73.010000000000005 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.340000000000003 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 64.340000000000003 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.209999999999994 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.209999999999994 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 73.549999999999997 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.329999999999998 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.430000000000007 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.340000000000003 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.420000000000002 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 72.329999999999998 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.329999999999998 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.540000000000006 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.41 HD12 ' HB ' ' A' ' 67' ' ' THR . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 73.109999999999999 110.817 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.230000000000004 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 75.340000000000003 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 74.030000000000001 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.439999999999998 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 72.420000000000002 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.049999999999997 113.631 -4.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 72.299999999999997 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.510000000000005 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.010000000000005 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 74.239999999999995 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 74.420000000000002 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 65.329999999999998 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.5 108.992 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.150000000000006 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 75.430000000000007 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 74.129999999999995 111.578 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.010000000000005 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.574 ' HG3' HG21 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 72.439999999999998 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 74.049999999999997 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 74.109999999999999 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.120000000000005 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.150000000000006 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 73.120000000000005 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 75.219999999999999 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.319999999999993 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 72.319999999999993 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 63.539999999999999 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 73.319999999999993 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.120000000000005 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 75.510000000000005 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 73.219999999999999 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.510000000000005 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 71.450000000000003 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 74.150000000000006 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 64.209999999999994 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 75.25 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.430000000000007 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.120000000000005 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.400000000000006 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.530000000000001 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.430000000000007 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 72.519999999999996 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.540000000000006 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.129999999999995 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 72.409999999999997 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 75.340000000000003 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.430000000000007 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 74.120000000000005 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.310000000000002 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.130000000000003 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 73.310000000000002 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.319999999999993 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 74.230000000000004 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.519999999999996 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 70.129999999999995 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.230000000000004 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.240000000000002 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.540000000000006 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 72.230000000000004 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.340000000000003 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.310000000000002 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.530000000000001 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.540000000000006 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 73.439999999999998 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.329999999999998 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 74.400000000000006 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 75.120000000000005 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 74.329999999999998 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.200000000000003 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 64.040000000000006 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.340000000000003 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.540000000000006 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.530000000000001 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 73.200000000000003 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HB2' HG22 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 73.400000000000006 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 70.510000000000005 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.340000000000003 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 70.129999999999995 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 73.140000000000001 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.340000000000003 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 75.530000000000001 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 75.319999999999993 112.88 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 73.109999999999999 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.464 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.329999999999998 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.219999999999999 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.239999999999995 111.094 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 74.200000000000003 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 74.200000000000003 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 74.109999999999999 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.450000000000003 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.319999999999993 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.319999999999993 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.439999999999998 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.030000000000001 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.607 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.099999999999994 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.510000000000005 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.329999999999998 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.099999999999994 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.520000000000003 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.530000000000001 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.493 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 71.310000000000002 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.510000000000005 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 73.239999999999995 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.571 ' SG ' HG13 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.230000000000004 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.129999999999995 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.450000000000003 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HB3' HG22 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.310000000000002 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 75.540000000000006 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 73.430000000000007 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 72.349999999999994 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 72.420000000000002 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 HG13 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 74.140000000000001 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.439999999999998 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.040000000000006 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 74.150000000000006 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HB2' HG23 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 74.319999999999993 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 72.120000000000005 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 75.430000000000007 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.140000000000001 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.450000000000003 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 74.319999999999993 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.219999999999999 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.219999999999999 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.561 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 65.120000000000005 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 61.43 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 74.230000000000004 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.439999999999998 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.239999999999995 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.040000000000006 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.230000000000004 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.400000000000006 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.109999999999999 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.120000000000005 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 72.219999999999999 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 74.530000000000001 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.140000000000001 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.420000000000002 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 74.409999999999997 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 71.340000000000003 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.150000000000006 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.019999999999996 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.420000000000002 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.420000000000002 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 73.420000000000002 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 71.510000000000005 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.319999999999993 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.120000000000005 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.349999999999994 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.340000000000003 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 73.019999999999996 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.519999999999996 110.241 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.421 ' HG ' ' HB2' ' A' ' 27' ' ' CYS . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 74.230000000000004 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.329999999999998 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.340000000000003 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.420000000000002 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 72.120000000000005 109.482 169.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 74.129999999999995 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.439999999999998 109.92 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.439999999999998 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 75.319999999999993 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.239999999999995 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 72.420000000000002 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 74.329999999999998 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 73.450000000000003 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.430000000000007 112.036 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.430000000000007 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.349999999999994 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 70.109999999999999 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.349999999999994 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.349999999999994 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.530000000000001 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 65.439999999999998 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.409999999999997 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.439999999999998 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.519999999999996 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 71.049999999999997 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.409999999999997 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.450000000000003 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 71.049999999999997 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.549 HG23 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 72.129999999999995 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 74.230000000000004 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.420000000000002 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.409999999999997 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HG1' ' A' ' 67' ' ' THR . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 74.319999999999993 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.349999999999994 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 75.209999999999994 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 74.450000000000003 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 72.109999999999999 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.140000000000001 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.450000000000003 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.349999999999994 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.109999999999999 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.150000000000006 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.340000000000003 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.593 HG12 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 75.109999999999999 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 62.399999999999999 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.329999999999998 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 64.230000000000004 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.119999999999997 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.349999999999994 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 64.519999999999996 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.299999999999997 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 74.409999999999997 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.420000000000002 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 54.340000000000003 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.010000000000005 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 65.019999999999996 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG23 HD23 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 71.310000000000002 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 71.219999999999999 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.439999999999998 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.340000000000003 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 61.119999999999997 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.239999999999995 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.109999999999999 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.409999999999997 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 73.209999999999994 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.200000000000003 108.768 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 75.150000000000006 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.340000000000003 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.349999999999994 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 63.229999999999997 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.476 ' HG1' HG21 ' A' ' 23' ' ' VAL . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 71.019999999999996 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 74.540000000000006 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.549 ' HD3' HG23 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 74.409999999999997 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 64.209999999999994 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.519999999999996 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 74.430000000000007 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 74.209999999999994 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.030000000000001 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.239999999999995 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.409999999999997 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 63.5 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.430000000000007 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.530000000000001 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 55.340000000000003 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.230000000000004 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.329999999999998 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.120000000000005 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.540000000000006 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.409999999999997 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.420000000000002 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 73.230000000000004 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.209999999999994 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 74.549999999999997 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.099999999999994 110.778 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.349999999999994 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 75.230000000000004 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.409999999999997 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.43 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 73.409999999999997 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 73.150000000000006 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 75.010000000000005 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 72.340000000000003 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.519999999999996 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.430000000000007 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.019999999999996 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 74.329999999999998 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.530000000000001 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG21 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.540000000000006 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 61.210000000000001 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.405 ' H ' HG21 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.530000000000001 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.430000000000007 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 63.229999999999997 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 73.230000000000004 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG2' HG21 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 73.030000000000001 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 72.109999999999999 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.439999999999998 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.109999999999999 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 72.200000000000003 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 74.510000000000005 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.400000000000006 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.310000000000002 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.209999999999994 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.099999999999994 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.239999999999995 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.219999999999999 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 73.25 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.299999999999997 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 75.319999999999993 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.109999999999999 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 75.310000000000002 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 52.219999999999999 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.409999999999997 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 72.219999999999999 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.439999999999998 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 75.310000000000002 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 74.510000000000005 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.510000000000005 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 75.109999999999999 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.219999999999999 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.109999999999999 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 64.430000000000007 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 73.219999999999999 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 74.209999999999994 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' H ' HD21 ' A' ' 55' ' ' ASN . 0.0 OUTLIER -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 112.04 -172.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.010000000000005 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.420000000000002 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 73.120000000000005 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.430000000000007 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.439999999999998 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.219999999999999 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.140000000000001 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 74.099999999999994 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 75.219999999999999 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.019999999999996 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.579 ' HA ' HD11 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.340000000000003 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 73.319999999999993 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.439999999999998 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 70.200000000000003 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 54.43 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 70.450000000000003 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 75.450000000000003 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.519999999999996 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.099999999999994 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.471 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.200000000000003 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 74.329999999999998 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.420000000000002 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 63.340000000000003 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.400000000000006 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 74.239999999999995 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.439999999999998 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.030000000000001 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.319999999999993 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.540000000000006 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.239999999999995 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.140000000000001 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 70.219999999999999 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 73.439999999999998 112.142 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.230000000000004 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.510000000000005 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.319999999999993 112.171 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.450000000000003 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.430000000000007 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 75.230000000000004 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.450000000000003 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.310000000000002 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.239999999999995 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.109999999999999 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 75.219999999999999 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 65.219999999999999 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.099999999999994 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 72.409999999999997 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.519999999999996 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.310000000000002 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 74.230000000000004 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 62.140000000000001 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 54.130000000000003 110.301 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 74.409999999999997 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 70.420000000000002 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.439999999999998 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 73.200000000000003 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 64.530000000000001 110.47 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.340000000000003 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 74.219999999999999 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.109999999999999 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 63.409999999999997 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.433 HG13 ' HG3' ' A' ' 60' ' ' ARG . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 74.5 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.030000000000001 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.239999999999995 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.540000000000006 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 64.030000000000001 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.200000000000003 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.200000000000003 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.230000000000004 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.349999999999994 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 HD13 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 73.120000000000005 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.230000000000004 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.430000000000007 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 73.439999999999998 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG22 HD22 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.299999999999997 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.019999999999996 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 74.200000000000003 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.439999999999998 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.510000000000005 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.239999999999995 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.039999999999999 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 71.540000000000006 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.010000000000005 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.420000000000002 114.155 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 HG12 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.439999999999998 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 75.439999999999998 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 75.519999999999996 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 73.239999999999995 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.209999999999994 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.510000000000005 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.25 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.450000000000003 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.119999999999997 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 73.030000000000001 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.350000000000001 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.240000000000002 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.230000000000004 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 72.5 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.109999999999999 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 75.409999999999997 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 72.400000000000006 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 73.109999999999999 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 61.399999999999999 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 74.049999999999997 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.109999999999999 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 74.439999999999998 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 72.120000000000005 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.310000000000002 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 74.310000000000002 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 74.099999999999994 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 74.209999999999994 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' HB1' ' A' ' 34' ' ' ALA . 9.9 p . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.508 0.671 . . . . 72.219999999999999 110.575 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.426 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 74.530000000000001 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 74.030000000000001 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 72.340000000000003 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 74.420000000000002 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 72.319999999999993 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.129999999999995 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.049999999999997 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 74.400000000000006 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 74.310000000000002 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.510000000000005 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.229999999999997 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.219999999999999 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.219999999999999 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 73.530000000000001 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.030000000000001 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 73.25 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 74.099999999999994 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 71.329999999999998 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.219999999999999 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.239999999999995 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.310000000000002 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 73.5 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.540000000000006 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.109999999999999 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 75.200000000000003 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 73.200000000000003 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.099999999999994 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.439999999999998 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.530000000000001 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 74.310000000000002 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.219999999999999 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 72.430000000000007 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.109999999999999 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 72.030000000000001 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 43.420000000000002 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 73.219999999999999 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 73.340000000000003 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 65.409999999999997 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 74.319999999999993 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.150000000000006 113.375 -172.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.349999999999994 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.140000000000001 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.140000000000001 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.239999999999995 111.06 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.040000000000006 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.109999999999999 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.329999999999998 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.099999999999994 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.340000000000003 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 74.049999999999997 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 72.019999999999996 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 74.430000000000007 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 72.430000000000007 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 75.340000000000003 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.584 HD21 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 64.329999999999998 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.584 ' HD2' HD21 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.530000000000001 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.329999999999998 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 ' HA ' HD12 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.430000000000007 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 72.209999999999994 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.109999999999999 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 72.129999999999995 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 71.540000000000006 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.230000000000004 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 54.399999999999999 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.200000000000003 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 73.540000000000006 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 74.040000000000006 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 73.540000000000006 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.310000000000002 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 75.25 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.349999999999994 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 74.219999999999999 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.129999999999995 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.340000000000003 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 74.5 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.129999999999995 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.450000000000003 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.540000000000006 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 73.239999999999995 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 74.400000000000006 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.984 -0.376 . . . . 71.519999999999996 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.809 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.140000000000001 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.613 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 73.319999999999993 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.340000000000003 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 74.239999999999995 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.430000000000007 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 75.439999999999998 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 65.129999999999995 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.120000000000005 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.340000000000003 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 72.140000000000001 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 75.209999999999994 110.221 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 64.540000000000006 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.310000000000002 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.340000000000003 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.540000000000006 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 75.519999999999996 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 74.140000000000001 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 74.409999999999997 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 75.519999999999996 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.400000000000006 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.129999999999995 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 63.109999999999999 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.459 HG13 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 71.439999999999998 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.635 ' HB2' HG11 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.299999999999997 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HB3' HG22 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.420000000000002 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 64.310000000000002 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 45.329999999999998 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 63.109999999999999 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 74.120000000000005 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.420000000000002 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.010000000000005 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.409999999999997 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 74.25 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 71.040000000000006 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.439999999999998 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.319999999999993 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.540000000000006 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.510000000000005 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 74.329999999999998 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.200000000000003 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 73.0 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 72.329999999999998 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 72.310000000000002 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 74.430000000000007 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 75.319999999999993 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 74.420000000000002 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.099999999999994 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 74.310000000000002 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.239999999999995 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.519999999999996 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.150000000000006 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.643 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.319999999999993 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.019999999999996 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 72.310000000000002 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 75.430000000000007 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 64.400000000000006 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 75.530000000000001 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.439999999999998 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 62.450000000000003 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 73.439999999999998 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.129999999999995 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 73.340000000000003 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 75.040000000000006 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 73.040000000000006 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.430000000000007 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.420000000000002 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.230000000000004 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 72.450000000000003 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.120000000000005 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.130000000000003 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.329999999999998 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 65.230000000000004 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.200000000000003 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.010000000000005 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.809 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.540000000000006 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 72.150000000000006 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 73.129999999999995 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 63.0 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.130000000000003 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 71.549999999999997 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 74.400000000000006 110.715 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 73.310000000000002 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 HG12 ' HB1' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 74.510000000000005 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 122.259 1.028 . . . . 75.310000000000002 109.898 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.329999999999998 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 71.400000000000006 109.879 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 74.209999999999994 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.319999999999993 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 73.200000000000003 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 75.319999999999993 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.019999999999996 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.219999999999999 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 71.430000000000007 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.430000000000007 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 75.120000000000005 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 75.409999999999997 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.509999999999998 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.420000000000002 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 74.129999999999995 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.329999999999998 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 73.219999999999999 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.530000000000001 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.409999999999997 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 73.409999999999997 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.310000000000002 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.439999999999998 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.319999999999993 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.450000000000003 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.400000000000006 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.140000000000001 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 73.5 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB2' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.399999999999999 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 70.150000000000006 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.310000000000002 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.310000000000002 109.483 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.510000000000005 110.624 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.540000000000006 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 64.420000000000002 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.129999999999995 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 73.519999999999996 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.319999999999993 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 63.310000000000002 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 72.340000000000003 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 75.430000000000007 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.409999999999997 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 71.109999999999999 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 74.409999999999997 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.120000000000005 110.349 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.340000000000003 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.430000000000007 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.310000000000002 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.319999999999993 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 74.319999999999993 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 72.430000000000007 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 75.200000000000003 109.61 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 74.109999999999999 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 75.319999999999993 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.209999999999994 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' O ' HD11 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.210000000000001 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 70.530000000000001 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 75.049999999999997 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 74.540000000000006 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 75.409999999999997 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 75.219999999999999 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.219999999999999 111.552 172.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 64.519999999999996 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 71.340000000000003 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 75.510000000000005 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.441 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 65.140000000000001 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 73.120000000000005 111.212 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.310000000000002 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 72.540000000000006 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.310000000000002 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.299999999999997 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 111.729 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.509999999999998 110.844 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 75.349999999999994 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.400000000000006 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 71.310000000000002 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 73.439999999999998 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.329999999999998 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.299999999999997 112.027 -176.673 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.544 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p . . . . . 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 73.340000000000003 111.207 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 62.329999999999998 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 71.099999999999994 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 73.319999999999993 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 72.439999999999998 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 74.140000000000001 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.420000000000002 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 73.109999999999999 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.310000000000002 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 74.109999999999999 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 75.450000000000003 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 73.400000000000006 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 75.200000000000003 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 53.100000000000001 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 90' ' ' ILE . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.319999999999993 107.119 172.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.239999999999995 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.200000000000003 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.049999999999997 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 55.310000000000002 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.109999999999999 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 72.010000000000005 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.540000000000006 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 74.209999999999994 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 65.420000000000002 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.329999999999998 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.140000000000001 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.209999999999994 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.540000000000006 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 75.310000000000002 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.519999999999996 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.530000000000001 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 74.030000000000001 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.129999999999995 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.539999999999999 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.120000000000005 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.230000000000004 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 75.420000000000002 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.109999999999999 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.109999999999999 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 62.409999999999997 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.340000000000003 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 63.420000000000002 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.230000000000004 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.562 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 75.420000000000002 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 71.319999999999993 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.409999999999997 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 73.120000000000005 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' H ' HD21 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 74.109999999999999 111.915 -173.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.519999999999996 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.120000000000005 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.540000000000006 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 71.120000000000005 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.450000000000003 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.230000000000004 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 71.099999999999994 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.329999999999998 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 75.400000000000006 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.200000000000003 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.520000000000003 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 74.120000000000005 111.381 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.239999999999995 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.540000000000006 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.530000000000001 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.150000000000006 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.349999999999994 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.149999999999999 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.450000000000003 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.439999999999998 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.140000000000001 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 73.510000000000005 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 60.240000000000002 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' HG11 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.420000000000002 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 72.510000000000005 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 73.530000000000001 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.109999999999999 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 70.400000000000006 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 73.510000000000005 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.530000000000001 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 70.430000000000007 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.530000000000001 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.310000000000002 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 75.109999999999999 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 34' ' ' ALA . 2.6 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.648 0.261 . . . . 72.519999999999996 110.804 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.435 ' HD1' ' HG2' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.209999999999994 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.019999999999996 109.675 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 74.439999999999998 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.099999999999994 110.092 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 74.209999999999994 112.985 -10.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.129999999999995 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 73.340000000000003 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 72.109999999999999 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 75.230000000000004 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.409999999999997 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' HG21 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 75.120000000000005 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.140000000000001 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.319999999999993 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.430000000000007 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 72.409999999999997 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.319999999999993 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 60.149999999999999 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.230000000000004 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.403 ' HG2' HG21 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.239999999999995 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.430000000000007 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 73.230000000000004 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.409999999999997 110.222 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 74.530000000000001 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.430000000000007 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.150000000000006 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 75.430000000000007 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 73.209999999999994 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.639 ' HB2' HG22 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.019999999999996 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 73.209999999999994 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 77' ' ' CYS . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.430000000000007 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.409999999999997 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.329999999999998 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.239999999999995 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.420000000000002 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.209999999999994 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.25 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.409999999999997 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.420000000000002 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 75.140000000000001 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 63.020000000000003 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.439999999999998 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.340000000000003 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.219999999999999 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' HD11 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.439999999999998 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.420000000000002 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.329999999999998 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.519999999999996 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.109999999999999 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.329999999999998 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.209999999999994 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.340000000000003 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 75.319999999999993 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.129999999999995 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 73.219999999999999 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 74.430000000000007 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.540000000000006 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG22 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.530000000000001 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 73.439999999999998 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 74.030000000000001 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 72.25 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 70.319999999999993 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.310000000000002 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.430000000000007 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.530000000000001 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.219999999999999 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 62.420000000000002 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.540000000000006 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.340000000000003 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.200000000000003 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.349999999999994 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 71.230000000000004 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 65.310000000000002 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 74.450000000000003 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.329999999999998 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG2' ' HD1' ' A' ' 5' ' ' HIS . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.030000000000001 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 74.230000000000004 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.430000000000007 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 74.040000000000006 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.430000000000007 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 73.209999999999994 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.239999999999995 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.441 HG12 ' HB1' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 75.430000000000007 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 34' ' ' ALA . 3.7 p . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 70.239999999999995 111.919 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.519999999999996 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.540000000000006 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.129999999999995 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.329999999999998 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 74.239999999999995 113.842 1.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.239999999999995 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 73.010000000000005 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.310000000000002 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 73.120000000000005 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.299999999999997 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.319999999999993 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 52.399999999999999 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 73.310000000000002 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 75.420000000000002 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 71.040000000000006 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.409999999999997 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.540000000000006 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.510000000000005 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.420000000000002 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.319999999999993 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 71.450000000000003 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.010000000000005 111.063 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.019999999999996 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.120000000000005 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 74.299999999999997 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.319999999999993 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 63.43 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.200000000000003 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 75.5 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.329999999999998 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.510000000000005 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.040000000000006 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 75.430000000000007 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 73.120000000000005 109.634 171.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.510000000000005 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.230000000000004 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 74.040000000000006 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 75.310000000000002 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.420000000000002 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 74.450000000000003 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.210000000000001 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.099999999999994 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.468 HG22 HD23 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 73.150000000000006 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 73.439999999999998 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 72.310000000000002 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.48 HD21 ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.329999999999998 109.838 -172.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 75.129999999999995 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.481 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 73.409999999999997 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 74.120000000000005 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.299999999999997 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 64.299999999999997 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 73.530000000000001 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.010000000000005 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 74.510000000000005 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 75.319999999999993 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.329999999999998 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.219999999999999 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.040000000000006 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.230000000000004 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.099999999999994 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.230000000000004 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.510000000000005 113.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG2' ' HG1' ' A' ' 87' ' ' THR . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.030000000000001 112.107 -175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 73.450000000000003 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 73.030000000000001 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.239999999999995 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 72.349999999999994 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.409999999999997 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 72.239999999999995 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.049999999999997 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.519999999999996 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.219999999999999 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 71.319999999999993 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 74.420000000000002 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.458 ' HG1' ' HG2' ' A' ' 74' ' ' GLU . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 72.409999999999997 110.208 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 73.549999999999997 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.140000000000001 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.519999999999996 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.230000000000004 111.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 72.219999999999999 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 74.209999999999994 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.340000000000003 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.310000000000002 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 72.299999999999997 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.649 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.439999999999998 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.510000000000005 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 73.439999999999998 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 75.049999999999997 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.592 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 74.340000000000003 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.420000000000002 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.239999999999995 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.5 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 73.120000000000005 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 71.030000000000001 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.329999999999998 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 64.319999999999993 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.592 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.340000000000003 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.43 ' HG3' HG21 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 62.43 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 74.430000000000007 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.120000000000005 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.430000000000007 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.019999999999996 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.540000000000006 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 71.219999999999999 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.340000000000003 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.240000000000002 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.239999999999995 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.439999999999998 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.530000000000001 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.430000000000007 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 72.219999999999999 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.219999999999999 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 74.340000000000003 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 63.219999999999999 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.340000000000003 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.519999999999996 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.209999999999994 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 62.219999999999999 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 64.049999999999997 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.319999999999993 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.319999999999993 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.420000000000002 110.372 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.540000000000006 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 73.25 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 74.209999999999994 111.829 -174.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.140000000000001 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 m170 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.439999999999998 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 73.129999999999995 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.140000000000001 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.519999999999996 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.43 HG21 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.519999999999996 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.329999999999998 108.689 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 71.140000000000001 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.450000000000003 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.539999999999999 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.049999999999997 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.486 ' HD3' HG23 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 74.219999999999999 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.530000000000001 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 73.299999999999997 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 74.549999999999997 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 63.340000000000003 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.409999999999997 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.329999999999998 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.2 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.540000000000006 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 73.329999999999998 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 74.319999999999993 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.310000000000002 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 63.219999999999999 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 73.030000000000001 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.329999999999998 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 74.239999999999995 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.649 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.129999999999995 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.409999999999997 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 73.140000000000001 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.209999999999994 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 71.120000000000005 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.549999999999997 111.759 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.420000000000002 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' HG13 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.340000000000003 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.099999999999994 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.340000000000003 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.349999999999994 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 75.209999999999994 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 71.439999999999998 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.019999999999996 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 73.239999999999995 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.209999999999994 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.230000000000004 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.120000000000005 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 74.099999999999994 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.340000000000003 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 64.140000000000001 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.230000000000004 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.219999999999999 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.439999999999998 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 73.230000000000004 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.437 ' HE3' HG21 ' A' ' 63' ' ' VAL . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.400000000000006 110.064 175.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 74.239999999999995 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 75.239999999999995 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 73.040000000000006 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.349999999999994 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.540000000000006 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 73.329999999999998 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.329999999999998 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.049999999999997 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.319999999999993 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.530000000000001 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.439999999999998 111.135 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.219999999999999 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 73.329999999999998 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.129999999999995 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 72.25 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.219999999999999 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 54.109999999999999 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.510000000000005 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 74.319999999999993 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 72.099999999999994 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.409999999999997 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.329999999999998 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.409999999999997 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.510000000000005 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.439999999999998 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.420000000000002 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.120000000000005 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 73.040000000000006 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.509999999999998 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.329999999999998 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.129999999999995 108.805 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.329999999999998 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.420000000000002 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG21 ' HE3' ' A' ' 24' ' ' MET . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 73.329999999999998 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 65.200000000000003 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.450000000000003 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.099999999999994 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 73.109999999999999 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 73.310000000000002 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 75.540000000000006 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.140000000000001 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.430000000000007 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 53.509999999999998 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 64.450000000000003 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.510000000000005 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.439999999999998 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.200000000000003 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 74.140000000000001 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.530000000000001 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.310000000000002 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 74.129999999999995 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.030000000000001 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 61.109999999999999 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.409999999999997 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.120000000000005 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 73.109999999999999 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.420000000000002 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.340000000000003 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 75.129999999999995 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 HG12 ' HB1' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.329999999999998 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 63.420000000000002 111.566 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.7 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 73.209999999999994 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.549999999999997 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.239999999999995 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.140000000000001 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.349999999999994 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.430000000000007 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.099999999999994 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.239999999999995 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.230000000000004 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.040000000000006 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.540000000000006 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' HD12 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.120000000000005 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 73.140000000000001 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.030000000000001 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.530000000000001 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.439999999999998 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 74.319999999999993 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.51 ' HG3' HG21 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 75.239999999999995 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 74.329999999999998 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 72.0 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.310000000000002 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.109999999999999 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 75.120000000000005 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.200000000000003 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.409999999999997 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.319999999999993 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.209999999999994 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 72.420000000000002 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.409999999999997 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 64.540000000000006 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.439999999999998 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 74.209999999999994 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.219999999999999 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 75.439999999999998 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 75.129999999999995 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.400000000000006 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 75.299999999999997 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.209999999999994 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.414 HG12 HD13 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 70.129999999999995 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.319999999999993 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.140000000000001 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.459 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.049999999999997 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.420000000000002 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 71.319999999999993 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 65.040000000000006 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 75.310000000000002 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.109999999999999 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 73.329999999999998 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.426 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.430000000000007 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.430000000000007 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.450000000000003 114.028 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.400000000000006 113.409 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 72.010000000000005 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.728 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 74.420000000000002 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.310000000000002 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 75.239999999999995 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.51 HG21 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 75.230000000000004 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 75.010000000000005 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 62.420000000000002 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 65.239999999999995 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' HD13 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 71.400000000000006 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 64.420000000000002 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 73.340000000000003 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.450000000000003 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.219999999999999 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 74.129999999999995 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.129999999999995 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 71.439999999999998 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.486 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.120000000000005 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.120000000000005 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.239999999999995 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.209999999999994 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.7 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.399999999999999 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.230000000000004 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.439999999999998 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.540000000000006 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 71.099999999999994 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 53.450000000000003 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 72.040000000000006 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.608 HD12 ' HB1' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 75.230000000000004 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.692 0.282 . . . . 72.230000000000004 111.512 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.230000000000004 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 74.109999999999999 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.530000000000001 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.530000000000001 111.077 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 72.230000000000004 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.109999999999999 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD23 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.099999999999994 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.439999999999998 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.487 ' HB2' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.229999999999997 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.593 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.420000000000002 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 64.549999999999997 112.289 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.448 ' H ' HG21 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 75.109999999999999 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 74.150000000000006 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.420000000000002 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.129999999999995 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 74.0 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 72.099999999999994 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 73.219999999999999 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.009999999999998 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.329999999999998 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.349999999999994 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.230000000000004 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.409999999999997 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.310000000000002 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 60.340000000000003 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.219999999999999 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 72.129999999999995 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.209999999999994 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.040000000000006 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.040000000000006 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 75.299999999999997 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.400000000000006 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 73.340000000000003 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.510000000000005 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.439999999999998 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.200000000000003 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.430000000000007 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.310000000000002 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.040000000000006 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 64.319999999999993 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.340000000000003 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 73.219999999999999 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.120000000000005 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 74.040000000000006 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.120000000000005 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.540000000000006 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 63.539999999999999 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 72.450000000000003 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 65.209999999999994 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.329999999999998 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 73.340000000000003 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.319999999999993 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.299999999999997 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 73.099999999999994 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.510000000000005 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.349999999999994 110.543 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.530000000000001 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 73.420000000000002 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.239999999999995 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.140000000000001 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 75.120000000000005 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.329999999999998 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.68 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.099999999999994 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 74.319999999999993 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 73.019999999999996 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 72.030000000000001 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.439999999999998 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.299999999999997 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 71.099999999999994 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.119999999999997 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.349999999999994 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.230000000000004 110.933 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.68 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.219999999999999 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.530000000000001 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 73.219999999999999 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.549999999999997 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 17' ' ' ALA . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.219999999999999 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 31' ' ' ARG . 7.0 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.286 0.476 . . . . 75.5 112.286 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.120000000000005 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.329999999999998 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 73.239999999999995 112.449 -1.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.140000000000001 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.099999999999994 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.439999999999998 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.049999999999997 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 75.420000000000002 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.540000000000006 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 74.120000000000005 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 75.430000000000007 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 HG21 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.519999999999996 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 73.340000000000003 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 73.420000000000002 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.299999999999997 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 71.099999999999994 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.040000000000006 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 72.099999999999994 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 64.129999999999995 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.140000000000001 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.319999999999993 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.409999999999997 110.525 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.319999999999993 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.430000000000007 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.520000000000003 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 74.420000000000002 111.464 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.049999999999997 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.430000000000007 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 74.430000000000007 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 74.340000000000003 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 61.119999999999997 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 72.219999999999999 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.420000000000002 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.430000000000007 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.430000000000007 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 71.209999999999994 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.219999999999999 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.329999999999998 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.409999999999997 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 74.120000000000005 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 71.239999999999995 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 75.099999999999994 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 72.5 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.519999999999996 110.669 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.340000000000003 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 72.409999999999997 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.340000000000003 112.132 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 74.540000000000006 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 75.329999999999998 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 73.200000000000003 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 72.540000000000006 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.420000000000002 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 73.349999999999994 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 75.040000000000006 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' HG23 ' A' ' 90' ' ' ILE . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 72.239999999999995 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.140000000000001 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.099999999999994 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.219999999999999 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 65.340000000000003 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.099999999999994 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 73.0 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.450000000000003 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.140000000000001 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 72.420000000000002 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.019999999999996 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.540000000000006 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 73.409999999999997 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.510000000000005 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 64.409999999999997 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 74.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 75.239999999999995 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.329999999999998 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.42 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.549999999999997 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 71.019999999999996 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.472 HG23 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.239999999999995 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 74.239999999999995 111.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 73.129999999999995 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 75.409999999999997 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 61.439999999999998 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 74.239999999999995 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 73.109999999999999 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.219999999999999 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 75.230000000000004 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.530000000000001 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.439999999999998 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.420000000000002 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.409999999999997 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 75.200000000000003 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.510000000000005 113.803 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 75.510000000000005 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 73.329999999999998 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.409999999999997 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 70.450000000000003 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.340000000000003 110.29 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.140000000000001 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.25 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 75.299999999999997 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.209999999999994 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 74.439999999999998 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.420000000000002 107.823 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.439999999999998 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.140000000000001 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 73.439999999999998 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 75.109999999999999 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 74.5 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 74.140000000000001 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.140000000000001 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.340000000000003 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 73.030000000000001 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 70.209999999999994 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG12 HD13 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.549999999999997 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 71.549999999999997 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.462 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.439999999999998 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 62.229999999999997 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 75.319999999999993 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 45' ' ' VAL . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.229999999999997 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 HG22 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 64.540000000000006 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 74.109999999999999 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.340000000000003 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB3' HH11 ' A' ' 60' ' ' ARG . 13.8 m120 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 73.230000000000004 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.219999999999999 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HG2' ' HD2' ' A' ' 59' ' ' HIS . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 72.140000000000001 112.804 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HD2' ' HG2' ' A' ' 58' ' ' PRO . 18.8 m-70 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.409999999999997 111.564 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.483 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.150000000000006 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.120000000000005 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 75.530000000000001 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 64.099999999999994 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 72.140000000000001 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.310000000000002 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 71.530000000000001 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.120000000000005 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.439999999999998 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 73.430000000000007 113.553 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 72.319999999999993 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 73.5 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.230000000000004 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.409999999999997 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 74.319999999999993 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 75.340000000000003 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.109999999999999 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.219999999999999 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 70.340000000000003 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.340000000000003 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.049999999999997 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.329999999999998 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.439999999999998 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 70.329999999999998 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 72.239999999999995 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 72.010000000000005 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 72.510000000000005 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.140000000000001 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.099999999999994 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.510000000000005 110.06 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 75.319999999999993 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.7 mtt -80.86 138.96 49.93 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 123.1 0.56 . . . . 73.510000000000005 109.764 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 4' ' ' VAL . 51.9 Cg_exo -55.42 -86.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.485 2.79 . . . . 64.5 114.331 -176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' H ' ' HB2' ' A' ' 3' ' ' PRO . 11.3 p -176.96 139.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 118.52 0.6 . . . . 71.540000000000006 111.93 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.329999999999998 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 74.040000000000006 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 72.310000000000002 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.519999999999996 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 75.349999999999994 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 73.430000000000007 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.349999999999994 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 74.510000000000005 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 74.140000000000001 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 71.530000000000001 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 73.200000000000003 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.150000000000006 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.598 HG23 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 74.200000000000003 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 73.340000000000003 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 72.450000000000003 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.239999999999995 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 72.040000000000006 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.625 ' HG3' HG23 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.25 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 72.129999999999995 110.685 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 73.200000000000003 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.030000000000001 109.746 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.420000000000002 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.049999999999997 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.200000000000003 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 75.230000000000004 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.439999999999998 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.129999999999995 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.140000000000001 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 73.209999999999994 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.508 HG23 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 55.43 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.450000000000003 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.109999999999999 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.329999999999998 108.273 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.409999999999997 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.310000000000002 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.450000000000003 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.310000000000002 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.150000000000006 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 73.019999999999996 110.889 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 74.219999999999999 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 72.420000000000002 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 73.120000000000005 109.283 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.340000000000003 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.310000000000002 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 72.319999999999993 111.378 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.549999999999997 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 62.229999999999997 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.420000000000002 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.689 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.129999999999995 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.230000000000004 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 74.310000000000002 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 74.129999999999995 107.666 173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.140000000000001 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.510000000000005 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 73.540000000000006 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 74.409999999999997 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.239999999999995 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.230000000000004 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.611 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 74.140000000000001 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 74.129999999999995 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 74.120000000000005 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.010000000000005 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.530000000000001 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.109999999999999 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.200000000000003 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.669 ' SG ' ' HB1' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.400000000000006 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.439999999999998 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 52.340000000000003 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.129999999999995 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.209999999999994 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 75.129999999999995 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.669 ' HB1' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.430000000000007 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.510000000000005 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 75.040000000000006 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 72.349999999999994 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.549999999999997 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.340000000000003 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.611 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.120000000000005 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.8 t60 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.541 0.21 . . . . 74.319999999999993 110.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.4 mtt -112.49 94.82 29.17 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.894 0.878 . . . . 73.120000000000005 109.641 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.07 -165.51 0.34 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.965 2.443 . . . . 74.109999999999999 112.985 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.58 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p -120.34 90.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.430000000000007 111.656 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.420000000000002 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.468 HG12 HG11 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 72.420000000000002 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 74.319999999999993 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 74.239999999999995 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 75.150000000000006 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.019999999999996 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 74.150000000000006 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 72.400000000000006 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.420000000000002 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.209999999999994 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.400000000000006 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 67' ' ' THR . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.319999999999993 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.219999999999999 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.329999999999998 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 73.219999999999999 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.219999999999999 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.5 ' HG3' HG21 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.439999999999998 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 52.049999999999997 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 73.329999999999998 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.230000000000004 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.099999999999994 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.56 HG12 HG12 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 73.140000000000001 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.430000000000007 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.129999999999995 110.647 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.420000000000002 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.219999999999999 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.150000000000006 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 60' ' ' ARG . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 74.310000000000002 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.409999999999997 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.439999999999998 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 75.540000000000006 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HB2' HG21 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 74.329999999999998 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.019999999999996 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.099999999999994 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 74.129999999999995 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 72.230000000000004 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 70.409999999999997 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.25 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 63.329999999999998 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.444 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 70.140000000000001 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.129999999999995 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.411 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.519999999999996 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 70.510000000000005 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG21 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.439999999999998 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 74.540000000000006 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.340000000000003 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.439999999999998 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 71.040000000000006 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.329999999999998 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG23 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.099999999999994 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 74.340000000000003 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.230000000000004 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' HB ' HG21 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 73.530000000000001 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.340000000000003 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 72.549999999999997 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.409999999999997 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 HG22 HD12 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.150000000000006 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 75.25 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' HG21 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 71.540000000000006 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.409999999999997 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.240000000000002 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 71.140000000000001 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.450000000000003 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.642 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.430000000000007 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.109999999999999 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.510000000000005 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 62.25 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.453 ' H ' HG11 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.439999999999998 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.439999999999998 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.409999999999997 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 73.319999999999993 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.642 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 75.129999999999995 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 60.020000000000003 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 75.329999999999998 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 75.140000000000001 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.563 HG12 ' HB1' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 64.140000000000001 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 119.7 -0.191 . . . . 74.310000000000002 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt 60.98 94.13 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 124.967 1.307 . . . . 74.109999999999999 111.396 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.76 160.02 47.17 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.386 2.058 . . . . 73.510000000000005 113.001 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG23 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p -127.85 72.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.319999999999993 110.462 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.219999999999999 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 74.040000000000006 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 74.319999999999993 110.312 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.149999999999999 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 75.430000000000007 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 72.439999999999998 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.409999999999997 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 72.450000000000003 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.439999999999998 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 74.450000000000003 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.439999999999998 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 73.209999999999994 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 75.420000000000002 109.235 168.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 71.430000000000007 113.339 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.439999999999998 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.546 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.209999999999994 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.572 HD12 HD21 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 75.340000000000003 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.340000000000003 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.230000000000004 111.189 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 73.239999999999995 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.030000000000001 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.030000000000001 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.430000000000007 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 74.019999999999996 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.349999999999994 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.219999999999999 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 74.430000000000007 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 64.530000000000001 110.823 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.400000000000006 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 74.319999999999993 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.209999999999994 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HZ2' ' HB2' ' A' ' 40' ' ' LYS . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.200000000000003 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.240000000000002 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.239999999999995 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 70.120000000000005 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 75.120000000000005 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.530000000000001 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 74.239999999999995 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.120000000000005 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.319999999999993 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 75.010000000000005 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 HD22 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 65.420000000000002 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 72.409999999999997 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.310000000000002 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.439999999999998 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 65.450000000000003 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.230000000000004 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 74.409999999999997 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.543 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.329999999999998 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.439999999999998 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 72.120000000000005 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 75.420000000000002 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.319999999999993 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 75.230000000000004 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.485 HD22 HG21 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.439999999999998 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.230000000000004 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.41 ' HB ' HD12 ' A' ' 90' ' ' ILE . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.439999999999998 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.230000000000004 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.420000000000002 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 71.239999999999995 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.310000000000002 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.350000000000001 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 73.230000000000004 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 73.010000000000005 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.340000000000003 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 64.340000000000003 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.209999999999994 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.209999999999994 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 73.549999999999997 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.329999999999998 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.430000000000007 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.340000000000003 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.420000000000002 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 72.329999999999998 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.329999999999998 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.540000000000006 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.41 HD12 ' HB ' ' A' ' 67' ' ' THR . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 73.109999999999999 110.817 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 111.816 0.302 . . . . 75.109999999999999 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptp 40.43 64.52 4.65 Favored Pre-proline 0 N--CA 1.509 2.491 0 C-N-CA 125.669 1.588 . . . . 65.409999999999997 114.689 -176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.64 76.82 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.917 2.411 . . . . 73.349999999999994 111.892 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.76 120.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.230000000000004 112.543 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 75.340000000000003 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 74.030000000000001 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.439999999999998 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 72.420000000000002 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.049999999999997 113.631 -4.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 72.299999999999997 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.510000000000005 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.010000000000005 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 74.239999999999995 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 74.420000000000002 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 65.329999999999998 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.5 108.992 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.150000000000006 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 75.430000000000007 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 74.129999999999995 111.578 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.010000000000005 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.574 ' HG3' HG21 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 72.439999999999998 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 74.049999999999997 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 74.109999999999999 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.120000000000005 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.150000000000006 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 73.120000000000005 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 75.219999999999999 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.319999999999993 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 72.319999999999993 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 63.539999999999999 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 73.319999999999993 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.120000000000005 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 75.510000000000005 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 73.219999999999999 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.510000000000005 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 71.450000000000003 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 74.150000000000006 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 64.209999999999994 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 75.25 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.430000000000007 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.120000000000005 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.400000000000006 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.530000000000001 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.430000000000007 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 72.519999999999996 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.540000000000006 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.129999999999995 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 72.409999999999997 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 75.340000000000003 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.430000000000007 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 74.120000000000005 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.310000000000002 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.130000000000003 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 73.310000000000002 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.319999999999993 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 74.230000000000004 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.519999999999996 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.574 HG21 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 70.129999999999995 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.230000000000004 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.240000000000002 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.540000000000006 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 72.230000000000004 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.340000000000003 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.310000000000002 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.530000000000001 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.540000000000006 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 73.439999999999998 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.329999999999998 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 74.400000000000006 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 75.120000000000005 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 74.329999999999998 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.200000000000003 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 64.040000000000006 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.340000000000003 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.540000000000006 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.530000000000001 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 73.200000000000003 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.466 ' HB2' HG22 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 73.400000000000006 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 70.510000000000005 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.340000000000003 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 70.129999999999995 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 73.140000000000001 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.340000000000003 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 75.530000000000001 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.459 0.171 . . . . 71.109999999999999 110.741 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -120.99 83.79 38.23 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 123.393 0.677 . . . . 72.140000000000001 110.765 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.425 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 58.5 Cg_endo -92.97 172.55 2.05 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.525 2.817 . . . . 74.409999999999997 113.762 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p -76.08 127.98 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 75.319999999999993 112.88 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 73.109999999999999 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.464 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.329999999999998 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.219999999999999 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.239999999999995 111.094 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 74.200000000000003 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 74.200000000000003 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 74.109999999999999 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.450000000000003 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.319999999999993 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.319999999999993 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.439999999999998 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.030000000000001 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.607 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.099999999999994 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.510000000000005 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.453 ' H ' HG23 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.329999999999998 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.607 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.099999999999994 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.520000000000003 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.530000000000001 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.493 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 71.310000000000002 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.510000000000005 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 73.239999999999995 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.571 ' SG ' HG13 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.230000000000004 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.129999999999995 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.450000000000003 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HB3' HG22 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.310000000000002 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 75.540000000000006 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 73.430000000000007 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 72.349999999999994 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 72.420000000000002 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 HG13 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 74.140000000000001 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.439999999999998 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.040000000000006 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 74.150000000000006 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HB2' HG23 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 74.319999999999993 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 72.120000000000005 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 75.430000000000007 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.140000000000001 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.450000000000003 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 74.319999999999993 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.219999999999999 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.219999999999999 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.561 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 65.120000000000005 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 61.43 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 74.230000000000004 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.439999999999998 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG21 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.239999999999995 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.040000000000006 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.230000000000004 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.400000000000006 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.109999999999999 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.120000000000005 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 72.219999999999999 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 74.530000000000001 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.140000000000001 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.493 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.420000000000002 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG21 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 74.409999999999997 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 71.340000000000003 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.150000000000006 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.019999999999996 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.420000000000002 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.420000000000002 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 73.420000000000002 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 71.510000000000005 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.319999999999993 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.120000000000005 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.349999999999994 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.340000000000003 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 73.019999999999996 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.519999999999996 110.241 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.421 ' HG ' ' HB2' ' A' ' 27' ' ' CYS . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 74.230000000000004 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.329999999999998 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.340000000000003 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.420000000000002 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 72.120000000000005 109.482 169.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 74.129999999999995 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.439999999999998 109.92 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.483 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.439999999999998 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 75.319999999999993 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.239999999999995 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 72.420000000000002 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 74.329999999999998 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 73.450000000000003 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.563 -0.162 . . . . 75.349999999999994 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -167.47 121.65 0.8 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 123.376 0.67 . . . . 71.319999999999993 110.727 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.92 99.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.971 2.448 . . . . 75.319999999999993 112.99 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p -72.0 96.54 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.430000000000007 112.036 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.430000000000007 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.349999999999994 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 70.109999999999999 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.349999999999994 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.349999999999994 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.530000000000001 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 65.439999999999998 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.409999999999997 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.439999999999998 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.519999999999996 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 71.049999999999997 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.409999999999997 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.450000000000003 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 71.049999999999997 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.549 HG23 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 72.129999999999995 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 74.230000000000004 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.420000000000002 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.409999999999997 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HG1' ' A' ' 67' ' ' THR . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 74.319999999999993 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.349999999999994 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 75.209999999999994 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 74.450000000000003 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 72.109999999999999 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.140000000000001 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.450000000000003 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.349999999999994 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.109999999999999 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.150000000000006 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.340000000000003 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.593 HG12 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 75.109999999999999 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 62.399999999999999 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.329999999999998 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 64.230000000000004 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.119999999999997 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.349999999999994 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 64.519999999999996 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.299999999999997 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 74.409999999999997 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.420000000000002 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 54.340000000000003 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.010000000000005 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 65.019999999999996 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG23 HD23 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 71.310000000000002 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 71.219999999999999 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.439999999999998 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.340000000000003 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 61.119999999999997 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.239999999999995 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.109999999999999 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.593 ' HG3' HG12 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.409999999999997 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 73.209999999999994 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.200000000000003 108.768 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 75.150000000000006 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD23 HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.340000000000003 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.349999999999994 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 63.229999999999997 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.476 ' HG1' HG21 ' A' ' 23' ' ' VAL . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 71.019999999999996 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 74.540000000000006 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.549 ' HD3' HG23 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 74.409999999999997 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 64.209999999999994 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.519999999999996 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 74.430000000000007 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 74.209999999999994 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.030000000000001 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.239999999999995 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.409999999999997 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 63.5 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.430000000000007 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.530000000000001 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 55.340000000000003 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.230000000000004 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.329999999999998 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.120000000000005 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.540000000000006 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.409999999999997 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.420000000000002 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 73.230000000000004 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.209999999999994 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 74.549999999999997 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.5 ttt -142.07 121.07 7.81 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.133 0.973 . . . . 74.430000000000007 109.388 172.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.37 108.01 2.41 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.114 1.876 . . . . 74.200000000000003 112.864 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.07 117.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.099999999999994 110.778 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.349999999999994 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 75.230000000000004 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.409999999999997 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.43 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 73.409999999999997 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 73.150000000000006 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 75.010000000000005 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 72.340000000000003 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.519999999999996 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.430000000000007 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.019999999999996 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 74.329999999999998 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.530000000000001 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG21 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.540000000000006 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 61.210000000000001 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.405 ' H ' HG21 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.530000000000001 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.430000000000007 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 63.229999999999997 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 73.230000000000004 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG2' HG21 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 73.030000000000001 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 72.109999999999999 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.439999999999998 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.109999999999999 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.538 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 72.200000000000003 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 74.510000000000005 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.400000000000006 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.310000000000002 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.209999999999994 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.099999999999994 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.239999999999995 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.219999999999999 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 73.25 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.299999999999997 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 75.319999999999993 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.109999999999999 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 75.310000000000002 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 52.219999999999999 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.409999999999997 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 72.219999999999999 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.439999999999998 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 75.310000000000002 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 74.510000000000005 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.510000000000005 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 75.109999999999999 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.219999999999999 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.109999999999999 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.466 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 64.430000000000007 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 73.219999999999999 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 74.209999999999994 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' H ' HD21 ' A' ' 55' ' ' ASN . 0.0 OUTLIER -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 112.04 -172.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.010000000000005 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.420000000000002 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 73.120000000000005 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.430000000000007 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.439999999999998 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.219999999999999 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.140000000000001 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 74.099999999999994 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 75.219999999999999 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.019999999999996 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.579 ' HA ' HD11 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.340000000000003 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 73.319999999999993 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.439999999999998 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 70.200000000000003 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 54.43 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 70.450000000000003 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 75.450000000000003 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.519999999999996 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.099999999999994 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.471 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.200000000000003 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 74.329999999999998 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.420000000000002 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 63.340000000000003 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.400000000000006 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 74.239999999999995 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.439999999999998 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.030000000000001 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.319999999999993 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.540000000000006 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.239999999999995 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.140000000000001 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 70.219999999999999 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.459 0.171 . . . . 63.310000000000002 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -145.59 150.71 44.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.308 0.643 . . . . 74.329999999999998 110.4 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.52 137.97 57.5 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.162 2.575 . . . . 71.400000000000006 114.301 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.56 111.81 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 73.439999999999998 112.142 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.230000000000004 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.510000000000005 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.319999999999993 112.171 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.450000000000003 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.430000000000007 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 75.230000000000004 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.450000000000003 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.310000000000002 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.239999999999995 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.451 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.109999999999999 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 75.219999999999999 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 65.219999999999999 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.099999999999994 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 72.409999999999997 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.519999999999996 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.310000000000002 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 74.230000000000004 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 62.140000000000001 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 54.130000000000003 110.301 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 74.409999999999997 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 70.420000000000002 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.439999999999998 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 73.200000000000003 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 64.530000000000001 110.47 172.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.340000000000003 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 74.219999999999999 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.109999999999999 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 63.409999999999997 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.433 HG13 ' HG3' ' A' ' 60' ' ' ARG . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 74.5 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.030000000000001 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.239999999999995 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.540000000000006 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 64.030000000000001 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.200000000000003 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.200000000000003 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.230000000000004 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.349999999999994 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 HD13 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 73.120000000000005 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.230000000000004 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.430000000000007 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 71.349999999999994 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 73.439999999999998 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG22 HD22 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.299999999999997 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.019999999999996 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 74.200000000000003 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.439999999999998 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 74.109999999999999 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.510000000000005 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.239999999999995 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.039999999999999 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 71.540000000000006 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.010000000000005 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.420000000000002 114.155 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD13 HG12 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.439999999999998 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' HG22 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 75.439999999999998 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 75.519999999999996 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 73.239999999999995 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.209999999999994 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.510000000000005 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.25 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.450000000000003 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.119999999999997 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 73.030000000000001 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.350000000000001 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.240000000000002 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.230000000000004 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 72.5 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.109999999999999 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 75.409999999999997 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 72.400000000000006 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 73.109999999999999 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 61.399999999999999 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 74.049999999999997 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.109999999999999 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 74.439999999999998 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 72.120000000000005 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.310000000000002 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 74.310000000000002 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 74.099999999999994 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 74.209999999999994 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.48 -0.193 . . . . 72.340000000000003 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.8 mtt -78.88 147.9 71.29 Favored Pre-proline 0 CA--C 1.57 1.731 0 C-N-CA 123.749 0.82 . . . . 72.400000000000006 111.654 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.8 143.6 29.27 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.937 3.092 . . . . 74.150000000000006 116.317 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG21 ' HB1' ' A' ' 34' ' ' ALA . 9.9 p -93.74 148.38 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.94 0.896 . . . . 72.219999999999999 110.575 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.426 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 74.530000000000001 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 74.030000000000001 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 72.340000000000003 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 74.420000000000002 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 72.319999999999993 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.129999999999995 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.049999999999997 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 74.400000000000006 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 74.310000000000002 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.510000000000005 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.229999999999997 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.219999999999999 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.219999999999999 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 73.530000000000001 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.030000000000001 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 73.25 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 74.099999999999994 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 71.329999999999998 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.219999999999999 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.239999999999995 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.310000000000002 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.729 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 73.5 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.540000000000006 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.109999999999999 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 75.200000000000003 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 73.200000000000003 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.099999999999994 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.439999999999998 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.530000000000001 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 74.310000000000002 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.219999999999999 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 72.430000000000007 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.109999999999999 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 72.030000000000001 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 43.420000000000002 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 73.219999999999999 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 73.340000000000003 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 65.409999999999997 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 74.319999999999993 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.150000000000006 113.375 -172.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.349999999999994 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.140000000000001 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.140000000000001 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.239999999999995 111.06 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.040000000000006 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.109999999999999 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.329999999999998 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.099999999999994 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.340000000000003 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 74.049999999999997 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 72.019999999999996 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 74.430000000000007 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 72.430000000000007 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 75.340000000000003 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.584 HD21 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 64.329999999999998 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.584 ' HD2' HD21 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.530000000000001 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.329999999999998 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 ' HA ' HD12 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.430000000000007 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 72.209999999999994 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.109999999999999 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 72.129999999999995 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 71.540000000000006 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.230000000000004 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 54.399999999999999 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.200000000000003 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 73.540000000000006 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 74.040000000000006 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 73.540000000000006 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.310000000000002 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 75.25 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.349999999999994 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 74.219999999999999 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.129999999999995 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.340000000000003 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 74.5 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.129999999999995 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.450000000000003 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.540000000000006 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 73.239999999999995 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 74.400000000000006 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.264 0.554 . . . . 73.530000000000001 109.932 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.65 123.6 20.36 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 123.222 0.609 . . . . 75.409999999999997 110.678 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -95.69 -166.28 0.11 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 123.439 2.759 . . . . 74.439999999999998 112.183 167.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p -107.98 153.75 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.493 0.717 . . . . 71.519999999999996 109.984 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.809 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.140000000000001 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.613 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 73.319999999999993 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.635 HG11 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.340000000000003 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 74.239999999999995 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.430000000000007 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 75.439999999999998 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 65.129999999999995 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.120000000000005 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.340000000000003 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 72.140000000000001 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 75.209999999999994 110.221 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 64.540000000000006 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.310000000000002 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.340000000000003 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.540000000000006 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 75.519999999999996 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 74.140000000000001 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 74.409999999999997 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 75.519999999999996 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.400000000000006 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.129999999999995 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 63.109999999999999 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.459 HG13 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 71.439999999999998 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.635 ' HB2' HG11 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.299999999999997 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HB3' HG22 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.420000000000002 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 64.310000000000002 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 45.329999999999998 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 63.109999999999999 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 74.120000000000005 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.420000000000002 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.010000000000005 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.409999999999997 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 74.25 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 71.040000000000006 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.439999999999998 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.319999999999993 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.540000000000006 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.510000000000005 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 74.329999999999998 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.200000000000003 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 73.0 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 72.329999999999998 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 72.310000000000002 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 74.430000000000007 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 75.319999999999993 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 74.420000000000002 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.099999999999994 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 74.310000000000002 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.239999999999995 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.519999999999996 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.150000000000006 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.643 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.319999999999993 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.019999999999996 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 72.310000000000002 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 75.430000000000007 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 64.400000000000006 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 75.530000000000001 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.439999999999998 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 62.450000000000003 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 73.439999999999998 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.129999999999995 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 73.340000000000003 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 75.040000000000006 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 73.040000000000006 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.551 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.430000000000007 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.420000000000002 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.230000000000004 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 72.450000000000003 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.120000000000005 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.130000000000003 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.329999999999998 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 65.230000000000004 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.200000000000003 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.010000000000005 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.809 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.540000000000006 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 72.150000000000006 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 73.129999999999995 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 63.0 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.130000000000003 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 71.549999999999997 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 74.400000000000006 110.715 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 73.310000000000002 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 HG12 ' HB1' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 74.510000000000005 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 110.031 -0.359 . . . . 72.420000000000002 110.031 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.5 mpt? -80.49 126.28 78.93 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.556 0.742 . . . . 75.439999999999998 111.222 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -62.08 -24.44 76.55 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.561 2.174 . . . . 72.349999999999994 111.897 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p -116.77 87.14 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.328 1.051 . . . . 75.310000000000002 109.898 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.329999999999998 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 71.400000000000006 109.879 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 74.209999999999994 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.319999999999993 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 73.200000000000003 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 75.319999999999993 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.019999999999996 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.219999999999999 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 71.430000000000007 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.430000000000007 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 75.120000000000005 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 75.409999999999997 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.509999999999998 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.420000000000002 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 74.129999999999995 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.329999999999998 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 73.219999999999999 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.530000000000001 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.571 ' HG3' HG21 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.409999999999997 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 73.409999999999997 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.310000000000002 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.439999999999998 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.319999999999993 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.450000000000003 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.400000000000006 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.140000000000001 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 73.5 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB2' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.399999999999999 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 70.150000000000006 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.310000000000002 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.310000000000002 109.483 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.510000000000005 110.624 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HB2' HG21 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.540000000000006 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 64.420000000000002 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.129999999999995 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 73.519999999999996 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.319999999999993 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 63.310000000000002 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 72.340000000000003 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 75.430000000000007 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.409999999999997 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 71.109999999999999 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 74.409999999999997 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.120000000000005 110.349 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.528 HG21 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.340000000000003 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.430000000000007 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.547 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.310000000000002 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 73.219999999999999 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.319999999999993 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 74.319999999999993 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 72.430000000000007 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 75.200000000000003 109.61 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.547 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 72.239999999999995 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 HG21 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 74.109999999999999 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 75.319999999999993 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.209999999999994 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' O ' HD11 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.210000000000001 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 70.530000000000001 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 75.049999999999997 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 74.540000000000006 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 75.409999999999997 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 75.219999999999999 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.219999999999999 111.552 172.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 64.519999999999996 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 71.340000000000003 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 75.510000000000005 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.441 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 65.140000000000001 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 73.120000000000005 111.212 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.310000000000002 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 72.540000000000006 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.310000000000002 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.299999999999997 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 111.729 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.509999999999998 110.844 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 75.349999999999994 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.400000000000006 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 71.310000000000002 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 73.439999999999998 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.329999999999998 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.299999999999997 112.027 -176.673 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.5 m80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 75.040000000000006 111.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 2' ' ' MET . 1.7 mpp? -73.65 122.74 88.34 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 110.88 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.66 21.13 1.03 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.959 2.439 . . . . 74.439999999999998 113.38 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.544 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p -73.52 92.15 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 73.340000000000003 111.207 178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 62.329999999999998 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 71.099999999999994 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 73.319999999999993 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 72.439999999999998 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 74.140000000000001 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.420000000000002 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 73.109999999999999 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.310000000000002 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 74.109999999999999 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 75.450000000000003 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 73.400000000000006 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 75.200000000000003 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB2' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 53.100000000000001 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 90' ' ' ILE . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.319999999999993 107.119 172.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.239999999999995 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.200000000000003 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.049999999999997 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 55.310000000000002 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.109999999999999 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 72.010000000000005 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.540000000000006 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 74.209999999999994 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 65.420000000000002 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.329999999999998 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.140000000000001 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.209999999999994 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.540000000000006 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 75.310000000000002 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.519999999999996 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.530000000000001 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 74.030000000000001 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.129999999999995 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.539999999999999 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.120000000000005 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.230000000000004 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 75.420000000000002 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.109999999999999 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.109999999999999 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 62.409999999999997 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.340000000000003 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.562 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 63.420000000000002 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.230000000000004 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.562 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 75.420000000000002 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 HG22 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 71.319999999999993 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.409999999999997 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 73.120000000000005 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' H ' HD21 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 74.109999999999999 111.915 -173.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.519999999999996 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.120000000000005 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.540000000000006 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 71.120000000000005 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.450000000000003 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.230000000000004 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 71.099999999999994 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.501 ' HB ' HG22 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.329999999999998 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 75.400000000000006 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.200000000000003 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.520000000000003 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 74.120000000000005 111.381 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.239999999999995 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.540000000000006 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.530000000000001 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.150000000000006 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.349999999999994 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.149999999999999 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.450000000000003 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.439999999999998 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.140000000000001 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 73.510000000000005 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 60.240000000000002 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' HG11 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.420000000000002 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 72.510000000000005 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 73.530000000000001 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.109999999999999 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 70.400000000000006 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 73.510000000000005 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.530000000000001 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 70.430000000000007 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.530000000000001 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.310000000000002 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.455 HG12 ' HB2' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 75.109999999999999 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.701 -0.481 . . . . 74.540000000000006 109.701 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -150.08 152.89 34.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.53 0.732 . . . . 74.030000000000001 111.251 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.52 -178.23 4.3 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.88 2.387 . . . . 64.349999999999994 113.892 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 34' ' ' ALA . 2.6 p -120.27 138.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.007 0.923 . . . . 72.519999999999996 110.804 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.435 ' HD1' ' HG2' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.209999999999994 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.019999999999996 109.675 172.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 74.439999999999998 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.099999999999994 110.092 -170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 74.209999999999994 112.985 -10.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.129999999999995 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 73.340000000000003 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 72.109999999999999 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 75.230000000000004 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.409999999999997 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' HG21 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 75.120000000000005 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.140000000000001 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.319999999999993 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.430000000000007 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 72.409999999999997 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.319999999999993 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 60.149999999999999 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.230000000000004 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.403 ' HG2' HG21 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.239999999999995 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.430000000000007 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' SG ' ' SG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 73.230000000000004 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.409999999999997 110.222 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 74.530000000000001 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.430000000000007 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.150000000000006 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 75.430000000000007 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 73.209999999999994 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.639 ' HB2' HG22 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.019999999999996 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 73.209999999999994 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 ' SG ' ' A' ' 77' ' ' CYS . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.430000000000007 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.409999999999997 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.329999999999998 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.239999999999995 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.420000000000002 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.209999999999994 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.25 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.409999999999997 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.420000000000002 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 75.140000000000001 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 63.020000000000003 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.439999999999998 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.340000000000003 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.219999999999999 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' O ' HD11 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.439999999999998 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.420000000000002 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.329999999999998 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.519999999999996 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.109999999999999 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.329999999999998 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.209999999999994 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.340000000000003 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 75.319999999999993 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.129999999999995 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.478 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 73.219999999999999 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 74.430000000000007 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.540000000000006 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG22 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.530000000000001 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 73.439999999999998 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 74.030000000000001 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 72.25 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 70.319999999999993 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.310000000000002 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.430000000000007 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.530000000000001 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.219999999999999 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 62.420000000000002 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.540000000000006 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.340000000000003 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.200000000000003 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.349999999999994 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 71.230000000000004 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 65.310000000000002 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 74.450000000000003 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.329999999999998 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG2' ' HD1' ' A' ' 5' ' ' HIS . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.030000000000001 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 74.230000000000004 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.430000000000007 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 74.040000000000006 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.430000000000007 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 73.209999999999994 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.239999999999995 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.441 HG12 ' HB1' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 75.430000000000007 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.235 -0.283 . . . . 62.030000000000001 110.235 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -81.01 151.18 70.03 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 122.708 0.403 . . . . 74.430000000000007 110.642 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.08 128.78 31.2 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.227 1.951 . . . . 63.450000000000003 110.303 165.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 34' ' ' ALA . 3.7 p -65.71 104.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 70.239999999999995 111.919 -173.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.519999999999996 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.540000000000006 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.129999999999995 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.329999999999998 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 74.239999999999995 113.842 1.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.239999999999995 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 73.010000000000005 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.310000000000002 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 73.120000000000005 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.299999999999997 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.319999999999993 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 52.399999999999999 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 73.310000000000002 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 75.420000000000002 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 71.040000000000006 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.409999999999997 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.540000000000006 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.510000000000005 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.420000000000002 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.319999999999993 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 71.450000000000003 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.010000000000005 111.063 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.019999999999996 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.120000000000005 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 74.299999999999997 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.319999999999993 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 63.43 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HG23 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.200000000000003 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.465 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 75.5 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.329999999999998 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.510000000000005 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.040000000000006 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 75.430000000000007 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 73.120000000000005 109.634 171.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.510000000000005 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.230000000000004 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 74.040000000000006 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 75.310000000000002 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.420000000000002 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 74.450000000000003 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.210000000000001 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.099999999999994 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.468 HG22 HD23 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 73.150000000000006 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 73.439999999999998 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 72.310000000000002 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.48 HD21 ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.329999999999998 109.838 -172.217 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 75.129999999999995 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.481 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 73.409999999999997 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 74.120000000000005 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.299999999999997 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 64.299999999999997 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 73.530000000000001 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.010000000000005 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 74.510000000000005 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 75.319999999999993 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.329999999999998 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.219999999999999 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.040000000000006 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.230000000000004 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.099999999999994 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.230000000000004 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.510000000000005 113.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG2' ' HG1' ' A' ' 87' ' ' THR . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.030000000000001 112.107 -175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 73.450000000000003 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 73.030000000000001 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.239999999999995 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 72.349999999999994 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.409999999999997 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 72.239999999999995 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.049999999999997 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.519999999999996 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.219999999999999 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 71.319999999999993 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 74.420000000000002 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.458 ' HG1' ' HG2' ' A' ' 74' ' ' GLU . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 72.409999999999997 110.208 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 73.549999999999997 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.140000000000001 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.519999999999996 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.813 -0.44 . . . . 71.329999999999998 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -112.6 127.36 26.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 123.087 0.555 . . . . 73.140000000000001 111.828 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -91.37 90.82 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 122.706 2.271 . . . . 72.109999999999999 112.151 170.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.82 100.51 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.230000000000004 111.42 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 72.219999999999999 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 74.209999999999994 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.340000000000003 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.310000000000002 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 72.299999999999997 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.649 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.439999999999998 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.510000000000005 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 73.439999999999998 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 75.049999999999997 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 74.340000000000003 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.420000000000002 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.239999999999995 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.5 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.486 HG23 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 73.120000000000005 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 71.030000000000001 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.329999999999998 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 64.319999999999993 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.592 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.340000000000003 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.43 ' HG3' HG21 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 62.43 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 74.430000000000007 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.120000000000005 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.430000000000007 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.019999999999996 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.540000000000006 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 71.219999999999999 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.340000000000003 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.240000000000002 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.239999999999995 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.439999999999998 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.530000000000001 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.430000000000007 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 72.219999999999999 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.219999999999999 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 74.340000000000003 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 63.219999999999999 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.340000000000003 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.519999999999996 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.209999999999994 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 62.219999999999999 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 64.049999999999997 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.319999999999993 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.319999999999993 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.420000000000002 110.372 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.540000000000006 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 73.25 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 74.209999999999994 111.829 -174.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.140000000000001 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 m170 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.439999999999998 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 73.129999999999995 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.140000000000001 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.519999999999996 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.43 HG21 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.519999999999996 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.329999999999998 108.689 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 71.140000000000001 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.450000000000003 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.539999999999999 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.049999999999997 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.486 ' HD3' HG23 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 74.219999999999999 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.530000000000001 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 73.299999999999997 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 74.549999999999997 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 63.340000000000003 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.409999999999997 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.329999999999998 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.2 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.540000000000006 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 73.329999999999998 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 74.319999999999993 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.310000000000002 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 63.219999999999999 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 73.030000000000001 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.329999999999998 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 74.239999999999995 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.649 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 72.120000000000005 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.129999999999995 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.409999999999997 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 73.140000000000001 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.209999999999994 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 71.120000000000005 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.317 0.579 . . . . 71.319999999999993 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -91.5 139.36 25.14 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.635 0.774 . . . . 74.340000000000003 110.52 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.79 -160.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.908 2.405 . . . . 74.319999999999993 113.013 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p -126.81 97.95 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.549999999999997 111.759 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.420000000000002 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HA ' HG13 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.340000000000003 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.099999999999994 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.340000000000003 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.349999999999994 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 75.209999999999994 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 71.439999999999998 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.019999999999996 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 73.239999999999995 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.209999999999994 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' HB ' HG21 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.230000000000004 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.120000000000005 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.646 ' HB1' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 74.099999999999994 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.340000000000003 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.444 HG23 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 64.140000000000001 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.230000000000004 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.219999999999999 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.439999999999998 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 73.230000000000004 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.437 ' HE3' HG21 ' A' ' 63' ' ' VAL . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.400000000000006 110.064 175.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 74.239999999999995 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 75.239999999999995 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 73.040000000000006 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.349999999999994 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.540000000000006 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 73.329999999999998 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.329999999999998 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.049999999999997 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.319999999999993 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.530000000000001 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.439999999999998 111.135 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.219999999999999 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 73.329999999999998 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.129999999999995 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 72.25 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.219999999999999 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 54.109999999999999 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.510000000000005 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 74.319999999999993 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 72.099999999999994 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.409999999999997 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.329999999999998 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.409999999999997 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.510000000000005 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.439999999999998 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.420000000000002 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.120000000000005 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 73.040000000000006 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.509999999999998 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.329999999999998 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.129999999999995 108.805 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.329999999999998 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.420000000000002 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG21 ' HE3' ' A' ' 24' ' ' MET . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 73.329999999999998 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 65.200000000000003 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.450000000000003 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.099999999999994 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 73.109999999999999 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 73.310000000000002 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.444 ' HG3' HG23 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 75.540000000000006 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.140000000000001 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.406 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.430000000000007 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 53.509999999999998 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 64.450000000000003 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.510000000000005 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.439999999999998 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.200000000000003 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 74.140000000000001 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.530000000000001 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.310000000000002 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 74.129999999999995 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.030000000000001 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 61.109999999999999 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.409999999999997 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.120000000000005 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 73.109999999999999 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.420000000000002 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG21 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.340000000000003 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 75.129999999999995 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 HG12 ' HB1' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.329999999999998 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.499 -0.556 . . . . 71.310000000000002 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.8 mtp -97.23 158.52 33.11 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.667 0.787 . . . . 75.109999999999999 112.096 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.55 147.43 38.74 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.22 2.613 . . . . 62.140000000000001 114.067 169.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG23 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p -97.8 120.13 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 63.420000000000002 111.566 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.7 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 73.209999999999994 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.549999999999997 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.239999999999995 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.140000000000001 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.349999999999994 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.430000000000007 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.099999999999994 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.239999999999995 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.230000000000004 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.040000000000006 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.540000000000006 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.608 ' HB1' HD12 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.120000000000005 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 73.140000000000001 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.030000000000001 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.530000000000001 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.439999999999998 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 74.319999999999993 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.51 ' HG3' HG21 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 75.239999999999995 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 74.329999999999998 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 72.0 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.310000000000002 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.109999999999999 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 75.120000000000005 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.200000000000003 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.409999999999997 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.319999999999993 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.209999999999994 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 72.420000000000002 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.409999999999997 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.728 HG21 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 64.540000000000006 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.439999999999998 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 74.209999999999994 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.219999999999999 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 75.439999999999998 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 75.129999999999995 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.400000000000006 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 75.299999999999997 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.209999999999994 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.414 HG12 HD13 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 70.129999999999995 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.319999999999993 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.140000000000001 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.459 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.049999999999997 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.420000000000002 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 71.319999999999993 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 65.040000000000006 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 75.310000000000002 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.109999999999999 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 73.329999999999998 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.426 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.430000000000007 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.430000000000007 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.450000000000003 114.028 -175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.400000000000006 113.409 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 72.010000000000005 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.728 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 74.420000000000002 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.310000000000002 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 75.239999999999995 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.51 HG21 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 75.230000000000004 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 75.010000000000005 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 62.420000000000002 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 65.239999999999995 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' HD13 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 71.400000000000006 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 64.420000000000002 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 73.340000000000003 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.450000000000003 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.219999999999999 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 74.129999999999995 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.129999999999995 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 71.439999999999998 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.486 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.120000000000005 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.120000000000005 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.239999999999995 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.209999999999994 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.7 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.399999999999999 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.230000000000004 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.439999999999998 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.540000000000006 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 71.099999999999994 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 53.450000000000003 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 72.040000000000006 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.608 HD12 ' HB1' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 75.230000000000004 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.904 0.383 . . . . 73.319999999999993 109.974 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.5 mtt -111.92 159.97 31.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 124.139 0.975 . . . . 74.209999999999994 109.96 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.91 174.43 9.65 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.044 1.829 . . . . 74.120000000000005 112.678 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p -100.61 149.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 122.935 0.494 . . . . 72.230000000000004 111.512 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.230000000000004 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 74.109999999999999 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.530000000000001 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 72.409999999999997 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.530000000000001 111.077 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 72.230000000000004 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.109999999999999 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.563 HG21 HD23 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.099999999999994 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.439999999999998 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.487 ' HB2' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.229999999999997 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.593 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.420000000000002 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 64.549999999999997 112.289 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' H ' HG21 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 75.109999999999999 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 74.150000000000006 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.420000000000002 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.129999999999995 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HG3' HG21 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 74.0 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.563 HD23 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 72.099999999999994 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 73.219999999999999 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.009999999999998 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.329999999999998 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.349999999999994 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.230000000000004 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.409999999999997 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.310000000000002 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 60.340000000000003 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.219999999999999 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 72.129999999999995 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 75.239999999999995 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.209999999999994 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.040000000000006 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.040000000000006 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 75.299999999999997 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.400000000000006 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 73.340000000000003 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.510000000000005 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.439999999999998 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.200000000000003 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.430000000000007 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.310000000000002 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.040000000000006 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG11 HG11 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 64.319999999999993 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.340000000000003 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 73.219999999999999 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.120000000000005 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 74.040000000000006 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.120000000000005 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.540000000000006 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 63.539999999999999 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 72.450000000000003 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 65.209999999999994 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.329999999999998 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 73.340000000000003 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.319999999999993 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.299999999999997 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 73.099999999999994 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 HG21 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.510000000000005 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.349999999999994 110.543 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.530000000000001 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 73.420000000000002 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.239999999999995 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.140000000000001 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 75.120000000000005 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.329999999999998 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.68 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.099999999999994 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 74.319999999999993 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 73.019999999999996 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 72.030000000000001 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.439999999999998 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.299999999999997 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 71.099999999999994 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.119999999999997 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.349999999999994 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.230000000000004 110.933 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.68 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.219999999999999 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.530000000000001 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.449 HG21 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 73.219999999999999 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.549999999999997 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 17' ' ' ALA . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.219999999999999 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.328 0.122 . . . . 73.030000000000001 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 141.89 97.46 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.032 0.533 . . . . 75.209999999999994 111.789 -175.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.76 141.11 58.29 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.638 2.225 . . . . 75.239999999999995 112.701 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 31' ' ' ARG . 7.0 p -78.92 134.93 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.028 0.531 . . . . 75.5 112.286 -177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.409999999999997 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.120000000000005 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.329999999999998 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 73.239999999999995 112.449 -1.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.140000000000001 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.099999999999994 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.439999999999998 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.049999999999997 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 75.420000000000002 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HB ' HG21 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.540000000000006 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 74.120000000000005 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 73.019999999999996 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 75.430000000000007 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 HG21 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.519999999999996 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 73.340000000000003 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 73.420000000000002 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.299999999999997 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 71.099999999999994 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.040000000000006 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 72.099999999999994 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 64.129999999999995 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.140000000000001 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.319999999999993 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 4' ' ' VAL . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.409999999999997 110.525 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.319999999999993 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.430000000000007 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.520000000000003 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 74.420000000000002 111.464 176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.049999999999997 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.430000000000007 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 74.430000000000007 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 74.340000000000003 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 61.119999999999997 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 72.219999999999999 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.420000000000002 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.515 HG13 HD13 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.430000000000007 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.430000000000007 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 71.209999999999994 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.219999999999999 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.329999999999998 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.409999999999997 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 74.120000000000005 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 71.239999999999995 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 75.099999999999994 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 72.5 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.519999999999996 110.669 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.340000000000003 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 72.409999999999997 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.340000000000003 112.132 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 74.540000000000006 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 75.329999999999998 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 73.200000000000003 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 71.450000000000003 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 72.540000000000006 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.420000000000002 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 73.349999999999994 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 75.040000000000006 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HA ' HG23 ' A' ' 90' ' ' ILE . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 72.239999999999995 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.140000000000001 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.099999999999994 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.219999999999999 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 65.340000000000003 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HG2' HG22 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.099999999999994 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 73.0 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.450000000000003 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.140000000000001 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 72.420000000000002 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.019999999999996 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.540000000000006 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 73.409999999999997 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.510000000000005 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 64.409999999999997 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 74.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 75.239999999999995 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.329999999999998 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.42 HG22 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.549999999999997 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 71.019999999999996 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.472 HG23 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.239999999999995 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.521 ' HB3' ' SD ' ' A' ' 2' ' ' MET . 65.2 m80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.702 0.286 . . . . 72.120000000000005 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 1' ' ' HIS . 1.3 mpt? 56.96 72.82 0.88 Allowed Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 125.599 1.56 . . . . 74.049999999999997 113.925 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' HG2' HH21 ' A' ' 31' ' ' ARG . 66.6 Cg_endo -84.31 172.73 9.25 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.754 2.303 . . . . 73.420000000000002 112.183 167.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -163.13 136.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 74.239999999999995 111.881 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 73.129999999999995 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 75.409999999999997 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 74.510000000000005 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 61.439999999999998 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 74.239999999999995 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 73.109999999999999 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.219999999999999 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 75.230000000000004 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.530000000000001 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.439999999999998 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.420000000000002 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.409999999999997 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 75.200000000000003 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.510000000000005 113.803 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 75.510000000000005 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.446 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 73.329999999999998 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.409999999999997 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 70.450000000000003 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.340000000000003 110.29 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.140000000000001 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.25 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 75.299999999999997 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.209999999999994 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 74.439999999999998 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 HH21 ' HG2' ' A' ' 3' ' ' PRO . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.420000000000002 107.823 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.439999999999998 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.140000000000001 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 73.439999999999998 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 75.109999999999999 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 74.5 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 74.140000000000001 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.140000000000001 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.340000000000003 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 73.030000000000001 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 70.209999999999994 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG12 HD13 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 75.329999999999998 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.549999999999997 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 71.549999999999997 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.462 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.439999999999998 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 62.229999999999997 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 75.319999999999993 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG11 HG11 ' A' ' 45' ' ' VAL . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.229999999999997 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 HG22 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 64.540000000000006 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 74.109999999999999 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.340000000000003 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB3' HH11 ' A' ' 60' ' ' ARG . 13.8 m120 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 73.230000000000004 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.219999999999999 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HG2' ' HD2' ' A' ' 59' ' ' HIS . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 72.140000000000001 112.804 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HD2' ' HG2' ' A' ' 58' ' ' PRO . 18.8 m-70 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.409999999999997 111.564 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.483 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.150000000000006 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.120000000000005 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 HD13 HG12 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 75.530000000000001 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 64.099999999999994 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 72.140000000000001 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.310000000000002 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 71.530000000000001 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.120000000000005 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.439999999999998 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 73.430000000000007 113.553 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 72.319999999999993 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 73.5 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.230000000000004 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.409999999999997 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 74.319999999999993 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 75.340000000000003 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.109999999999999 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.219999999999999 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 70.340000000000003 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.340000000000003 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.049999999999997 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.329999999999998 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.439999999999998 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 70.329999999999998 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 72.239999999999995 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 72.010000000000005 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 72.510000000000005 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.140000000000001 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.099999999999994 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.510000000000005 110.06 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.884 0.373 . . . . 64.31 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.33 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 64.03 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 64.2 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.52 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 40.44 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 64.13 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.31 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 73.04 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 63.23 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 70.11 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 51.13 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.15 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 72.44 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 64.41 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 63.44 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.24 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 64.04 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.13 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 64.42 110.685 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 71.24 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.03 109.746 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.42 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.05 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.2 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 70.23 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.44 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.13 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.14 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 72.22 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 34.23 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.45 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.11 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 75' ' ' PHE . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.41 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.31 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.45 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.45 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.31 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.15 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.33 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 71.34 110.889 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 73.41 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 51.51 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 53.13 109.283 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.31 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 73.12 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.31 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 71.24 111.378 -172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.712 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.31 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 53.31 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.42 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.712 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.13 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.23 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 73.44 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 63.24 107.666 173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.14 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.51 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 65.23 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 73.45 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.24 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.23 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 63.14 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 71.23 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 73.44 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.01 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.53 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.11 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.2 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.4 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.44 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 42.53 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.13 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.21 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.13 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 44.34 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.43 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.51 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 72.52 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 52.02 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.55 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.34 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.12 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.589 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.43 111.656 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.42 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 63.4 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 63.41 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.21 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 70.0 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 65.52 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.02 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 64.23 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 64.33 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.03 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.42 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.21 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.4 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 69' ' ' PRO . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.32 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.22 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.33 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 70.4 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.22 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.44 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 42.45 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 42.44 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.23 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.1 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 61.41 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.43 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.13 110.647 -173.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.42 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.22 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.35 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.15 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 29' ' ' VAL . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 61.13 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.41 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.44 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 65.33 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 55.3 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.02 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.1 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 65.23 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 71.44 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 44.24 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.12 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 61.22 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.51 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 44.45 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.13 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.52 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 64.53 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.21 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 72.21 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 61.02 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.34 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.44 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 64.41 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.33 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG22 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.1 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 70.55 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.23 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 71.2 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.34 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 64.11 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.34 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.15 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 61.34 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 64.34 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.02 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.41 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.24 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 62.23 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.45 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.22 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.11 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.51 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 64.43 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 44.11 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.44 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.22 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.41 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 72.32 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 73.23 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 55.22 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 65.13 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 74.13 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 43.32 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p . . . . . 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.21 110.462 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.22 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 84' ' ' ALA . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.33 109.335 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 71.15 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 60.4 110.312 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.15 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 74.34 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 40.35 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.41 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 71.33 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.4 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 65.43 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.44 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 23.12 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 74.34 109.235 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' THR . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.42 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 18' ' ' ILE . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 54.04 113.339 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.33 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.44 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.21 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 60.35 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.34 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' ' 36' ' ' VAL . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.23 111.189 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 63.43 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.03 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.03 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.43 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 73.44 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.35 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.03 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 73.52 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG11 ' SG ' ' A' ' 27' ' ' CYS . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 63.0 110.823 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.4 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 72.52 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.21 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 71' ' ' ASP . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.33 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.2 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.24 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.24 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 54.03 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 74.44 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.53 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 73.23 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.12 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.32 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 74.33 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 HD21 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 43.43 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 63.33 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.31 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.34 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 60.45 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.23 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 55.42 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.33 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.44 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 71.22 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 71.41 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.15 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 62.34 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.44 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.23 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.31 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' THR . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.44 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.23 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.42 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 32.44 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.3 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.35 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 70.24 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 55.42 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.34 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 43.13 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.21 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.21 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 72.12 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.33 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.43 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.34 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.41 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 63.43 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.33 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 42.5 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.41 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 71.34 110.817 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.23 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 44.15 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 72.4 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.44 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 53.11 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.05 113.631 -4.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 71.25 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.51 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.01 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 72.34 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 73.33 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 61.42 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.42 108.992 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.15 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 43.23 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 72.53 111.578 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.01 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.58 ' HG3' HG22 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 70.41 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 73.3 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 53.1 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.12 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.15 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 64.12 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 63.01 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.32 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 45.2 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 62.34 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 71.01 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.12 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 72.43 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 64.34 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.51 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 70.25 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 61.21 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 41.13 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 71.44 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.43 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.11 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.4 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.53 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.43 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 63.13 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.54 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.13 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 71.45 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 74.13 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.43 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 72.4 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.31 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.13 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 61.22 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.32 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 73.01 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.52 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 64.32 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.35 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.23 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.24 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.54 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 71.53 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.34 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.31 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.53 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.54 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 62.21 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.33 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 73.41 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 70.34 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 53.42 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.2 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 61.45 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.34 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.54 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.53 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 55.32 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 53.34 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 61.22 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.12 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 62.43 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 72.24 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.34 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 71.53 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 73.31 112.88 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 65.13 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.1 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.22 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.24 111.094 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 43.14 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 71.43 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 71.3 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.45 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.21 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.32 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.11 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.44 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.03 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.1 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.51 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.497 ' H ' HG22 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.33 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.1 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.41 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.53 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.488 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 55.32 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.51 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 72.33 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.23 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.13 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.45 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB3' HG23 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.31 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 70.01 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 72.2 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 54.45 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 63.33 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 HG11 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 73.24 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.44 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.04 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 72.02 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 72.33 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 61.1 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 44.23 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.14 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.45 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 71.35 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.22 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.22 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.621 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 54.45 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 53.05 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 73.54 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.621 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.44 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.24 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.04 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.23 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.24 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.11 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.12 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 70.33 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 73.01 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.14 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.42 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.41 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 64.34 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 64.5 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.15 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.02 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.42 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.42 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 71.5 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 65.52 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.32 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.12 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.35 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.34 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 54.43 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.52 110.241 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.41 ' SG ' ' CZ3' ' A' ' 38' ' ' TRP . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 41.45 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.33 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.34 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.42 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 64.3 109.482 169.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 72.05 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.44 109.92 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.44 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 70.03 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.24 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 71.31 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.2 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 62.42 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 72.53 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.531 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.43 112.036 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.43 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.35 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 42.12 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.35 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.35 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.14 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 44.42 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.41 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.23 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.52 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 65.32 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.35 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.45 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 60.11 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.58 HG22 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 45.02 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 70.15 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.42 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.41 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 15' ' ' VAL . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 51.25 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.34 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 73.43 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 71.02 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 64.14 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.14 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.45 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.35 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.11 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.12 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.15 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.34 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.624 HG11 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 72.55 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 61.44 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.33 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 43.42 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.12 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.35 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 61.44 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.3 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.14 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 62.44 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.1 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 53.03 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.01 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 53.23 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG22 HD21 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 64.31 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 51.41 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.01 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.24 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.21 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.02 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 54.23 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.24 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.11 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG3' HG11 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.41 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 65.34 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 25' ' ' LEU . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.2 108.768 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 64.35 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.34 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.35 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 52.25 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' HD12 ' A' ' 64' ' ' LEU . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 62.13 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 64.34 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HD3' HG22 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 61.11 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 63.41 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.52 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 64.55 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 71.25 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.03 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.24 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.41 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 50.52 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.43 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.53 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 50.05 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.23 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.33 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.12 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.54 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.41 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.42 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 62.04 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.21 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 73.32 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.1 110.778 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.35 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 74.34 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.41 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.4 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 61.53 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 72.03 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 72.13 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 54.32 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.41 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.43 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.02 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.53 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.54 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 53.54 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.53 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.43 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 35.11 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 60.33 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 52.21 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 64.12 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.13 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.11 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 60.11 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 64.23 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.4 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.31 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.03 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.1 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.24 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.22 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.41 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 72.0 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.3 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 64.24 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.11 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 72.35 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 45.21 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.41 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 65.1 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.12 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 72.22 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 72.1 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.51 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 44.51 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.22 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.03 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 52.33 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 62.53 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 71.12 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.33 112.04 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.01 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.42 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 52.24 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.43 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.44 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.03 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.14 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 70.43 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.02 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.628 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.34 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.32 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 72.41 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.44 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 62.15 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 12.35 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 51.14 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 65.31 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.52 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 76.3 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.1 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.47 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.2 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 72.25 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 35.52 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 52.5 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.4 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 54.41 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.44 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.03 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.32 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.47 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.54 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.24 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.14 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 51.14 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 62.53 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 61.12 112.142 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.23 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.51 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 30' ' ' ASP . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.32 112.171 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.45 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.43 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 71.34 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.45 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.31 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.32 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.24 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.11 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 63.13 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 62.43 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.1 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 70.22 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.52 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.22 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 55.22 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 52.32 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.414 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 51.43 110.301 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 63.12 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 20.4 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.44 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.1 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 62.4 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB2' HG13 ' A' ' 7' ' ' VAL . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 62.01 110.47 172.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.34 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 63.31 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.11 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 44.25 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 73.02 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.03 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.24 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.54 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 63.5 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.2 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.2 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.22 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.35 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 71.24 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.23 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.43 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 63.41 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 71.33 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.3 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.02 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 71.13 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.44 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 42.21 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.51 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.24 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.04 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 70.42 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.01 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.414 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.24 114.155 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.44 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 73.31 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 74.44 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 61.41 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.21 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.51 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.22 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.45 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.12 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 71.44 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.35 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.24 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.23 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 62.52 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.11 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 73.34 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 53.31 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 54.42 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 55.23 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 51.11 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.11 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 73.43 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 71.4 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 51.14 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 65.31 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 73.14 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 34' ' ' ALA . 9.9 p . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.508 0.671 . . . . 72.22 110.575 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.516 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 64.4 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 73.41 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 63.12 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.13 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 71.01 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 71.04 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.13 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.05 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 64.45 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 61.03 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.51 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.23 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.22 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.22 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 51.33 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.03 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 71.12 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 63.13 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 63.13 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.23 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.22 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.24 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.31 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 65.51 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.54 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.11 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 74.31 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 72.15 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.1 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.14 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.53 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 65.11 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.22 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 55.12 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.11 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 70.35 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 33.04 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 61.52 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 70.41 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 52.03 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 71.22 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.15 113.375 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.34 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.14 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.14 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 HD23 ' A' ' 64' ' ' LEU . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.24 111.06 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.04 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.11 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.33 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.1 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.41 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.34 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.24 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 73.04 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 51.3 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 44.54 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 64.52 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 74.31 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 33.42 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HD2' HD22 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.53 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.33 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.43 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 65.32 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.11 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 65.42 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 53.41 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.23 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 43.21 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.2 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 63.55 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 72.41 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 63.43 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.31 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 63.41 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.35 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 72.11 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.13 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.34 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 63.11 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.13 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.45 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.54 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 72.22 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 71.42 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.984 -0.376 . . . . 54.43 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.787 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.14 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 52.24 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.34 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 61.53 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.43 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 73.31 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 63.12 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.22 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 54.11 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 72.15 110.221 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 62.41 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 62.33 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.31 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.34 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.31 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 64.13 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 52.13 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 62.01 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 70.44 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.4 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.13 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 61.22 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 50.23 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.624 ' HB2' HG13 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.3 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' HB3' HG23 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.42 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 63.35 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 31.21 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 50.03 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 73.54 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.42 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.01 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.41 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 71.43 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 64.03 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.44 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.02 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.54 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.24 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 73.43 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.2 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 65.45 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 61.13 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.1 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 54.13 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG22 HD21 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 72.01 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 61.32 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 70.42 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.1 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 70.34 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.24 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.52 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.15 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.32 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.02 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 64.45 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 61.23 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 61.32 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 72.33 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.455 ' HD2' HD13 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.44 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 61.33 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 72.05 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.11 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 70.35 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 74.01 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 62.22 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.43 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.42 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.23 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 64.21 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.12 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.13 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.33 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 51.12 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.2 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.01 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.787 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.54 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 70.2 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 54.41 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 44.44 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.13 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 52.12 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 61.12 110.715 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 72.31 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 63.4 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 122.259 1.028 . . . . 75.31 109.898 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.13 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' ALA . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 64.53 109.879 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 72.41 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.32 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 72.41 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 74.01 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.02 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.22 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 63.24 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.43 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 62.32 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 73.31 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.41 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 64.23 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.14 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 64.52 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.53 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.575 ' HG3' HG22 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.41 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 53.43 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.31 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.13 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.44 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.32 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.45 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.11 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.14 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 72.42 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.4 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 53.34 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.03 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.14 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.31 109.483 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.23 110.624 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.54 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 61.23 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.13 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 70.14 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.32 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 62.33 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 64.14 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 64.32 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.41 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 63.15 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 71.11 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 64' ' ' LEU . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.12 110.349 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.34 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.43 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.566 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.15 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 63.34 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.32 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 63.12 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 70.41 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 63.23 109.61 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 71.25 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.32 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 54.31 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 24.21 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.11 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.21 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 61.51 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 62.44 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 71.53 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 64.33 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 73.34 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 90' ' ' ILE . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.22 111.552 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 50.32 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 64.41 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 71.14 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.3 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 64.43 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 83' ' ' CYS . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 70.34 111.212 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.31 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 61.24 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.31 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.3 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 78' ' ' VAL . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.32 111.729 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.51 110.844 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 65.24 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.4 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 61.41 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 63.01 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.33 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG12 ' HA3' ' A' ' 72' ' ' GLY . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.11 112.027 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.545 HG13 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p . . . . . 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 71.43 111.207 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 52.44 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 70.51 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 62.15 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 64.01 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 71.42 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.34 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 72.41 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.31 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 63.44 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 71.42 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 70.24 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 71.42 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 22.31 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.32 107.119 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.24 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.2 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.05 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 54.51 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.11 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 63.52 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.647 HD12 HD13 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.54 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 41.3 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 52.21 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.33 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.14 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.21 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.54 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.33 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 60.22 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.52 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.53 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.4 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 71.35 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.531 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.13 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.54 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.12 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.11 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 73.15 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.11 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.11 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 54.11 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.34 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.41 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.589 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 40.14 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.13 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.32 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 33.03 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.25 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 71.22 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 73.23 111.915 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.52 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.12 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.54 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 63.32 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.14 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.23 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 HD12 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 70.54 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.05 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 71.5 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.2 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.32 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 72.12 111.381 -173.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.24 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.54 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.53 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.15 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.35 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.15 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.45 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.44 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.14 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 61.24 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 51.51 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.545 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.42 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 70.22 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 63.23 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.11 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 62.3 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 71.21 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.53 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 61.11 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.53 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.31 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 73.25 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 34' ' ' ALA . 2.6 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.648 0.261 . . . . 72.52 110.804 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.21 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.02 109.675 172.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 70.22 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.1 110.092 -170.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 34.33 112.985 -10.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.13 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 71.21 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 71.41 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 63.23 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.41 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.34 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 72.24 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.14 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.32 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.32 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 63.25 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.13 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 54.45 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.2 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.4 ' HG2' HG22 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.24 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.43 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' CB ' ' HG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 63.53 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 59' ' ' HIS . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.41 110.222 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 52.35 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.13 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.15 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 62.32 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 71.32 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.02 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 72.44 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.43 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.41 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.33 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.24 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.42 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.21 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.05 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.41 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.42 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 52.11 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 62.12 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.44 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.34 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.22 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.44 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.42 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.33 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.24 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.11 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.33 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.21 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.34 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 51.24 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.13 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 71.0 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 71.21 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.54 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.53 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 61.14 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 73.55 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 55.1 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 65.31 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.31 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.41 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.13 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.22 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 41.4 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.54 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.34 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.2 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.35 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 70.44 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 62.22 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 72.01 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.33 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.03 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 73.21 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.43 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 71.41 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.43 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 72.31 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.24 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 62.22 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 34' ' ' ALA . 3.7 p . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 63.21 111.919 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.52 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.23 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.13 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.33 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 27' ' ' CYS . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 63.21 113.842 1.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.23 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 62.51 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.25 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 51.52 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.3 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.32 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 40.11 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 51.44 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 73.34 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 54.22 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.11 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.54 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.51 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.42 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.32 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 51.51 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.01 111.063 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.33 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.02 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.12 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 62.01 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.32 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 61.51 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.2 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 73.24 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.33 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.51 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.04 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 65.22 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA3' ' A' ' 73' ' ' GLY . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 62.41 109.634 171.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.24 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.51 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.11 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.23 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 64.0 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 64.05 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.42 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 71.53 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.21 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.1 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 71.32 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 63.25 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 45.43 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.33 109.838 -172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 70.35 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 65.02 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 62.21 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.3 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.459 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 61.34 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 62.31 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.01 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 52.14 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 63.02 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.33 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.24 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.13 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.22 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.04 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.23 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.1 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.23 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 40' ' ' LYS . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.51 113.724 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.03 112.107 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 71.31 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 71.23 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.24 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 65.24 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.41 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 61.02 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.05 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.52 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.22 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 65.53 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.23 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 64.42 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 64.55 110.208 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 23.24 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.14 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.52 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.23 111.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.34 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 71.1 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 72.52 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.34 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.31 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 65.12 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.44 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.51 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 61.44 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 72.14 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 52.25 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.42 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.23 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.2 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.491 HG22 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 41.22 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 52.04 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.33 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 63.23 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.34 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.454 ' HG3' HG22 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 61.31 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 61.54 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.12 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.43 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.618 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.02 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.54 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 63.52 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.34 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.24 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.24 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.44 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.53 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.43 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 62.41 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.22 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.54 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 73.25 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 34.54 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.34 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.13 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.21 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 35.21 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 44.24 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.32 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.32 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 64' ' ' LEU . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.1 110.372 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.41 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.32 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 72.53 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 71.22 111.829 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.42 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.14 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 1.6 m80 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.44 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 72.34 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.14 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.52 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.52 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.33 108.689 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 53.22 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.45 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.54 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.05 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HD3' HG22 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 63.43 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.53 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 71.22 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 54.23 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 52.04 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.41 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.33 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.0 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.21 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 71.14 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 72.03 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.31 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 54.2 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 64.42 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.33 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 72.12 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 50.04 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.13 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.41 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 64.04 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.35 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.21 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 61.44 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.55 111.759 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.42 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.457 ' HA ' HG12 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.34 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.1 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.34 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.35 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 72.23 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 54.42 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.02 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 54.41 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.21 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.21 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.12 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 65.42 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.34 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 63.24 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.23 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.22 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.44 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 71.54 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.4 110.064 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 72.32 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 73.32 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 72.04 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.35 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.54 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 62.23 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.33 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.05 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.32 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.53 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' HG3' ' A' ' 60' ' ' ARG . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.44 111.135 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.22 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 72.32 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.13 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 71.13 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.22 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 51.25 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.51 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 72.21 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 54.15 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.41 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.33 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.4 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.41 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.03 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.51 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.44 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.45 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.42 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.12 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 60.02 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.51 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.52 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.33 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HG3' HG11 ' A' ' 36' ' ' VAL . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.13 108.805 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.33 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.22 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 72.21 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 53.44 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.45 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.1 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 54.11 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 71.11 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 71.34 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.14 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.43 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 33.14 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 54.24 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.51 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.44 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.2 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 33.11 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.53 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.31 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 71.54 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.03 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 55.44 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.33 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.41 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.12 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 62.12 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.42 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.34 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 73.14 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.65 HG12 ' HB3' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.33 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 61.04 111.566 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.701 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 71.11 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.55 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.24 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.14 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.35 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.43 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.1 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.24 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.23 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.04 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.54 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.33 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.12 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 62.44 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.03 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.53 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.44 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 72.31 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 74.45 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 73.33 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 61.33 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.548 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.31 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.11 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 63.31 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.2 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.41 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.32 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.21 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 24.23 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.41 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 52.15 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.44 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.551 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 73.32 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.22 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 71.35 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 73.33 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.4 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 70.33 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.21 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 65.13 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.32 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.14 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.507 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.05 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.42 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 63.14 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 55.34 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 65.31 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.11 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.567 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 72.44 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.45 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.43 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.43 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.45 114.028 -175.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.4 113.409 175.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 71.24 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.729 ' HG3' HG22 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 64.24 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.31 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 62.14 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 71.15 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 74.32 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 53.24 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 62.21 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.535 ' HA ' HD12 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 64.02 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 53.44 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 70.15 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.31 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.22 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 53.22 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.13 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 64.03 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.42 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.12 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.12 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.24 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.21 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.701 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.4 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.23 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.44 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.21 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 54.22 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 52.41 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 61.01 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 63.12 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.692 0.282 . . . . 72.23 111.512 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.23 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 73.33 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.23 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 62.24 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.53 111.077 -171.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 65.5 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.11 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.576 HG21 HD21 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.1 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.44 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.23 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.42 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 68' ' ' GLN . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 61.1 112.289 173.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 74.12 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 64.11 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.42 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.13 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.501 ' HG3' HG22 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 73.41 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 54.41 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 64.12 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.01 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.33 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.03 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.23 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.32 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.13 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 44.44 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.22 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 64.53 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 44.33 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.05 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.04 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.04 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 70.44 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.4 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 72.25 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.51 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.44 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.2 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.41 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.21 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.43 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.31 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.04 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 54.33 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.34 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 72.32 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.12 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 70.05 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.12 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.54 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 61.3 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 70.01 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 63.13 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.33 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 62.0 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.32 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.3 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 65.14 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.42 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.403 ' HA ' HG22 ' A' ' 19' ' ' THR . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.35 110.543 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.53 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 64.34 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.24 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.14 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 63.14 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.33 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.1 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 72.32 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 63.55 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 64.51 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.44 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.43 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.3 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 64.01 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.12 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.35 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.23 110.933 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.11 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.53 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 70.31 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.55 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 67' ' ' THR . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.22 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.286 0.476 . . . . 75.5 112.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.13 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.12 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.33 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 60.32 112.449 -1.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.14 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.1 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.44 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.05 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 74.13 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.54 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 63.22 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 70.14 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.52 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.534 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 53.12 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 63.12 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.3 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 35.42 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.44 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.04 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 53.44 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 63.34 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.14 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.32 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.41 110.525 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.32 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.43 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.52 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 70.33 111.464 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.554 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.05 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.43 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.33 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 72.31 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 71.51 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 52.33 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 61.2 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.42 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.11 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.43 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.43 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 64.45 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.21 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.33 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.41 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 72.23 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 65.22 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 63.2 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 63.41 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.52 110.669 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.34 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 71.54 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.34 112.132 -176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 72.24 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 74.22 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 71.54 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 34.3 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 54.1 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.42 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 53.3 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 73.3 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' ' 19' ' ' THR . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 64.33 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.14 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.1 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.22 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 62.0 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.1 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 72.25 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.45 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.14 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 62.52 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.02 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.54 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 71.33 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.51 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 63.11 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 73.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 73.25 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.33 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.44 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 63.22 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.24 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 64.24 111.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 72.02 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 70.13 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 71.32 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 52.45 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 73.24 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 52.31 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.22 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 74.42 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.53 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.44 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.42 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.41 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 72.55 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.402 HG22 ' HG3' ' A' ' 69' ' ' PRO . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.51 113.803 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 63.12 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 70.42 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.41 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 64.34 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.34 110.29 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.11 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.2 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 44.15 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.21 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 70.11 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.23 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.42 107.823 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.13 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.14 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 65.44 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 70.33 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 63.14 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 64.14 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.14 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.34 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 71.24 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 64.13 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.32 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 73.15 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.55 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 63.15 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.44 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 54.41 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 73.31 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 48' ' ' SER . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.23 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 32.11 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 73.21 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.34 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.506 ' HB3' HH11 ' A' ' 60' ' ' ARG . 87.1 m-20 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 71.21 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.22 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 71.43 112.804 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.34 111.564 -176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.506 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.15 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.12 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 63.31 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 62.42 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 70.44 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.31 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 64.43 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.12 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.44 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG3' HG22 ' A' ' 19' ' ' THR . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 64.23 113.553 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 51.43 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 61.13 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.23 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.41 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 63.2 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 35.8 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 71.41 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.11 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.22 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 61.24 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.34 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.05 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.33 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.44 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 52.35 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 60.11 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 71.5 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 71.12 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.14 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.1 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.51 110.06 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 74.21 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.7 mtt -80.86 138.96 49.93 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 123.1 0.56 . . . . 70.41 109.764 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.42 -86.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.485 2.79 . . . . 64.5 114.331 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -176.96 139.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 118.52 0.6 . . . . 64.31 111.93 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.33 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 64.03 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 64.2 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.52 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 40.44 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 64.13 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.31 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.35 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 73.04 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 63.23 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 70.11 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 51.13 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.15 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 72.44 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 64.41 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 63.44 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.24 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 64.04 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.13 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 64.42 110.685 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 71.24 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.03 109.746 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.42 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.05 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.2 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 70.23 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.44 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.13 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.14 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 72.22 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 34.23 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.45 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.11 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 75' ' ' PHE . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.3 108.273 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.41 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.31 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.45 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.45 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.31 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.15 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.33 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 71.34 110.889 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 73.41 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 51.51 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 53.13 109.283 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.31 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 73.12 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.31 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 71.24 111.378 -172.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.712 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.31 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 53.31 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.42 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.712 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.13 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.23 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 73.44 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 63.24 107.666 173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.14 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.51 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 65.23 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 73.45 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.24 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.23 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 63.14 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 71.23 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 73.44 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.01 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.53 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.11 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.2 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.4 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.44 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 42.53 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.13 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.21 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.13 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 44.34 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.43 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.51 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 72.52 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 52.02 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.55 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.34 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.12 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.8 t60 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.541 0.21 . . . . 74.32 110.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.4 mtt -112.49 94.82 29.17 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.894 0.878 . . . . 63.32 109.641 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.07 -165.51 0.34 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.965 2.443 . . . . 72.23 112.985 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.589 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p -120.34 90.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.43 111.656 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.42 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 63.4 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 63.41 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.21 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 70.0 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 65.52 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.02 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 64.23 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 64.33 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.03 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.42 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.21 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.4 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 69' ' ' PRO . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.32 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.22 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.33 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 70.4 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.22 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.44 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 42.45 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 42.44 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.23 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.1 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 61.41 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.43 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.13 110.647 -173.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.42 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.22 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.35 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.15 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 29' ' ' VAL . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 61.13 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.41 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.44 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 65.33 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 55.3 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.02 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.1 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 65.23 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 71.44 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 44.24 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.12 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 61.22 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.51 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 44.45 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.13 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.52 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 64.53 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.21 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 72.21 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 61.02 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.34 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.44 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 64.41 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.33 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG22 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.1 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 70.55 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.23 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 71.2 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.34 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 64.11 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.34 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.15 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 61.34 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 64.34 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.02 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.41 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.24 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 62.23 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.45 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.22 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.11 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.51 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 64.43 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 44.11 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.44 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.22 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.41 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 72.32 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 73.23 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 55.22 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 65.13 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 74.13 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 43.32 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 119.7 -0.191 . . . . 65.12 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt 60.98 94.13 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 124.967 1.307 . . . . 74.11 111.396 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.76 160.02 47.17 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.386 2.058 . . . . 64.35 113.001 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p -127.85 72.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.21 110.462 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.22 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 84' ' ' ALA . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.33 109.335 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 71.15 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 60.4 110.312 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.15 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 74.34 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 40.35 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.41 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 71.33 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.4 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 65.43 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.44 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 23.12 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 74.34 109.235 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' THR . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.42 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 18' ' ' ILE . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 54.04 113.339 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.33 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.44 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.21 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 60.35 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.34 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' ' 36' ' ' VAL . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.23 111.189 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 63.43 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.03 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.03 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.43 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 73.44 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.35 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.03 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 73.52 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG11 ' SG ' ' A' ' 27' ' ' CYS . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 63.0 110.823 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.4 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 72.52 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.21 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 71' ' ' ASP . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.33 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.2 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.24 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.24 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 54.03 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 74.44 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.53 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 73.23 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.12 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.32 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 74.33 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 HD21 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 43.43 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 63.33 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.31 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.34 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 60.45 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.23 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 55.42 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.33 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.44 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 71.22 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 71.41 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.15 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 62.34 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.44 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.23 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.31 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' THR . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.44 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.23 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.42 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 32.44 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.3 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.35 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 70.24 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 55.42 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.34 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 43.13 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.21 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.21 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 72.12 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.33 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.43 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.34 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.41 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 63.43 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.33 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 42.5 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.41 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 71.34 110.817 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 111.816 0.302 . . . . 75.11 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptp 40.43 64.52 4.65 Favored Pre-proline 0 N--CA 1.509 2.491 0 C-N-CA 125.669 1.588 . . . . 63.51 114.689 -176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.64 76.82 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.917 2.411 . . . . 62.01 111.892 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.76 120.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.23 112.543 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 44.15 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 72.4 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.44 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 53.11 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.05 113.631 -4.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HA ' ' NE ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 71.25 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.51 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.01 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 72.34 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 73.33 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 61.42 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.42 108.992 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.15 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 43.23 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 72.53 111.578 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.01 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.58 ' HG3' HG22 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 70.41 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 73.3 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 53.1 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.12 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.15 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 64.12 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 63.01 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.32 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 45.2 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 62.34 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 71.01 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.12 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 72.43 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 64.34 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.51 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 70.25 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 61.21 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 41.13 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 71.44 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.43 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.11 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.4 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.53 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.43 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 63.13 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.54 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.13 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 71.45 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 74.13 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.43 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 72.4 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.31 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.13 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 61.22 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.32 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 73.01 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.52 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 64.32 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.35 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.23 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.24 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.54 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 71.53 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.34 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.31 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.53 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.54 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 62.21 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.33 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 73.41 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 70.34 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 53.42 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.2 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 61.45 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.34 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.54 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.53 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 55.32 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 53.34 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 61.22 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.12 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 62.43 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 72.24 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.34 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 71.53 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.459 0.171 . . . . 64.4 110.741 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -120.99 83.79 38.23 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 123.393 0.677 . . . . 72.14 110.765 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 58.5 Cg_endo -92.97 172.55 2.05 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.525 2.817 . . . . 74.41 113.762 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p -76.08 127.98 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 73.31 112.88 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 65.13 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.1 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.22 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.24 111.094 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 43.14 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 71.43 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 71.3 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.45 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.21 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.32 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.11 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.44 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.03 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.1 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.51 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.497 ' H ' HG22 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.33 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.1 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.41 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.53 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.488 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 55.32 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.51 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 72.33 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.23 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.13 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.45 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB3' HG23 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.31 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 70.01 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 72.2 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 54.45 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 63.33 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 HG11 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 73.24 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.44 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.04 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 72.02 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 72.33 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 61.1 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 44.23 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.14 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.45 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 71.35 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.22 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.22 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.621 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 54.45 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 53.05 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 73.54 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.621 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.44 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.24 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.04 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.23 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.24 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.11 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.12 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 70.33 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 73.01 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.14 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.42 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.41 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 64.34 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 64.5 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.15 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.02 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.42 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.42 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 71.5 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 65.52 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.32 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.12 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.35 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.34 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 54.43 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.52 110.241 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.41 ' SG ' ' CZ3' ' A' ' 38' ' ' TRP . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 41.45 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.33 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.34 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.42 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 64.3 109.482 169.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 72.05 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.44 109.92 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.44 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 70.03 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.24 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 71.31 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.2 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 62.42 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 72.53 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.563 -0.162 . . . . 75.35 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -167.47 121.65 0.8 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 123.376 0.67 . . . . 71.32 110.727 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.92 99.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.971 2.448 . . . . 75.32 112.99 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p -72.0 96.54 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.43 112.036 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.43 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.35 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 42.12 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.35 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.35 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.14 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 44.42 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.41 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.23 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.52 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 65.32 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.35 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.45 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 60.11 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.58 HG22 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 45.02 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 70.15 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.42 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.41 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 15' ' ' VAL . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 51.25 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.34 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 73.43 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 71.02 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 64.14 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.14 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.45 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.35 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.11 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.12 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.15 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.34 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.624 HG11 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 72.55 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 61.44 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.33 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 43.42 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.12 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.35 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 61.44 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.3 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.14 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 62.44 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.1 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 53.03 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.01 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 53.23 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG22 HD21 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 64.31 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 51.41 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.01 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.24 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.21 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.02 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 54.23 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.24 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.11 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG3' HG11 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.41 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 65.34 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 25' ' ' LEU . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.2 108.768 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 64.35 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.34 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.35 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 52.25 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' HD12 ' A' ' 64' ' ' LEU . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 62.13 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 64.34 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HD3' HG22 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 61.11 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 63.41 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.52 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 64.55 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 71.25 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.03 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.24 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.41 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 50.52 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.43 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.53 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 50.05 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.23 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.33 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.12 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.54 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.41 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.42 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 62.04 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.21 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 73.32 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.917 0.389 . . . . 74.31 111.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.5 ttt -142.07 121.07 7.81 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.133 0.973 . . . . 74.43 109.388 172.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.37 108.01 2.41 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.114 1.876 . . . . 74.2 112.864 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.07 117.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.1 110.778 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.35 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 74.34 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.41 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.4 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 61.53 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 72.03 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 72.13 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 54.32 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.41 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.43 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.02 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.53 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.54 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 53.54 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.53 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.43 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 35.11 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 60.33 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 52.21 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 64.12 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.13 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.11 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 60.11 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 64.23 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.4 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.31 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.03 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.1 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.24 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.22 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.41 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 72.0 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.3 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 64.24 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.11 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 72.35 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 45.21 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.41 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 65.1 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.12 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 72.22 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 72.1 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.51 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 44.51 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.22 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.03 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 52.33 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 62.53 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 71.12 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.33 112.04 -172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.01 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.42 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 52.24 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.43 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.44 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.03 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.14 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 54.21 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 70.43 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.02 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.628 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.34 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.32 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 72.41 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.44 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 62.15 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 12.35 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 51.14 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 65.31 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.52 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 76.3 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.1 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.47 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.2 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 72.25 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 35.52 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 52.5 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.4 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 54.41 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.44 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.03 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.32 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.47 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.54 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.24 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.14 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 51.14 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 62.53 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.459 0.171 . . . . 63.31 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -145.59 150.71 44.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.308 0.643 . . . . 61.33 110.4 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.52 137.97 57.5 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.162 2.575 . . . . 63.41 114.301 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.56 111.81 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 61.12 112.142 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.23 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.51 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 30' ' ' ASP . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.32 112.171 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.45 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.43 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 71.34 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.45 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.31 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.32 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.24 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.11 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 63.13 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 62.43 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.1 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 70.22 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.52 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.22 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 55.22 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 52.32 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.414 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 51.43 110.301 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 63.12 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 20.4 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.44 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.1 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 62.4 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB2' HG13 ' A' ' 7' ' ' VAL . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 62.01 110.47 172.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.34 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 63.31 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.11 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 44.25 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 73.02 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.03 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.24 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.54 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 63.5 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.2 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.2 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.22 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.35 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 71.24 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.23 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.43 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 63.41 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 71.33 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.3 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.02 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 71.13 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.44 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 42.21 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.51 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.24 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.04 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 70.42 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.01 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.414 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.24 114.155 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.44 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 73.31 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 74.44 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 61.41 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.21 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.51 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.22 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.45 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.12 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 71.44 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.35 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.24 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.23 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 62.52 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.11 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 73.34 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 53.31 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 54.42 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 55.23 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 51.11 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.11 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 73.43 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 71.4 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 51.14 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 65.31 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 73.14 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.48 -0.193 . . . . 72.24 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.8 mtt -78.88 147.9 71.29 Favored Pre-proline 0 CA--C 1.57 1.731 0 C-N-CA 123.749 0.82 . . . . 72.14 111.654 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.8 143.6 29.27 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.937 3.092 . . . . 73.51 116.317 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 34' ' ' ALA . 9.9 p -93.74 148.38 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.94 0.896 . . . . 72.22 110.575 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.516 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 64.4 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 73.41 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 63.12 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.13 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 71.01 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 71.04 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.13 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.05 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 64.45 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 61.03 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.51 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.23 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.22 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.22 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 51.33 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.03 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 71.12 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 63.13 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 63.13 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.23 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.22 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.24 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.31 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 65.51 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.54 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.11 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 74.31 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 72.15 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.1 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.14 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.53 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 65.11 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.22 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 55.12 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.11 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 70.35 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 33.04 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 61.52 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 70.41 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 52.03 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 71.22 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.15 113.375 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.34 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.14 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.14 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 HD23 ' A' ' 64' ' ' LEU . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.24 111.06 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.04 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.11 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.33 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.1 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.41 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.34 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.24 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 73.04 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 51.3 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 44.54 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 64.52 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 74.31 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 33.42 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HD2' HD22 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.53 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.33 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.43 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 65.32 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.11 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 65.42 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 53.41 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.23 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 43.21 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.2 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 63.55 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 72.41 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 63.43 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.31 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 63.41 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.35 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 72.11 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.13 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.34 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 63.11 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.13 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.45 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.54 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 72.22 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 71.42 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.264 0.554 . . . . 73.53 109.932 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.65 123.6 20.36 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 123.222 0.609 . . . . 75.41 110.678 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -95.69 -166.28 0.11 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 123.439 2.759 . . . . 73.33 112.183 167.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p -107.98 153.75 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.493 0.717 . . . . 54.43 109.984 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.787 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.14 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 52.24 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.34 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 61.53 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.43 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 73.31 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 63.12 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.22 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 54.11 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 72.15 110.221 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 62.41 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 62.33 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.31 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.34 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.31 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 64.13 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 52.13 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 62.01 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 70.44 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.4 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.13 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 61.22 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 50.23 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.624 ' HB2' HG13 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.3 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' HB3' HG23 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.42 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 63.35 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 31.21 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 50.03 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 73.54 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.42 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.01 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.41 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 71.43 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 64.03 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.44 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.02 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.54 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.24 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 73.43 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.2 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 65.45 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 61.13 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.1 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 54.13 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG22 HD21 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 72.01 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 61.32 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 70.42 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.1 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 70.34 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.24 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.52 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.15 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.32 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.02 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 64.45 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 61.23 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 61.32 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 72.33 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' HD2' HD13 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.44 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 61.33 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 72.05 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.11 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 70.35 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 74.01 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 62.22 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.43 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.42 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.23 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 64.21 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.12 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.13 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.33 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 51.12 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.2 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.01 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.787 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.54 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 70.2 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 54.41 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 44.44 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.13 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 52.12 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 61.12 110.715 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 72.31 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 63.4 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 110.031 -0.359 . . . . 72.42 110.031 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.5 mpt? -80.49 126.28 78.93 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.556 0.742 . . . . 75.44 111.222 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -62.08 -24.44 76.55 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.561 2.174 . . . . 72.35 111.897 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p -116.77 87.14 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.328 1.051 . . . . 75.31 109.898 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.13 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' ALA . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 64.53 109.879 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 72.41 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.32 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 72.41 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 74.01 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.02 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.22 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 63.24 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.43 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 62.32 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 73.31 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.41 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.42 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 64.23 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.14 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 64.52 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.53 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.575 ' HG3' HG22 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.41 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 53.43 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.31 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.13 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.44 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.32 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.45 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.11 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.14 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 72.42 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.4 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 53.34 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.03 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.14 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.31 109.483 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.23 110.624 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.54 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 61.23 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.13 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 70.14 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.32 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 62.33 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 64.14 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 64.32 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.41 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 63.15 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 71.11 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 64' ' ' LEU . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.12 110.349 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.34 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.43 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.566 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.15 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 63.34 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.32 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 63.12 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 70.41 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 63.23 109.61 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 71.25 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.32 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 54.31 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 24.21 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.11 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.21 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 61.51 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 62.44 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 71.53 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 64.33 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 73.34 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 90' ' ' ILE . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.22 111.552 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 50.32 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 64.41 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 71.14 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.3 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 64.43 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 83' ' ' CYS . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 70.34 111.212 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.31 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 61.24 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.31 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.3 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 78' ' ' VAL . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.32 111.729 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.51 110.844 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 65.24 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.4 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 61.41 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 63.01 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.33 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG12 ' HA3' ' A' ' 72' ' ' GLY . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.11 112.027 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.5 m80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 75.04 111.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.7 mpp? -73.65 122.74 88.34 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.861 0.864 . . . . 72.12 110.88 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 2' ' ' MET . 2.5 Cg_endo -82.66 21.13 1.03 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.959 2.439 . . . . 74.44 113.38 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.545 HG13 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p -73.52 92.15 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 71.43 111.207 178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 52.44 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 70.51 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 62.15 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 64.01 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 71.42 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.34 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 72.41 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.31 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 63.44 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 71.42 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 70.24 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 71.42 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 22.31 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.32 107.119 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.24 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.2 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.05 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 54.51 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.11 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 63.52 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.647 HD12 HD13 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.54 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 41.3 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 52.21 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.33 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.14 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.21 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.54 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.33 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 60.22 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.52 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.53 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.4 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 71.35 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.531 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.13 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.54 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.12 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.11 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 73.15 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.11 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.11 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 54.11 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.34 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.41 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.589 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 40.14 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.13 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.32 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 33.03 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.25 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 71.22 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 73.23 111.915 -173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.52 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.12 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.54 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 63.32 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.14 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.23 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 HD12 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 70.54 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.05 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 71.5 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.2 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.32 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 72.12 111.381 -173.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.24 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.54 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.53 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.15 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.35 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.15 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.45 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.44 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.14 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 61.24 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 51.51 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.42 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 70.22 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 63.23 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.11 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 62.3 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 71.21 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.53 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 61.11 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.53 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.31 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 73.25 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.701 -0.481 . . . . 62.42 109.701 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -150.08 152.89 34.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.53 0.732 . . . . 74.03 111.251 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.52 -178.23 4.3 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.88 2.387 . . . . 61.11 113.892 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 34' ' ' ALA . 2.6 p -120.27 138.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.007 0.923 . . . . 72.52 110.804 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.21 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.02 109.675 172.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 70.22 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.1 110.092 -170.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 34.33 112.985 -10.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.13 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 71.21 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 71.41 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 63.23 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.41 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.34 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 72.24 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.14 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.32 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.32 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 63.25 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.13 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 54.45 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.2 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.4 ' HG2' HG22 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.24 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.43 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' CB ' ' HG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 63.53 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 59' ' ' HIS . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.41 110.222 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 52.35 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.13 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.15 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 62.32 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 71.32 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.02 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 72.44 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.43 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.41 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.33 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.24 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.42 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.21 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.05 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.41 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.42 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 52.11 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 62.12 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.44 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.34 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.22 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.44 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.42 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.33 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.24 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.11 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.33 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.21 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.34 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 51.24 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.13 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 71.0 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 71.21 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.54 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.53 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 61.14 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 73.55 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 55.1 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 65.31 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.31 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.41 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.13 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.22 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 41.4 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.54 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.34 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.2 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.35 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 70.44 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 62.22 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 72.01 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.33 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.03 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 73.21 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.43 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 71.41 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.43 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 72.31 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.24 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 62.22 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.235 -0.283 . . . . 62.03 110.235 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -81.01 151.18 70.03 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 122.708 0.403 . . . . 74.43 110.642 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.08 128.78 31.2 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.227 1.951 . . . . 63.45 110.303 165.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 34' ' ' ALA . 3.7 p -65.71 104.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 63.21 111.919 -173.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.52 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.23 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.13 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.33 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 27' ' ' CYS . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 63.21 113.842 1.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.23 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 62.51 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.25 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 51.52 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.3 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.32 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 40.11 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 51.44 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 73.34 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 54.22 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.11 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.54 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.51 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.42 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.32 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 51.51 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.01 111.063 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.33 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.02 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.12 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 62.01 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.32 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 61.51 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.2 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 73.24 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.33 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.51 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.04 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 65.22 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA3' ' A' ' 73' ' ' GLY . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 62.41 109.634 171.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.24 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.51 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.11 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.23 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 64.0 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 64.05 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.42 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 71.53 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.21 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.1 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 71.32 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 63.25 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 45.43 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.33 109.838 -172.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 70.35 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 65.02 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 62.21 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.3 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 61.34 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 62.31 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.01 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 52.14 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 63.02 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.33 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.24 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.13 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.22 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.04 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.23 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.1 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.23 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 40' ' ' LYS . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.51 113.724 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.03 112.107 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 71.31 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 71.23 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.24 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 65.24 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.41 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 61.02 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.05 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.52 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.22 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 65.53 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.23 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 64.42 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 64.55 110.208 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 23.24 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.14 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.52 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.813 -0.44 . . . . 71.33 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -112.6 127.36 26.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 123.087 0.555 . . . . 62.14 111.828 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -91.37 90.82 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 122.706 2.271 . . . . 72.11 112.151 170.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.82 100.51 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.23 111.42 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.34 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 71.1 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 72.52 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.34 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.31 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 65.12 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.44 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.51 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 61.44 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 72.14 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 52.25 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.42 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.23 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.2 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.491 HG22 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 41.22 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 52.04 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.33 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 63.23 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.34 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.454 ' HG3' HG22 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 61.31 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 61.54 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.12 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.43 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.618 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.02 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.54 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 63.52 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.34 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.24 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.24 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.44 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.53 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.43 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 62.41 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.22 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.54 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 73.25 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 34.54 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.34 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.13 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.21 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 35.21 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 44.24 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.32 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.32 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 64' ' ' LEU . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.1 110.372 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.41 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.32 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 72.53 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 71.22 111.829 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.42 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.14 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 1.6 m80 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.44 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 72.34 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.14 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.52 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.52 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.33 108.689 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 53.22 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.45 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.54 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.05 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HD3' HG22 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 63.43 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.53 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 71.22 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 54.23 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 52.04 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.41 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.33 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.0 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.21 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 71.14 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 72.03 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.31 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 54.2 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 64.42 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.33 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 72.12 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 50.04 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.13 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.41 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 64.04 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.35 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.21 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 61.44 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.317 0.579 . . . . 61.32 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -91.5 139.36 25.14 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.635 0.774 . . . . 23.2 110.52 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.79 -160.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.908 2.405 . . . . 74.32 113.013 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p -126.81 97.95 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.55 111.759 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.42 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' HA ' HG12 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.34 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.1 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.34 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.35 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 72.23 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 54.42 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.02 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 54.41 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.21 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.21 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.12 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 65.42 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.34 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 63.24 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.23 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.22 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.44 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 71.54 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.4 110.064 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 72.32 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 73.32 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 72.04 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.35 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.54 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 62.23 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.33 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.05 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.32 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.53 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' HG3' ' A' ' 60' ' ' ARG . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.44 111.135 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.22 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 72.32 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.13 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 71.13 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.22 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 51.25 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.51 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 72.21 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 54.15 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.41 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.33 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.4 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.41 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.03 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.51 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.44 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.45 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.42 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.12 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 60.02 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.51 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.52 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.33 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HG3' HG11 ' A' ' 36' ' ' VAL . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.13 108.805 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.33 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.22 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 72.21 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 53.44 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.45 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.1 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 54.11 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 71.11 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 71.34 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.14 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.43 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 33.14 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 54.24 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.51 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.44 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.2 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 33.11 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.53 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.31 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 71.54 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.03 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 55.44 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.33 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.41 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.12 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 62.12 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.42 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.34 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 73.14 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.65 HG12 ' HB3' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.33 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.499 -0.556 . . . . 64.12 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.8 mtp -97.23 158.52 33.11 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.667 0.787 . . . . 75.11 112.096 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.55 147.43 38.74 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.22 2.613 . . . . 62.11 114.067 169.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p -97.8 120.13 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 61.04 111.566 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.701 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 71.11 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.55 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.24 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.14 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.35 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.43 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.1 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.24 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.23 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.04 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.54 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.33 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.12 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 62.44 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.03 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.53 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.44 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 72.31 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 74.45 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 73.33 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 61.33 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.548 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.31 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.11 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 63.31 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.2 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.41 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.32 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.21 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 24.23 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.41 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 52.15 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.44 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.551 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 73.32 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.22 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 71.35 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 73.33 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.4 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 70.33 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.21 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 65.13 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.32 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.14 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.507 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.05 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.42 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 63.14 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 55.34 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 65.31 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.11 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.567 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 72.44 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.45 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.43 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.43 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.45 114.028 -175.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.4 113.409 175.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 71.24 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.729 ' HG3' HG22 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 64.24 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.31 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 62.14 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 71.15 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 74.32 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 53.24 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 62.21 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.535 ' HA ' HD12 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 64.02 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 53.44 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 70.15 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.31 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.22 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 53.22 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.13 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 64.03 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.42 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.12 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.12 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.24 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.21 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.701 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.4 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.23 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.44 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.21 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 54.22 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 52.41 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 61.01 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 63.12 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.904 0.383 . . . . 73.32 109.974 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.5 mtt -111.92 159.97 31.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 124.139 0.975 . . . . 70.03 109.96 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.91 174.43 9.65 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.044 1.829 . . . . 73.21 112.678 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p -100.61 149.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 122.935 0.494 . . . . 72.23 111.512 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.23 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 73.33 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.23 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 62.24 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.53 111.077 -171.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 65.5 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.11 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.576 HG21 HD21 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.1 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.44 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.23 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.42 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 68' ' ' GLN . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 61.1 112.289 173.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 74.12 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 64.11 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.42 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.13 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.501 ' HG3' HG22 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 73.41 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 54.41 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 64.12 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.01 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.33 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.03 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.23 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.32 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.13 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 44.44 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.22 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 64.53 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 44.33 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.05 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.04 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.04 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 70.44 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.4 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 72.25 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.51 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.44 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.2 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.41 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.21 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.43 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.31 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.04 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 54.33 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.34 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 72.32 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.12 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 70.05 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.12 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.54 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 61.3 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 70.01 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 63.13 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.33 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 62.0 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.32 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.3 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 65.14 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.42 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.403 ' HA ' HG22 ' A' ' 19' ' ' THR . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.35 110.543 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.53 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 64.34 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.24 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.14 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 63.14 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.33 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.1 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 72.32 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 63.55 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 64.51 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.44 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.43 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.3 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 64.01 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.12 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.35 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.23 110.933 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.11 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.53 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 70.31 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.55 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 67' ' ' THR . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.22 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.328 0.122 . . . . 73.03 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 141.89 97.46 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.032 0.533 . . . . 71.04 111.789 -175.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.76 141.11 58.29 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.638 2.225 . . . . 74.1 112.701 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p -78.92 134.93 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.028 0.531 . . . . 75.5 112.286 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.13 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.12 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.33 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 60.32 112.449 -1.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.14 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.1 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.44 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.05 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 74.13 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.54 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 64.44 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 63.22 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 70.14 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.52 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.534 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 53.12 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 63.12 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.3 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 35.42 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.44 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.04 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 53.44 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 63.34 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.14 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.32 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.41 110.525 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.32 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.43 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.52 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 70.33 111.464 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.05 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.43 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.33 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 72.31 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 71.51 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 52.33 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 61.2 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.42 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.11 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.43 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.43 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 64.45 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.21 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.33 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.41 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 72.23 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 65.22 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 63.2 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 63.41 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.52 110.669 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.34 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 71.54 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.34 112.132 -176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 72.24 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 74.22 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 71.54 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 34.3 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 54.1 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.42 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 53.3 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 73.3 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' ' 19' ' ' THR . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 64.33 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.14 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.1 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.22 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 62.0 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.1 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 72.25 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.45 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.14 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 62.52 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.02 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.54 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 71.33 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.51 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 63.11 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 73.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 73.25 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.33 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.44 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 63.22 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.24 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.529 ' HB3' ' SD ' ' A' ' 2' ' ' MET . 65.2 m80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.702 0.286 . . . . 72.12 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 1' ' ' HIS . 1.3 mpt? 56.96 72.82 0.88 Allowed Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 125.599 1.56 . . . . 64.45 113.925 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HG2' HH21 ' A' ' 31' ' ' ARG . 66.6 Cg_endo -84.31 172.73 9.25 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.754 2.303 . . . . 73.42 112.183 167.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -163.13 136.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 64.24 111.881 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 72.02 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 70.13 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 71.32 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 52.45 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 73.24 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 52.31 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.22 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 74.42 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.53 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.44 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.42 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.41 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 72.55 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.402 HG22 ' HG3' ' A' ' 69' ' ' PRO . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.51 113.803 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 63.12 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 70.42 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.41 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 64.34 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.34 110.29 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.11 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.2 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 44.15 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.21 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 70.11 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.23 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.502 HH21 ' HG2' ' A' ' 3' ' ' PRO . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.42 107.823 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.13 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.14 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 65.44 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 70.33 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 63.14 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 64.14 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.14 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.34 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 71.24 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 64.13 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.32 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 73.15 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.55 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 63.15 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.44 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 54.41 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 73.31 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 48' ' ' SER . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.23 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 32.11 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 73.21 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.34 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.506 ' HB3' HH11 ' A' ' 60' ' ' ARG . 87.1 m-20 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 71.21 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.22 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 71.43 112.804 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.34 111.564 -176.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.506 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.15 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.12 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 63.31 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 62.42 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 70.44 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.31 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 64.43 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.12 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.44 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG3' HG22 ' A' ' 19' ' ' THR . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 64.23 113.553 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 51.43 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 61.13 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.23 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.41 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 63.2 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 35.8 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 71.41 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.11 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.22 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 61.24 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.34 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.05 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.33 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.44 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 52.35 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 60.11 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 71.5 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 71.12 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.14 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.1 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.51 110.06 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.499 1.978 0 CA-C-O 120.884 0.373 . . . . 64.310000000000002 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.329999999999998 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 64.030000000000001 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 64.200000000000003 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.519999999999996 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 40.439999999999998 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 64.129999999999995 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.349999999999994 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 73.040000000000006 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 63.229999999999997 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 70.109999999999999 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 51.130000000000003 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.150000000000006 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 72.439999999999998 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 64.409999999999997 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 63.439999999999998 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.239999999999995 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 64.040000000000006 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.129999999999995 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 64.420000000000002 110.685 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 71.239999999999995 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.030000000000001 109.746 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.420000000000002 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.049999999999997 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.200000000000003 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 70.230000000000004 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.439999999999998 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.129999999999995 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.140000000000001 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 72.219999999999999 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 34.229999999999997 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.450000000000003 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.109999999999999 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 75' ' ' PHE . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.299999999999997 108.273 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.409999999999997 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.310000000000002 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.450000000000003 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.310000000000002 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.150000000000006 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 71.340000000000003 110.889 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 73.409999999999997 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 51.509999999999998 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 53.130000000000003 109.283 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.310000000000002 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 73.120000000000005 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.310000000000002 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.494 HD22 ' N ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 71.239999999999995 111.378 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.712 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.310000000000002 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 53.310000000000002 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.420000000000002 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.712 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.129999999999995 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.230000000000004 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 73.439999999999998 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 63.240000000000002 107.666 173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.140000000000001 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.510000000000005 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 65.230000000000004 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 73.450000000000003 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.239999999999995 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.230000000000004 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 63.140000000000001 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 71.230000000000004 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 73.439999999999998 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.010000000000005 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.530000000000001 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.109999999999999 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.200000000000003 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.400000000000006 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.439999999999998 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 42.530000000000001 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.129999999999995 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.209999999999994 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 44.340000000000003 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.430000000000007 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.510000000000005 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 72.519999999999996 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 52.020000000000003 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.549999999999997 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.340000000000003 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.120000000000005 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.589 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.430000000000007 111.656 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.420000000000002 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 63.399999999999999 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 63.409999999999997 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 70.0 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 65.519999999999996 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.019999999999996 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 64.230000000000004 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 64.329999999999998 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.420000000000002 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.209999999999994 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.400000000000006 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 69' ' ' PRO . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.319999999999993 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.219999999999999 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.329999999999998 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 70.400000000000006 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.219999999999999 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.439999999999998 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 42.450000000000003 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 42.439999999999998 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.230000000000004 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.099999999999994 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 61.409999999999997 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.430000000000007 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.129999999999995 110.647 -173.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.420000000000002 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.219999999999999 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.150000000000006 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 29' ' ' VAL . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 61.130000000000003 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.409999999999997 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.439999999999998 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 65.329999999999998 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 55.299999999999997 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.019999999999996 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.099999999999994 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 65.230000000000004 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 71.439999999999998 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 44.240000000000002 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.120000000000005 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 61.219999999999999 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.51 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 44.450000000000003 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.129999999999995 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.519999999999996 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 64.530000000000001 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.209999999999994 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 72.209999999999994 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 61.020000000000003 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.340000000000003 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.439999999999998 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 64.409999999999997 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.329999999999998 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG22 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.099999999999994 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 70.549999999999997 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.230000000000004 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 71.200000000000003 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.340000000000003 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 64.109999999999999 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.340000000000003 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.150000000000006 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 61.340000000000003 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 64.340000000000003 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.409999999999997 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.240000000000002 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 62.229999999999997 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.450000000000003 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.219999999999999 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.109999999999999 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.510000000000005 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 64.430000000000007 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 44.109999999999999 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.439999999999998 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.219999999999999 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.409999999999997 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 72.319999999999993 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 73.230000000000004 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 55.219999999999999 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 65.129999999999995 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 74.129999999999995 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 43.32 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p . . . . . 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.209999999999994 110.462 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.219999999999999 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 84' ' ' ALA . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 71.150000000000006 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 60.399999999999999 110.312 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.149999999999999 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 40.350000000000001 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.409999999999997 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 71.329999999999998 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.400000000000006 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 65.430000000000007 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.439999999999998 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 23.120000000000001 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 74.340000000000003 109.235 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' THR . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 18' ' ' ILE . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 54.039999999999999 113.339 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.439999999999998 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.209999999999994 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 60.350000000000001 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.340000000000003 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' ' 36' ' ' VAL . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.230000000000004 111.189 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 63.43 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.030000000000001 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.030000000000001 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.430000000000007 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 73.439999999999998 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.349999999999994 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.030000000000001 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 73.519999999999996 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG11 ' SG ' ' A' ' 27' ' ' CYS . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 63.0 110.823 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.400000000000006 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 72.519999999999996 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.209999999999994 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 71' ' ' ASP . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.200000000000003 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.240000000000002 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.239999999999995 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 54.030000000000001 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 74.439999999999998 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.530000000000001 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 73.230000000000004 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.120000000000005 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.319999999999993 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 74.329999999999998 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 HD21 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 43.43 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 63.329999999999998 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.310000000000002 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.340000000000003 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 60.450000000000003 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.230000000000004 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 55.420000000000002 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.329999999999998 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.439999999999998 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 71.219999999999999 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 71.409999999999997 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.150000000000006 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 62.340000000000003 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.439999999999998 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.230000000000004 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' THR . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.439999999999998 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.230000000000004 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.420000000000002 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 32.439999999999998 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.299999999999997 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.350000000000001 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 70.239999999999995 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 55.420000000000002 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.340000000000003 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 43.130000000000003 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.209999999999994 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.209999999999994 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 72.120000000000005 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.329999999999998 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.430000000000007 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.340000000000003 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.409999999999997 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 63.43 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.329999999999998 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 42.5 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.409999999999997 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 71.340000000000003 110.817 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.230000000000004 112.543 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 44.149999999999999 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 72.400000000000006 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.439999999999998 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 53.109999999999999 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.049999999999997 113.631 -4.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 71.25 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.510000000000005 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.010000000000005 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 72.340000000000003 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 73.329999999999998 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 61.420000000000002 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.420000000000002 108.992 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.150000000000006 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 43.229999999999997 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 72.530000000000001 111.578 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.010000000000005 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.58 ' HG3' HG22 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 70.409999999999997 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 73.299999999999997 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 53.100000000000001 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.120000000000005 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.150000000000006 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 64.120000000000005 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 63.009999999999998 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.319999999999993 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 45.200000000000003 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 62.340000000000003 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 71.010000000000005 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.120000000000005 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 72.430000000000007 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 64.340000000000003 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.510000000000005 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 70.25 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 61.210000000000001 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 41.130000000000003 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 71.439999999999998 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.430000000000007 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.109999999999999 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.400000000000006 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.530000000000001 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.430000000000007 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 63.130000000000003 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.540000000000006 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.129999999999995 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 71.450000000000003 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 74.129999999999995 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.430000000000007 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 72.400000000000006 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.310000000000002 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.130000000000003 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 61.219999999999999 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.319999999999993 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 73.010000000000005 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.519999999999996 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.230000000000004 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.240000000000002 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.540000000000006 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 71.530000000000001 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.340000000000003 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.310000000000002 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.530000000000001 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.540000000000006 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 62.210000000000001 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.329999999999998 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 73.409999999999997 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 70.340000000000003 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 53.420000000000002 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.200000000000003 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 61.450000000000003 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.340000000000003 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.540000000000006 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.530000000000001 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 55.32 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 53.340000000000003 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 61.219999999999999 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.120000000000005 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 62.43 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 72.239999999999995 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.340000000000003 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 71.530000000000001 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 73.310000000000002 112.88 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 65.129999999999995 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.099999999999994 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.219999999999999 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.239999999999995 111.094 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 43.140000000000001 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 71.430000000000007 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 71.299999999999997 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.450000000000003 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.209999999999994 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.319999999999993 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.439999999999998 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.030000000000001 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.099999999999994 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.510000000000005 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.497 ' H ' HG22 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.329999999999998 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.099999999999994 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.409999999999997 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.530000000000001 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.488 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 55.32 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.510000000000005 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 72.329999999999998 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.230000000000004 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.129999999999995 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.450000000000003 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB3' HG23 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.310000000000002 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 70.010000000000005 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 72.200000000000003 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 54.450000000000003 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 63.329999999999998 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 HG11 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 73.239999999999995 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.439999999999998 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.040000000000006 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 72.019999999999996 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 72.329999999999998 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 61.100000000000001 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 44.229999999999997 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.140000000000001 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.450000000000003 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 71.349999999999994 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.219999999999999 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.219999999999999 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.621 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 54.450000000000003 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 53.049999999999997 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 73.540000000000006 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.621 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.439999999999998 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.239999999999995 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.040000000000006 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.230000000000004 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.239999999999995 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.109999999999999 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.120000000000005 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 70.329999999999998 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 73.010000000000005 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.140000000000001 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.420000000000002 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 64.340000000000003 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 64.5 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.150000000000006 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.019999999999996 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.420000000000002 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.420000000000002 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 71.5 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 65.519999999999996 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.319999999999993 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.120000000000005 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.349999999999994 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.340000000000003 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 54.43 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.519999999999996 110.241 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.41 ' SG ' ' CZ3' ' A' ' 38' ' ' TRP . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 41.450000000000003 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.329999999999998 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.340000000000003 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.420000000000002 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 64.299999999999997 109.482 169.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 72.049999999999997 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.439999999999998 109.92 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.439999999999998 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 70.030000000000001 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.239999999999995 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 71.310000000000002 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 62.420000000000002 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 72.530000000000001 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.531 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.430000000000007 112.036 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.430000000000007 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.349999999999994 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 42.119999999999997 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.349999999999994 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.349999999999994 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.140000000000001 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 44.420000000000002 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.409999999999997 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.230000000000004 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.519999999999996 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 65.319999999999993 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.349999999999994 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.450000000000003 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 60.109999999999999 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.58 HG22 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 45.020000000000003 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 70.150000000000006 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.420000000000002 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.409999999999997 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 15' ' ' VAL . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 51.25 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.340000000000003 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 73.430000000000007 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 71.019999999999996 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 64.140000000000001 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.140000000000001 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.450000000000003 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.349999999999994 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.109999999999999 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.150000000000006 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.340000000000003 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.624 HG11 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 72.549999999999997 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 61.439999999999998 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.329999999999998 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 43.420000000000002 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.119999999999997 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.349999999999994 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 61.439999999999998 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.299999999999997 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 62.439999999999998 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.099999999999994 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 53.030000000000001 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.010000000000005 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 53.229999999999997 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG22 HD21 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 64.310000000000002 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 51.409999999999997 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.010000000000005 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.019999999999996 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 54.229999999999997 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.239999999999995 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.109999999999999 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG3' HG11 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.409999999999997 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 65.340000000000003 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 25' ' ' LEU . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.200000000000003 108.768 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 64.349999999999994 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.340000000000003 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.349999999999994 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 52.25 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' HD12 ' A' ' 64' ' ' LEU . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 62.130000000000003 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 64.340000000000003 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HD3' HG22 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 61.109999999999999 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 63.409999999999997 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.519999999999996 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 64.549999999999997 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 71.25 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.030000000000001 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.239999999999995 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.409999999999997 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 50.520000000000003 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.430000000000007 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.530000000000001 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 50.049999999999997 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.230000000000004 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.329999999999998 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.120000000000005 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.540000000000006 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.409999999999997 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.420000000000002 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 62.039999999999999 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.209999999999994 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 73.319999999999993 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.099999999999994 110.778 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.349999999999994 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 74.340000000000003 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.409999999999997 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.399999999999999 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 61.530000000000001 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 72.030000000000001 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 72.129999999999995 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 54.32 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.409999999999997 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.430000000000007 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.019999999999996 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 73.219999999999999 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.530000000000001 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.540000000000006 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 53.539999999999999 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.530000000000001 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.430000000000007 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 35.109999999999999 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 60.329999999999998 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 52.210000000000001 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 64.120000000000005 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.130000000000003 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.109999999999999 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 60.109999999999999 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 64.230000000000004 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.400000000000006 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.310000000000002 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.030000000000001 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.099999999999994 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.239999999999995 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.219999999999999 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 72.0 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.299999999999997 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 64.239999999999995 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.109999999999999 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 72.349999999999994 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 45.210000000000001 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.409999999999997 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 65.099999999999994 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.120000000000005 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 72.219999999999999 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 72.099999999999994 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.510000000000005 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 44.509999999999998 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.219999999999999 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.030000000000001 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 52.329999999999998 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 62.530000000000001 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 71.120000000000005 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.586 HD22 ' H ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 112.04 -172.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.010000000000005 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.420000000000002 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 52.240000000000002 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.430000000000007 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.439999999999998 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.030000000000001 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.140000000000001 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 54.210000000000001 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 70.430000000000007 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.019999999999996 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.628 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.340000000000003 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 72.409999999999997 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.439999999999998 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 62.149999999999999 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 12.35 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 51.140000000000001 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 65.310000000000002 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.519999999999996 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.099999999999994 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.47 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.200000000000003 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 72.25 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 35.520000000000003 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 52.5 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.400000000000006 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 54.409999999999997 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.439999999999998 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.030000000000001 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.319999999999993 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.47 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.540000000000006 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.239999999999995 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.140000000000001 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 51.140000000000001 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 62.530000000000001 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 61.119999999999997 112.142 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.230000000000004 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.510000000000005 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 30' ' ' ASP . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.319999999999993 112.171 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.450000000000003 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.430000000000007 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 71.340000000000003 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.450000000000003 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.310000000000002 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.239999999999995 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.109999999999999 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 63.130000000000003 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 62.43 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.099999999999994 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 70.219999999999999 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.519999999999996 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.219999999999999 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 55.219999999999999 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 52.32 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.414 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 51.43 110.301 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 63.119999999999997 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 20.399999999999999 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.439999999999998 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 62.399999999999999 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB2' HG13 ' A' ' 7' ' ' VAL . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 62.009999999999998 110.47 172.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.340000000000003 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 63.310000000000002 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.109999999999999 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 44.25 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 73.019999999999996 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.030000000000001 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.239999999999995 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.540000000000006 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 63.5 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.200000000000003 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.200000000000003 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.219999999999999 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.349999999999994 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 71.239999999999995 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.230000000000004 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.430000000000007 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 63.409999999999997 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 71.329999999999998 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.299999999999997 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.019999999999996 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 71.129999999999995 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.439999999999998 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 42.210000000000001 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.510000000000005 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.239999999999995 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.039999999999999 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 70.420000000000002 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.010000000000005 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.414 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.239999999999995 114.155 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.439999999999998 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 73.310000000000002 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 74.439999999999998 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 61.409999999999997 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.209999999999994 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.510000000000005 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.219999999999999 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.450000000000003 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.119999999999997 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 71.439999999999998 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.350000000000001 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.240000000000002 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.230000000000004 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 62.520000000000003 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.109999999999999 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 73.340000000000003 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 53.310000000000002 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 54.420000000000002 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 55.229999999999997 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 51.109999999999999 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.109999999999999 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 73.430000000000007 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 71.400000000000006 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 51.140000000000001 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 65.310000000000002 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 73.140000000000001 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 34' ' ' ALA . 9.9 p . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 121.508 0.671 . . . . 72.219999999999999 110.575 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.516 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 64.400000000000006 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 73.409999999999997 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 63.119999999999997 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 71.010000000000005 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 71.040000000000006 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.129999999999995 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.049999999999997 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 64.450000000000003 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 61.030000000000001 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.510000000000005 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.229999999999997 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.219999999999999 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.219999999999999 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 51.329999999999998 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.030000000000001 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 63.130000000000003 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 63.130000000000003 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.219999999999999 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.239999999999995 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.310000000000002 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 65.510000000000005 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.540000000000006 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.109999999999999 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 74.310000000000002 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 72.150000000000006 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.099999999999994 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.140000000000001 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.530000000000001 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 65.109999999999999 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.219999999999999 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 55.119999999999997 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.109999999999999 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 70.349999999999994 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 33.039999999999999 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 61.520000000000003 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 70.409999999999997 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 52.030000000000001 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 71.219999999999999 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.150000000000006 113.375 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.340000000000003 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.140000000000001 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.140000000000001 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 HD23 ' A' ' 64' ' ' LEU . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.239999999999995 111.06 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.040000000000006 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.109999999999999 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.329999999999998 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.099999999999994 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.340000000000003 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 73.040000000000006 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 51.299999999999997 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 44.539999999999999 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 64.519999999999996 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 74.310000000000002 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 33.420000000000002 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HD2' HD22 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.530000000000001 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.329999999999998 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.430000000000007 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 65.319999999999993 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.109999999999999 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 65.420000000000002 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 53.409999999999997 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.230000000000004 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 43.210000000000001 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.200000000000003 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 63.549999999999997 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 72.409999999999997 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 63.43 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.310000000000002 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 63.409999999999997 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.349999999999994 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 72.109999999999999 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.129999999999995 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.340000000000003 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 63.109999999999999 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.129999999999995 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.450000000000003 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.540000000000006 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 72.219999999999999 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 71.420000000000002 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.984 -0.376 . . . . 54.43 109.984 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.787 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.140000000000001 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 52.240000000000002 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.340000000000003 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 61.530000000000001 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.430000000000007 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 73.310000000000002 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 63.119999999999997 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.120000000000005 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.219999999999999 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 54.109999999999999 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 72.150000000000006 110.221 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 62.409999999999997 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 62.329999999999998 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.310000000000002 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.340000000000003 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.310000000000002 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 64.129999999999995 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 52.130000000000003 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 62.009999999999998 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 70.439999999999998 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.400000000000006 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.129999999999995 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 61.219999999999999 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 50.229999999999997 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.624 ' HB2' HG13 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.299999999999997 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.504 ' HB3' HG23 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.420000000000002 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 63.350000000000001 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 31.210000000000001 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 50.030000000000001 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 73.540000000000006 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.420000000000002 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.010000000000005 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.409999999999997 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 71.430000000000007 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 64.030000000000001 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.439999999999998 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.019999999999996 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.540000000000006 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.239999999999995 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 73.430000000000007 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.200000000000003 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 65.450000000000003 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 61.130000000000003 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 54.130000000000003 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG22 HD21 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 72.010000000000005 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 61.32 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 70.420000000000002 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.099999999999994 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 70.340000000000003 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.239999999999995 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.519999999999996 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.150000000000006 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.319999999999993 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.019999999999996 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 64.450000000000003 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 61.229999999999997 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 61.32 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 72.329999999999998 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.455 ' HD2' HD13 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.439999999999998 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 61.329999999999998 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 72.049999999999997 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.109999999999999 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 70.349999999999994 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 74.010000000000005 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 62.219999999999999 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.430000000000007 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.420000000000002 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.230000000000004 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 64.209999999999994 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.120000000000005 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.130000000000003 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.329999999999998 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 51.119999999999997 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.200000000000003 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.010000000000005 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.787 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.540000000000006 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 70.200000000000003 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 54.409999999999997 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 44.439999999999998 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.130000000000003 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 52.119999999999997 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 61.119999999999997 110.715 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 72.310000000000002 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 63.399999999999999 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.561 1.37 0 CA-C-O 122.259 1.028 . . . . 75.310000000000002 109.898 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.129999999999995 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' ALA . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 64.530000000000001 109.879 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 72.409999999999997 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.319999999999993 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 72.409999999999997 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 74.010000000000005 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.019999999999996 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.219999999999999 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 63.240000000000002 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.430000000000007 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 62.32 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 73.310000000000002 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.409999999999997 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.420000000000002 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 64.230000000000004 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.140000000000001 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 64.519999999999996 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.530000000000001 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.575 ' HG3' HG22 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.409999999999997 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 53.43 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.310000000000002 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.439999999999998 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.319999999999993 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.450000000000003 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.109999999999999 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.140000000000001 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 72.420000000000002 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.399999999999999 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 53.340000000000003 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.140000000000001 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.310000000000002 109.483 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.230000000000004 110.624 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.540000000000006 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 61.229999999999997 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.129999999999995 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 70.140000000000001 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.319999999999993 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 62.329999999999998 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 64.140000000000001 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 64.319999999999993 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.409999999999997 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 63.149999999999999 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 71.109999999999999 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 64' ' ' LEU . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.120000000000005 110.349 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.340000000000003 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.430000000000007 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.566 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.150000000000006 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 63.340000000000003 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.319999999999993 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 63.119999999999997 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 70.409999999999997 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 63.229999999999997 109.61 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 71.25 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 54.310000000000002 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 24.210000000000001 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.109999999999999 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.210000000000001 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 61.509999999999998 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 62.439999999999998 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 71.530000000000001 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 73.340000000000003 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 90' ' ' ILE . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.219999999999999 111.552 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 50.32 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 64.409999999999997 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 71.140000000000001 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 64.430000000000007 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 83' ' ' CYS . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 70.340000000000003 111.212 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.310000000000002 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 61.240000000000002 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.310000000000002 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.299999999999997 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 78' ' ' VAL . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 111.729 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.509999999999998 110.844 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 65.239999999999995 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.400000000000006 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 61.409999999999997 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 63.009999999999998 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.329999999999998 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG12 ' HA3' ' A' ' 72' ' ' GLY . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.109999999999999 112.027 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.545 HG13 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p . . . . . 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 71.430000000000007 111.207 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 52.439999999999998 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 70.510000000000005 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 62.149999999999999 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 64.010000000000005 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 71.420000000000002 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.340000000000003 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 72.409999999999997 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.310000000000002 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 63.439999999999998 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 71.420000000000002 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 70.239999999999995 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 71.420000000000002 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 22.309999999999999 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.319999999999993 107.119 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.239999999999995 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.200000000000003 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.049999999999997 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 54.509999999999998 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.109999999999999 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 63.520000000000003 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.647 HD12 HD13 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.540000000000006 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 41.299999999999997 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 52.210000000000001 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.329999999999998 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.140000000000001 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.209999999999994 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.540000000000006 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 60.219999999999999 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.519999999999996 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.530000000000001 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 71.349999999999994 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.531 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.129999999999995 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.539999999999999 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.120000000000005 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.109999999999999 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 73.150000000000006 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.109999999999999 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.109999999999999 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 54.109999999999999 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.340000000000003 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.589 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 40.140000000000001 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.129999999999995 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.319999999999993 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 33.030000000000001 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.25 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 71.219999999999999 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.518 HD22 ' H ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 73.230000000000004 111.915 -173.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.519999999999996 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.120000000000005 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.540000000000006 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 63.32 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.140000000000001 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.230000000000004 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 HD12 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 70.540000000000006 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.049999999999997 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 71.5 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.200000000000003 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.32 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 72.120000000000005 111.381 -173.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.239999999999995 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.540000000000006 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.530000000000001 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.150000000000006 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.349999999999994 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.149999999999999 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.450000000000003 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.439999999999998 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.140000000000001 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 61.240000000000002 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 51.509999999999998 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.545 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.420000000000002 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 70.219999999999999 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 63.229999999999997 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.109999999999999 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 62.299999999999997 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 71.209999999999994 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.530000000000001 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 61.109999999999999 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.530000000000001 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.310000000000002 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 73.25 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 34' ' ' ALA . 2.6 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.648 0.261 . . . . 72.519999999999996 110.804 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.209999999999994 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.019999999999996 109.675 172.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 70.219999999999999 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.099999999999994 110.092 -170.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 34.329999999999998 112.985 -10.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.129999999999995 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 71.209999999999994 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 71.409999999999997 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 63.229999999999997 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.409999999999997 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 72.239999999999995 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.140000000000001 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.319999999999993 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.319999999999993 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 63.25 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.129999999999995 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 54.450000000000003 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.200000000000003 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.4 ' HG2' HG22 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.239999999999995 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.430000000000007 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' CB ' ' HG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 63.530000000000001 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 59' ' ' HIS . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.409999999999997 110.222 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 52.350000000000001 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.129999999999995 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.150000000000006 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 62.32 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 71.319999999999993 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.019999999999996 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 72.439999999999998 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.52 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.430000000000007 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.409999999999997 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.329999999999998 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.239999999999995 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.420000000000002 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.209999999999994 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.049999999999997 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.409999999999997 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.420000000000002 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 52.109999999999999 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 62.119999999999997 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.439999999999998 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.340000000000003 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.219999999999999 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.439999999999998 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.420000000000002 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.329999999999998 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.239999999999995 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.109999999999999 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.329999999999998 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.209999999999994 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.340000000000003 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 51.240000000000002 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.129999999999995 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 71.0 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 71.209999999999994 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.540000000000006 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.530000000000001 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 61.140000000000001 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 73.549999999999997 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 55.100000000000001 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 65.310000000000002 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.310000000000002 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.409999999999997 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.129999999999995 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.219999999999999 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 41.399999999999999 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.540000000000006 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.340000000000003 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.200000000000003 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.349999999999994 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 70.439999999999998 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 62.219999999999999 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 72.010000000000005 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.329999999999998 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.030000000000001 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 73.209999999999994 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.430000000000007 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 71.409999999999997 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.430000000000007 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 72.310000000000002 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.239999999999995 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 62.219999999999999 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 34' ' ' ALA . 3.7 p . . . . . 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 63.210000000000001 111.919 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.519999999999996 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.230000000000004 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.129999999999995 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.329999999999998 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 27' ' ' CYS . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 63.210000000000001 113.842 1.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.230000000000004 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 62.509999999999998 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.25 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 51.520000000000003 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.299999999999997 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.319999999999993 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 40.109999999999999 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 51.439999999999998 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 73.340000000000003 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 54.219999999999999 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.109999999999999 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.540000000000006 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.510000000000005 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.420000000000002 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.319999999999993 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 51.509999999999998 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.010000000000005 111.063 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.019999999999996 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.120000000000005 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 62.009999999999998 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.319999999999993 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 61.509999999999998 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.200000000000003 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 73.239999999999995 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.329999999999998 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.510000000000005 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.040000000000006 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 65.219999999999999 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA3' ' A' ' 73' ' ' GLY . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 62.409999999999997 109.634 171.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.510000000000005 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.230000000000004 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 64.0 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 64.049999999999997 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.420000000000002 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 71.530000000000001 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.210000000000001 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.099999999999994 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 71.319999999999993 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 63.25 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 45.43 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.329999999999998 109.838 -172.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 70.349999999999994 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 65.019999999999996 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 62.210000000000001 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.299999999999997 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.459 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 61.340000000000003 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 62.310000000000002 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.010000000000005 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 52.140000000000001 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 63.020000000000003 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.329999999999998 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.219999999999999 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.040000000000006 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.230000000000004 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.099999999999994 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.230000000000004 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 40' ' ' LYS . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.510000000000005 113.724 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.030000000000001 112.107 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 71.310000000000002 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 71.230000000000004 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.239999999999995 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 65.239999999999995 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.409999999999997 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 61.020000000000003 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.049999999999997 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.519999999999996 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.219999999999999 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 65.530000000000001 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 64.420000000000002 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 64.549999999999997 110.208 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 23.239999999999998 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.140000000000001 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.519999999999996 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.230000000000004 111.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 71.099999999999994 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 72.519999999999996 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.340000000000003 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.310000000000002 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 65.120000000000005 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.439999999999998 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.510000000000005 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 61.439999999999998 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 72.140000000000001 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 52.25 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.420000000000002 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.230000000000004 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.200000000000003 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.491 HG22 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 41.219999999999999 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 52.039999999999999 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.329999999999998 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 63.229999999999997 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.340000000000003 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.454 ' HG3' HG22 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 61.310000000000002 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 61.539999999999999 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.120000000000005 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.430000000000007 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.618 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.019999999999996 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.540000000000006 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 63.520000000000003 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.340000000000003 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.240000000000002 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.239999999999995 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.439999999999998 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.530000000000001 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.430000000000007 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 62.409999999999997 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.219999999999999 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 73.25 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 34.539999999999999 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.340000000000003 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.129999999999995 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.209999999999994 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 35.210000000000001 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 44.240000000000002 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.319999999999993 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.319999999999993 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 64' ' ' LEU . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.099999999999994 110.372 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.409999999999997 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 72.530000000000001 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.46 HD22 ' H ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 71.219999999999999 111.829 -174.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.140000000000001 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 m170 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.439999999999998 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 72.340000000000003 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.140000000000001 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.519999999999996 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.519999999999996 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.329999999999998 108.689 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 53.219999999999999 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.450000000000003 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.539999999999999 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.049999999999997 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HD3' HG22 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 63.43 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.530000000000001 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 71.219999999999999 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 54.229999999999997 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 52.039999999999999 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.409999999999997 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.329999999999998 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.2 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.209999999999994 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 71.140000000000001 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 72.030000000000001 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.310000000000002 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 54.200000000000003 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 64.420000000000002 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.329999999999998 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 72.120000000000005 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 50.039999999999999 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.129999999999995 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.409999999999997 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 64.040000000000006 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.209999999999994 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 61.439999999999998 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.549999999999997 111.759 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.420000000000002 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.457 ' HA ' HG12 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.340000000000003 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.099999999999994 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.340000000000003 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.349999999999994 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 72.230000000000004 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 54.420000000000002 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.019999999999996 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 54.409999999999997 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.209999999999994 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.209999999999994 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.120000000000005 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 65.420000000000002 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.340000000000003 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 63.240000000000002 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.230000000000004 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.219999999999999 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.439999999999998 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 71.540000000000006 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.400000000000006 110.064 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 72.319999999999993 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 73.319999999999993 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 72.040000000000006 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.349999999999994 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.540000000000006 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 62.229999999999997 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.329999999999998 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.049999999999997 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.319999999999993 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.530000000000001 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' HG3' ' A' ' 60' ' ' ARG . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.439999999999998 111.135 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.219999999999999 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.129999999999995 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 71.129999999999995 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.219999999999999 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 51.25 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.510000000000005 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 72.209999999999994 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 54.149999999999999 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.409999999999997 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.329999999999998 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.409999999999997 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.030000000000001 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.510000000000005 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.439999999999998 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.420000000000002 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.120000000000005 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 60.020000000000003 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.509999999999998 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.329999999999998 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HG3' HG11 ' A' ' 36' ' ' VAL . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.129999999999995 108.805 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.329999999999998 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.219999999999999 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 72.209999999999994 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 53.439999999999998 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.450000000000003 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.099999999999994 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 54.109999999999999 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 71.109999999999999 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 71.340000000000003 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.140000000000001 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.430000000000007 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 33.140000000000001 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 54.240000000000002 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.510000000000005 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.439999999999998 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.200000000000003 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 33.109999999999999 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.530000000000001 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.310000000000002 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 71.540000000000006 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.030000000000001 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 55.439999999999998 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.409999999999997 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.120000000000005 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 62.119999999999997 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.420000000000002 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.340000000000003 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 73.140000000000001 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.65 HG12 ' HB3' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.329999999999998 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 61.039999999999999 111.566 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.701 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 71.109999999999999 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.549999999999997 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.239999999999995 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.140000000000001 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.349999999999994 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.430000000000007 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.099999999999994 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.239999999999995 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.230000000000004 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.040000000000006 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.540000000000006 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.120000000000005 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 62.439999999999998 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.030000000000001 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.530000000000001 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.439999999999998 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 72.310000000000002 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 74.450000000000003 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 73.329999999999998 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 61.329999999999998 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.548 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.310000000000002 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.109999999999999 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 63.310000000000002 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.200000000000003 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.409999999999997 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.319999999999993 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.209999999999994 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 24.23 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.409999999999997 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 52.149999999999999 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.439999999999998 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.551 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 73.319999999999993 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.219999999999999 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 71.349999999999994 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 73.329999999999998 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.400000000000006 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 70.329999999999998 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.209999999999994 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 65.129999999999995 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.319999999999993 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.140000000000001 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.507 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.049999999999997 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.420000000000002 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 63.140000000000001 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 55.340000000000003 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 65.310000000000002 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.109999999999999 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.567 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 72.439999999999998 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.45 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.430000000000007 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.430000000000007 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.450000000000003 114.028 -175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.400000000000006 113.409 175.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 71.239999999999995 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.729 ' HG3' HG22 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 64.239999999999995 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.310000000000002 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 62.140000000000001 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 71.150000000000006 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 74.319999999999993 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 53.240000000000002 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 62.210000000000001 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.535 ' HA ' HD12 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 64.019999999999996 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 53.439999999999998 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 70.150000000000006 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.310000000000002 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.219999999999999 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 53.219999999999999 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.129999999999995 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 64.030000000000001 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.120000000000005 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.120000000000005 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.239999999999995 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.209999999999994 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.701 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.399999999999999 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.230000000000004 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.439999999999998 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.209999999999994 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 54.219999999999999 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 52.409999999999997 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 61.009999999999998 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 63.119999999999997 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.692 0.282 . . . . 72.230000000000004 111.512 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.230000000000004 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 73.329999999999998 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.230000000000004 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 62.240000000000002 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.530000000000001 111.077 -171.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 65.5 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.109999999999999 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.576 HG21 HD21 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.099999999999994 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.439999999999998 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.229999999999997 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.420000000000002 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 68' ' ' GLN . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 61.100000000000001 112.289 173.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 74.120000000000005 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 64.109999999999999 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.420000000000002 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.129999999999995 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.501 ' HG3' HG22 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 73.409999999999997 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 54.409999999999997 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 64.120000000000005 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.009999999999998 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.329999999999998 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.030000000000001 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.230000000000004 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.319999999999993 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.130000000000003 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 44.439999999999998 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.219999999999999 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 64.530000000000001 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 44.329999999999998 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.049999999999997 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.040000000000006 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.040000000000006 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 70.439999999999998 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.400000000000006 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 72.25 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.510000000000005 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.439999999999998 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.200000000000003 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.430000000000007 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.310000000000002 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.040000000000006 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 54.329999999999998 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.340000000000003 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 72.319999999999993 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.120000000000005 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 70.049999999999997 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.120000000000005 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.540000000000006 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 61.299999999999997 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 70.010000000000005 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 63.130000000000003 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.329999999999998 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 62.0 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.319999999999993 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.299999999999997 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 65.140000000000001 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.420000000000002 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.403 ' HA ' HG22 ' A' ' 19' ' ' THR . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.349999999999994 110.543 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.530000000000001 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 64.340000000000003 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.239999999999995 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.140000000000001 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 63.140000000000001 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.329999999999998 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.099999999999994 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 72.319999999999993 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 63.549999999999997 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 64.510000000000005 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.439999999999998 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.299999999999997 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 64.010000000000005 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.119999999999997 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.349999999999994 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.230000000000004 110.933 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.109999999999999 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.530000000000001 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 70.310000000000002 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.549999999999997 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 67' ' ' THR . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.219999999999999 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.286 0.476 . . . . 75.5 112.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.129999999999995 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.120000000000005 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.329999999999998 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 60.32 112.449 -1.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.140000000000001 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.099999999999994 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.439999999999998 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.049999999999997 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 74.129999999999995 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.540000000000006 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 64.439999999999998 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 63.219999999999999 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 70.140000000000001 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.519999999999996 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.534 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 53.119999999999997 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 63.119999999999997 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.299999999999997 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 35.420000000000002 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.040000000000006 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 53.439999999999998 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 63.340000000000003 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.140000000000001 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.319999999999993 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.409999999999997 110.525 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.319999999999993 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.430000000000007 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.520000000000003 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 70.329999999999998 111.464 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.554 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.049999999999997 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.430000000000007 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 72.310000000000002 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 71.510000000000005 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 52.329999999999998 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 61.200000000000003 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.420000000000002 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.430000000000007 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.430000000000007 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 64.450000000000003 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.209999999999994 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.329999999999998 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.409999999999997 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 72.230000000000004 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 65.219999999999999 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 63.200000000000003 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 63.409999999999997 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.519999999999996 110.669 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.340000000000003 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 71.540000000000006 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.340000000000003 112.132 -176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 72.239999999999995 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 74.219999999999999 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 71.540000000000006 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 34.299999999999997 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.414 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 54.100000000000001 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.420000000000002 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 53.299999999999997 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 73.299999999999997 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' ' 19' ' ' THR . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 64.329999999999998 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.140000000000001 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.099999999999994 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.219999999999999 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 62.0 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.099999999999994 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 72.25 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.450000000000003 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.140000000000001 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 62.520000000000003 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.019999999999996 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.540000000000006 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 71.329999999999998 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.510000000000005 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 63.109999999999999 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 73.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 73.25 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.329999999999998 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.439999999999998 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 63.219999999999999 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.239999999999995 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 64.239999999999995 111.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 72.019999999999996 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 70.129999999999995 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 71.319999999999993 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 52.450000000000003 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 73.239999999999995 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 52.310000000000002 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.219999999999999 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 74.420000000000002 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.530000000000001 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.439999999999998 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.420000000000002 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.409999999999997 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 72.549999999999997 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.402 HG22 ' HG3' ' A' ' 69' ' ' PRO . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.510000000000005 113.803 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 63.119999999999997 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 70.420000000000002 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.409999999999997 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 64.340000000000003 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.340000000000003 110.29 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.109999999999999 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.200000000000003 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 44.149999999999999 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.209999999999994 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 70.109999999999999 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.420000000000002 107.823 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.129999999999995 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.140000000000001 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 65.439999999999998 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 70.329999999999998 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 63.140000000000001 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 64.140000000000001 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.140000000000001 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.340000000000003 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 71.239999999999995 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 64.129999999999995 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 73.150000000000006 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.549999999999997 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 63.149999999999999 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.439999999999998 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 54.409999999999997 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 73.310000000000002 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 48' ' ' SER . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.229999999999997 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 32.109999999999999 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 73.209999999999994 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.340000000000003 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.506 ' HB3' HH11 ' A' ' 60' ' ' ARG . 13.8 m120 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 71.209999999999994 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.219999999999999 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HG2' ' HD2' ' A' ' 59' ' ' HIS . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 71.430000000000007 112.804 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.437 ' HD2' ' HG2' ' A' ' 58' ' ' PRO . 18.8 m-70 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.340000000000003 111.564 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.506 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.150000000000006 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.120000000000005 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 63.310000000000002 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 62.420000000000002 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 70.439999999999998 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.310000000000002 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 64.430000000000007 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.120000000000005 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.439999999999998 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG3' HG22 ' A' ' 19' ' ' THR . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 64.230000000000004 113.553 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 51.43 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 61.130000000000003 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.230000000000004 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.409999999999997 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 63.200000000000003 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 71.409999999999997 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.109999999999999 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.219999999999999 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 61.240000000000002 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.340000000000003 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.049999999999997 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.329999999999998 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.439999999999998 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 52.350000000000001 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 60.109999999999999 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 71.5 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 71.120000000000005 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.140000000000001 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.099999999999994 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.510000000000005 110.06 -179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 74.209999999999994 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.7 mtt -80.86 138.96 49.93 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 123.1 0.56 . . . . 70.409999999999997 109.764 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.42 -86.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.485 2.79 . . . . 64.5 114.331 -176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -176.96 139.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 118.52 0.6 . . . . 64.310000000000002 111.93 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.01 113.39 7.68 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.175 0.99 . . . . 72.329999999999998 110.781 174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.451 HG12 HG12 ' A' ' 29' ' ' VAL . 68.2 mt -62.47 113.83 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.101 0.96 . . . . 64.030000000000001 111.409 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -74.26 -25.3 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.644 0.609 . . . . 64.200000000000003 112.644 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -151.26 134.4 8.9 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.181 0.593 . . . . 73.519999999999996 110.794 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -87.66 150.4 35.69 Favored 'Cis proline' 0 C--N 1.375 1.972 0 CA-C-N 120.217 1.113 . . . . 40.439999999999998 113.907 -5.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -106.1 64.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.72 0.808 . . . . 64.129999999999995 111.446 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -175.34 170.96 2.97 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.205 1.002 . . . . 74.310000000000002 110.887 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -72.83 118.77 16.17 Favored 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 115.796 -0.638 . . . . 73.349999999999994 109.458 166.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.32 102.36 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.857 0.463 . . . . 73.040000000000006 111.287 -172.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -90.08 112.52 24.0 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.664 -0.495 . . . . 63.229999999999997 109.664 175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.1 t -102.87 118.18 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.37 0.668 . . . . 70.109999999999999 109.616 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.62 122.92 31.2 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.689 -0.856 . . . . 51.130000000000003 108.689 166.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -130.62 158.5 39.85 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.776 0.83 . . . . 64.5 111.346 -177.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.614 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 36.1 mm -131.74 162.84 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 124.703 1.201 . . . . 75.150000000000006 107.918 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG22 ' HD3' ' A' ' 69' ' ' PRO . 75.1 p -56.15 -35.01 66.68 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 113.416 0.895 . . . . 72.439999999999998 113.416 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.9 m -96.35 20.72 10.05 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.366 0.666 . . . . 64.409999999999997 112.075 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 72.9 mm-40 -107.59 160.73 15.46 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.359 0.664 . . . . 63.439999999999998 111.482 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.5 p -115.66 109.87 18.35 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 72.239999999999995 110.169 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -96.2 107.92 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.585 0.707 . . . . 64.040000000000006 109.778 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.635 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.3 ttt -107.73 95.05 5.42 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.108 -0.951 . . . . 74.129999999999995 109.254 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -77.11 152.33 35.01 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.618 0.767 . . . . 64.420000000000002 110.685 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.86 136.69 24.41 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.068 0.547 . . . . 71.239999999999995 111.122 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -144.85 117.34 8.56 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.495 1.118 . . . . 74.030000000000001 109.746 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.66 129.79 55.34 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.621 0.768 . . . . 74.420000000000002 110.534 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 HG12 ' A' ' 6' ' ' ILE . 17.4 m -95.53 168.33 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.228 0.611 . . . . 74.049999999999997 111.7 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -70.68 -41.17 72.39 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.031 -0.986 . . . . 63.200000000000003 112.176 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -113.26 128.59 56.52 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.242 0.617 . . . . 70.230000000000004 111.249 -173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.35 -25.07 65.55 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.945 0.898 . . . . 75.439999999999998 110.599 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.54 -36.96 79.68 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.333 1.453 . . . . 73.129999999999995 112.936 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.13 82.66 37.65 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.133 0.573 . . . . 65.140000000000001 112.16 -170.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HB3' ' HD3' ' A' ' 60' ' ' ARG . 11.4 Cg_exo -74.1 144.8 34.3 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 123.301 2.667 . . . . 72.219999999999999 112.758 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG22 ' HG3' ' A' ' 60' ' ' ARG . 18.7 m -76.82 151.47 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.352 0.596 . . . . 34.229999999999997 111.702 176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.5 mtm180 -104.79 135.96 45.19 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.642 -0.873 . . . . 72.450000000000003 108.642 168.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -85.52 132.36 34.21 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.421 -0.585 . . . . 73.25 109.421 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 12.8 m-85 -115.74 127.51 55.17 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.773 0.429 . . . . 73.109999999999999 111.323 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 75' ' ' PHE . 6.8 tmtt? -90.55 91.18 8.32 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.273 -1.01 . . . . 73.299999999999997 108.273 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 51.78 40.72 28.26 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.913 0.885 . . . . 75.409999999999997 112.635 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.64 -23.08 27.37 Favored Glycine 0 CA--C 1.544 1.866 0 N-CA-C 114.614 0.606 . . . . 74.310000000000002 114.614 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.99 -26.7 68.38 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 112.9 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.0 tt0 72.44 124.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.448 1.499 . . . . 71.450000000000003 111.297 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -71.99 125.03 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 124.334 1.054 . . . . 74.310000000000002 110.672 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -110.11 149.24 30.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.779 0.832 . . . . 72.150000000000006 110.277 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 116.57 9.04 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.845 0.858 . . . . 74.329999999999998 110.789 -177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 47.6 t -131.16 179.15 6.18 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.37 1.068 . . . . 71.340000000000003 110.889 -175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.91 -40.52 96.69 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.232 1.013 . . . . 73.409999999999997 112.563 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -110.94 -10.92 14.38 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.594 0.758 . . . . 51.509999999999998 112.022 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 38.0 t -107.11 103.4 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 109.283 -0.636 . . . . 53.130000000000003 109.283 176.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.7 m -117.96 131.15 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 CA-C-O 121.503 0.668 . . . . 73.310000000000002 111.908 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.1 107.18 18.02 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.038 0.935 . . . . 73.120000000000005 110.428 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 61' ' ' ARG . 10.4 mm-40 -96.89 123.49 40.61 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.429 0.691 . . . . 74.310000000000002 109.996 -176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.494 HD22 ' N ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -135.5 140.05 44.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.891 0.477 . . . . 71.239999999999995 111.378 -172.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.712 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 7.1 pt-20 -155.61 91.32 1.3 Allowed 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.196 0.998 . . . . 72.310000000000002 110.171 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.93 -121.6 26.2 Favored Glycine 0 CA--C 1.547 2.08 0 CA-C-O 119.457 -0.635 . . . . 53.310000000000002 114.101 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.84 -22.22 43.1 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.758 2.306 . . . . 74.420000000000002 113.696 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.712 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 13.5 m-70 -85.35 127.36 34.32 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.193 0.597 . . . . 74.129999999999995 110.833 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HD3' ' HB3' ' A' ' 35' ' ' PRO . 23.6 mmm180 -127.33 131.58 50.4 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.125 0.97 . . . . 73.230000000000004 109.272 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 79.8 mtt-85 -130.7 148.6 52.5 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.353 0.661 . . . . 73.439999999999998 111.533 -172.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tt -125.31 103.19 7.8 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 107.666 -1.235 . . . . 63.240000000000002 107.666 173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 24' ' ' MET . 35.0 t -98.12 118.71 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 CA-C-O 120.854 0.359 . . . . 65.140000000000001 110.781 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.98 99.06 51.16 Favored Pre-proline 0 CA--C 1.561 1.399 0 C-N-CA 123.86 0.864 . . . . 74.510000000000005 108.758 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -59.48 -49.05 11.38 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.334 2.689 . . . . 65.230000000000004 113.64 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 92.33 3.88 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.306 0.642 . . . . 73.450000000000003 109.404 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 m -72.67 97.1 2.1 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.018 -0.537 . . . . 73.239999999999995 111.142 -173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.87 161.81 76.74 Favored Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.013 0.925 . . . . 75.230000000000004 111.466 -175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 90' ' ' ILE . 28.0 Cg_endo -61.57 -21.84 73.0 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 121.883 1.722 . . . . 63.140000000000001 111.614 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.0 m -61.46 -38.25 86.54 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.097 0.959 . . . . 71.230000000000004 111.644 170.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -84.82 5.98 26.46 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.573 0.749 . . . . 73.439999999999998 112.654 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.3 71.97 2.89 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 113.895 0.318 . . . . 70.010000000000005 113.895 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.56 -162.46 9.86 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 122.883 0.278 . . . . 63.530000000000001 112.455 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -103.01 120.97 41.59 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.306 0.574 . . . . 75.109999999999999 111.632 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 85.5 m-85 -96.39 123.04 39.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.466 1.106 . . . . 74.200000000000003 110.619 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -112.39 109.37 18.95 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.888 0.875 . . . . 74.25 109.947 -175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 84' ' ' ALA . 29.4 p -88.78 98.42 11.7 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 121.358 0.599 . . . . 64.400000000000006 110.183 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.07 111.33 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.881 0.872 . . . . 54.439999999999998 111.467 -174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.71 -43.91 29.56 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.249 0.547 . . . . 42.530000000000001 110.434 169.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.19 -73.7 0.23 Allowed Glycine 0 N--CA 1.471 0.975 0 CA-C-N 115.32 -0.854 . . . . 64.129999999999995 111.192 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -41.22 61.64 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.6 0.76 . . . . 75.209999999999994 110.827 172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.62 149.32 44.15 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.635 -0.711 . . . . 74.129999999999995 111.163 -171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m -144.1 134.86 25.06 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.75 0.82 . . . . 44.340000000000003 110.547 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 77' ' ' CYS . . . -98.64 146.36 25.93 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.614 0.366 . . . . 74.430000000000007 110.118 173.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -115.81 128.02 55.51 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.478 0.711 . . . . 75.510000000000005 111.16 -170.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -120.87 108.87 14.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.653 0.781 . . . . 72.519999999999996 109.679 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.9 m -93.44 101.7 13.91 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.156 0.582 . . . . 52.020000000000003 110.846 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.18 123.95 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.298 0.639 . . . . 74.549999999999997 110.456 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.5 p -122.25 114.97 21.56 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.176 0.99 . . . . 65.340000000000003 110.784 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 69' ' ' PRO . 26.1 mm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 122.045 0.926 . . . . 74.120000000000005 111.106 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.8 t60 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.541 0.21 . . . . 74.319999999999993 110.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.4 mtt -112.49 94.82 29.17 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.894 0.878 . . . . 63.32 109.641 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.07 -165.51 0.34 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.965 2.443 . . . . 72.230000000000004 112.985 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.589 HG22 ' HB1' ' A' ' 79' ' ' ALA . 2.8 p -120.34 90.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 122.438 1.113 . . . . 75.430000000000007 111.656 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -85.77 -178.28 6.57 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.829 -1.078 . . . . 73.420000000000002 111.408 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 29' ' ' VAL . 55.1 mt -126.05 118.81 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.249 1.02 . . . . 63.399999999999999 109.595 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.55 -28.94 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.758 0.423 . . . . 63.409999999999997 111.326 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 28.8 t70 -146.87 133.73 9.95 Favored Pre-proline 0 CA--C 1.563 1.456 0 C-N-CA 124.038 0.935 . . . . 75.209999999999994 110.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.6 155.24 99.94 Favored 'Cis proline' 0 C--N 1.372 1.796 0 CA-C-N 120.26 1.129 . . . . 70.0 113.092 -1.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -79.64 4.04 17.26 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.543 0.737 . . . . 65.519999999999996 112.25 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -165.67 -177.65 4.46 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.976 0.91 . . . . 74.019999999999996 111.436 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.53 119.3 12.1 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.156 0.982 . . . . 64.230000000000004 111.54 168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.3 t -92.43 112.22 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 122.752 0.421 . . . . 64.329999999999998 110.918 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.83 124.01 32.6 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.882 -0.785 . . . . 75.25 108.882 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.75 112.66 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.231 0.612 . . . . 73.030000000000001 110.863 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -77.29 114.08 15.73 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.124 -1.065 . . . . 74.420000000000002 108.124 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -120.58 156.24 32.04 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.452 0.644 . . . . 64.209999999999994 112.409 -173.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -118.86 143.13 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 C-N-CA 124.596 1.158 . . . . 72.400000000000006 108.092 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.464 HG23 ' HD3' ' A' ' 69' ' ' PRO . 65.2 m -58.08 -44.85 87.81 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.01 0.924 . . . . 73.319999999999993 113.091 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 t -87.85 8.49 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.31 0.644 . . . . 71.219999999999999 112.541 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -107.42 160.84 15.34 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.572 0.749 . . . . 72.329999999999998 111.72 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.8 p -97.02 124.26 40.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.747 0.819 . . . . 70.400000000000006 111.432 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -109.89 120.68 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.525 0.73 . . . . 74.219999999999999 110.948 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.509 ' HG3' HG22 ' A' ' 63' ' ' VAL . 49.8 ttm -100.65 104.89 16.22 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.551 0.74 . . . . 74.439999999999998 110.003 172.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -78.33 98.81 6.08 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.656 0.782 . . . . 42.450000000000003 109.546 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.5 128.17 36.46 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.446 0.699 . . . . 42.439999999999998 111.686 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.7 t -146.12 126.71 14.2 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 74.230000000000004 110.696 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 38.0 tt0 -125.25 116.86 22.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.478 1.111 . . . . 71.099999999999994 109.296 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 36' ' ' VAL . 35.7 m -89.4 168.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.741 -0.6 . . . . 61.409999999999997 111.819 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.87 -42.24 40.7 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.565 0.746 . . . . 74.430000000000007 111.64 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 4' ' ' VAL . 17.9 tpt180 -99.57 113.11 25.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.572 0.349 . . . . 70.129999999999995 110.647 -173.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -65.83 -36.45 83.53 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.885 0.874 . . . . 70.420000000000002 112.356 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.35 -31.24 63.57 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.828 1.047 . . . . 73.219999999999999 113.828 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.61 123.33 69.6 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.679 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.94 84.61 1.99 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.898 2.399 . . . . 75.150000000000006 110.403 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG11 HG11 ' A' ' 29' ' ' VAL . 4.1 m -71.5 152.59 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-O 121.065 0.459 . . . . 61.130000000000003 111.373 -172.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.82 142.15 51.37 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 112.57 0.582 . . . . 73.409999999999997 112.57 -162.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -95.82 138.01 34.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.568 1.147 . . . . 75.439999999999998 109.977 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 54.7 m-85 -119.13 127.28 53.2 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.04 0.536 . . . . 65.329999999999998 110.466 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 45' ' ' VAL . 4.2 tmtt? -95.82 99.07 10.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.386 -0.968 . . . . 55.299999999999997 108.386 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 60.96 22.93 13.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.836 1.255 . . . . 64.019999999999996 111.524 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.84 2.53 88.53 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 116.167 -0.47 . . . . 64.099999999999994 114.176 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -83.18 3.49 30.73 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.701 0.8 . . . . 65.230000000000004 112.071 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 70.33 125.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.379 1.472 . . . . 71.439999999999998 112.154 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 HG22 ' HB2' ' A' ' 40' ' ' LYS . 46.3 t -80.16 117.36 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.017 0.437 . . . . 44.240000000000002 110.08 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -111.44 152.95 26.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.948 0.899 . . . . 74.120000000000005 109.335 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.21 94.18 0.5 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.091 0.556 . . . . 61.219999999999999 111.099 -175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.51 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 34.6 t -86.69 -176.35 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.766 0.826 . . . . 44.450000000000003 111.065 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.58 -45.0 85.78 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.108 0.963 . . . . 71.129999999999995 110.865 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HD1' ' HG2' ' A' ' 65' ' ' PRO . 95.3 m-85 -89.18 -42.84 11.42 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.358 -0.837 . . . . 75.519999999999996 111.776 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.9 t -69.01 98.81 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 120.947 0.403 . . . . 64.530000000000001 111.141 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 63' ' ' VAL . 18.4 m -109.86 119.82 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.724 0.773 . . . . 73.209999999999994 109.855 174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 81.5 mt -95.24 116.74 29.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.758 0.823 . . . . 72.209999999999994 110.442 -177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -96.14 120.09 35.8 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.292 -0.633 . . . . 61.020000000000003 109.292 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -130.7 115.14 16.28 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -175.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.69 92.55 3.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.744 1.218 . . . . 75.340000000000003 109.021 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.73 -111.73 3.76 Favored Glycine 0 CA--C 1.553 2.422 0 CA-C-O 119.219 -0.767 . . . . 71.439999999999998 113.788 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.61 -11.81 15.42 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.964 2.442 . . . . 64.409999999999997 113.541 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 46.7 m-70 -77.64 110.21 12.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.249 0.619 . . . . 70.329999999999998 109.66 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.571 ' HG3' HG22 ' A' ' 36' ' ' VAL . 22.9 mmm180 -134.06 96.09 3.56 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.933 0.893 . . . . 71.099999999999994 110.218 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.5 ptp180 -121.66 156.71 32.44 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.751 0.648 . . . . 70.549999999999997 112.751 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.13 117.31 33.73 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.614 1.166 . . . . 71.230000000000004 108.626 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.6 t -106.23 129.14 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.165 0.586 . . . . 71.200000000000003 110.193 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.52 104.85 27.71 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.67 0.788 . . . . 71.340000000000003 109.816 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HG2' ' HD1' ' A' ' 50' ' ' PHE . 32.1 Cg_endo -62.76 -49.34 5.5 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.53 2.82 . . . . 64.109999999999999 114.179 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.05 91.36 3.56 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.067 0.547 . . . . 71.340000000000003 109.844 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 90' ' ' ILE . 8.7 m -72.84 88.58 1.34 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.327 0.651 . . . . 72.150000000000006 111.35 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -73.0 146.28 87.25 Favored Pre-proline 0 N--CA 1.486 1.342 0 C-N-CA 124.19 0.996 . . . . 61.340000000000003 112.087 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HD3' HG23 ' A' ' 19' ' ' THR . 76.0 Cg_exo -51.73 -38.48 66.72 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.674 2.916 . . . . 64.340000000000003 114.573 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 96.6 p -65.79 -39.52 91.04 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 111.019 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 19.4 t70 -75.63 -10.17 59.21 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 123.75 0.82 . . . . 73.409999999999997 111.621 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.03 69.22 3.3 Favored Glycine 0 N--CA 1.475 1.287 0 O-C-N 122.026 -0.422 . . . . 44.240000000000002 113.203 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.07 -150.31 7.27 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 122.904 -0.174 . . . . 62.229999999999997 113.094 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -92.35 127.22 37.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.83 0.852 . . . . 65.450000000000003 110.287 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 90.0 m-85 -113.32 114.01 26.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.882 0.473 . . . . 72.219999999999999 110.24 177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.3 tt0 -102.16 99.46 9.59 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.808 0.843 . . . . 73.109999999999999 109.542 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 51.3 t -88.78 98.03 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.97 0.508 . . . . 75.510000000000005 109.973 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.9 t -88.17 118.07 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.323 0.649 . . . . 64.430000000000007 110.393 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -74.94 -46.15 37.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.276 0.56 . . . . 63.32 111.159 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.44 -52.7 0.73 Allowed Glycine 0 N--CA 1.47 0.91 0 CA-C-N 114.957 -1.019 . . . . 44.109999999999999 110.683 -174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.473 ' H ' HG13 ' A' ' 4' ' ' VAL . 31.1 t70 -85.97 -56.68 3.35 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.922 -0.77 . . . . 73.25 108.922 170.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -104.62 -179.58 3.98 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.455 0.702 . . . . 71.439999999999998 111.895 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 53.1 t -154.12 124.67 7.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.721 0.808 . . . . 74.219999999999999 110.98 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.49 130.22 40.96 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.105 0.962 . . . . 70.409999999999997 110.394 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -106.84 130.57 54.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.391 0.676 . . . . 72.319999999999993 111.653 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.664 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 22.3 m-85 -117.08 143.05 46.22 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.661 1.185 . . . . 73.230000000000004 109.061 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.3 m -137.0 105.3 5.72 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.282 0.633 . . . . 55.219999999999999 110.097 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.59 130.66 45.95 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.534 0.733 . . . . 65.129999999999995 110.67 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.6 m -124.86 112.58 16.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.057 0.943 . . . . 74.129999999999995 109.787 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 17' ' ' ALA . 46.6 mt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.897 0.879 . . . . 43.32 110.71 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 119.7 -0.191 . . . . 65.120000000000005 110.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt 60.98 94.13 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 124.967 1.307 . . . . 74.109999999999999 111.396 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.76 160.02 47.17 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.386 2.058 . . . . 64.349999999999994 113.001 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 79' ' ' ALA . 7.1 p -127.85 72.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-O 123.288 1.518 . . . . 74.209999999999994 110.462 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -75.69 132.93 40.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 113.809 -1.541 . . . . 74.219999999999999 109.592 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 HG21 ' HB2' ' A' ' 84' ' ' ALA . 36.2 mt -76.32 96.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 109.335 -0.617 . . . . 64.329999999999998 109.335 171.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.0 m -68.62 -22.88 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 71.150000000000006 113.04 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 37.3 t70 -153.23 110.34 2.63 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.099 0.56 . . . . 60.399999999999999 110.312 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 55.7 Cg_endo -86.95 162.62 50.31 Favored 'Cis proline' 0 C--N 1.378 2.131 0 CA-C-N 119.946 1.017 . . . . 62.149999999999999 114.556 -1.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -93.76 -10.77 33.11 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 111.256 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.04 -167.86 2.65 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.516 0.727 . . . . 40.350000000000001 111.926 -166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.11 114.1 21.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.344 1.058 . . . . 72.409999999999997 110.348 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 78.9 t -86.47 110.48 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 122.818 0.447 . . . . 71.329999999999998 109.881 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -78.39 110.86 13.83 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.309 0.576 . . . . 74.400000000000006 110.787 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.04 138.32 48.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 125.133 1.373 . . . . 65.430000000000007 109.901 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -130.35 121.51 26.13 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.423 0.689 . . . . 74.439999999999998 109.714 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.57 156.48 48.81 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.448 0.699 . . . . 23.120000000000001 111.92 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 51.1 mm -91.48 162.46 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.365 0 C-N-CA 124.478 1.111 . . . . 74.340000000000003 109.235 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' THR . 80.9 p -62.67 9.88 0.04 OUTLIER 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.451 1.649 . . . . 62.0 115.451 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 m -141.56 16.79 2.19 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.793 0.837 . . . . 64.420000000000002 112.499 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 18' ' ' ILE . 17.4 mm-40 -89.82 165.78 13.93 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.339 0.866 . . . . 54.039999999999999 113.339 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.3 115.46 29.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 110.652 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.7 t -124.43 123.39 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 123.747 0.819 . . . . 72.439999999999998 111.682 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.567 ' HG2' HG13 ' A' ' 63' ' ' VAL . 79.3 mtp -105.4 100.14 9.73 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.613 0.765 . . . . 74.209999999999994 110.904 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.597 HD12 HD22 ' A' ' 62' ' ' LEU . 69.9 mt -83.08 129.32 35.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.632 0.773 . . . . 60.350000000000001 109.573 173.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -126.31 121.62 33.14 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.653 0.612 . . . . 71.340000000000003 112.653 -172.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' SG ' HG11 ' A' ' 36' ' ' VAL . 34.9 t -122.82 137.31 54.97 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.728 1.211 . . . . 74.230000000000004 111.189 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.21 145.14 28.14 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.075 0.55 . . . . 63.43 111.17 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.8 170.67 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.483 1.113 . . . . 73.030000000000001 111.872 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -82.22 -40.25 21.92 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.638 0.375 . . . . 74.030000000000001 110.899 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -89.53 96.51 10.73 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.312 0.645 . . . . 73.430000000000007 109.998 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -61.6 -23.45 66.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.753 0.821 . . . . 73.439999999999998 112.865 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.02 -31.16 70.8 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 124.492 1.117 . . . . 72.349999999999994 112.285 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.42 99.34 52.68 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.495 0.718 . . . . 73.030000000000001 110.952 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.22 177.13 5.5 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.02 2.48 . . . . 73.519999999999996 113.606 172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG11 ' SG ' ' A' ' 27' ' ' CYS . 2.8 m -109.29 157.02 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 120.991 0.424 . . . . 63.0 110.823 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' CYS . 93.7 mtt180 -97.68 156.59 16.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.277 -0.638 . . . . 75.400000000000006 109.277 165.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -106.66 126.43 52.27 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.19 0.596 . . . . 72.519999999999996 110.173 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 44.4 m-85 -118.23 178.17 4.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.486 1.115 . . . . 75.209999999999994 110.443 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HE2' ' HA ' ' A' ' 71' ' ' ASP . 5.0 ttmp? -133.79 -91.54 0.35 Allowed 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 123.148 0.579 . . . . 75.329999999999998 110.145 173.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.35 -34.22 23.69 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.69 1.196 . . . . 74.200000000000003 111.285 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 177.11 -29.18 0.07 OUTLIER Glycine 0 N--CA 1.469 0.856 0 N-CA-C 110.524 -1.031 . . . . 54.240000000000002 110.524 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.59 147.18 41.89 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.712 0.805 . . . . 74.239999999999995 110.774 170.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 10.5 pt-20 -92.71 147.76 22.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.458 0.647 . . . . 54.030000000000001 110.301 171.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.6 t -88.75 105.26 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 124.279 1.032 . . . . 74.439999999999998 110.824 -169.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -93.93 63.84 3.31 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 108.533 -0.914 . . . . 75.530000000000001 108.533 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 47.65 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.126 1.371 . . . . 73.230000000000004 113.031 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.95 70.83 3.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.758 -0.589 . . . . 73.120000000000005 111.337 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.8 t70 53.54 -70.57 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 126.453 1.901 . . . . 74.319999999999993 113.898 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.18 -37.62 84.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.255 1.022 . . . . 74.329999999999998 111.677 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG22 HD21 ' A' ' 64' ' ' LEU . 55.0 t -61.67 123.89 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 122.802 0.441 . . . . 43.43 111.957 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.95 128.44 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 123.708 0.803 . . . . 63.329999999999998 110.293 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.66 118.63 37.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 74.310000000000002 110.691 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -106.24 137.53 44.02 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.461 0.705 . . . . 73.340000000000003 111.372 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -134.74 127.94 31.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.759 0.824 . . . . 60.450000000000003 111.284 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.6 86.23 2.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.669 0.788 . . . . 75.230000000000004 109.02 173.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.44 -114.11 6.23 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-O 119.236 -0.758 . . . . 55.420000000000002 113.188 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 5.7 Cg_endo -77.66 -15.06 15.55 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.394 2.062 . . . . 72.329999999999998 112.592 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -73.55 116.28 13.95 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.802 0.841 . . . . 61.439999999999998 110.322 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.13 105.51 6.71 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.394 1.078 . . . . 71.219999999999999 109.47 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -127.56 135.39 50.25 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.155 0.798 . . . . 71.409999999999997 113.155 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD22 HD12 ' A' ' 25' ' ' LEU . 8.9 tt -96.97 107.88 20.5 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.149 1.38 . . . . 74.150000000000006 109.233 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG13 ' HG2' ' A' ' 24' ' ' MET . 62.8 t -106.58 132.42 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-O 121.416 0.627 . . . . 62.340000000000003 111.288 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.521 HD21 HG22 ' A' ' 51' ' ' VAL . 1.9 mm? -111.98 119.76 43.56 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.469 1.107 . . . . 73.439999999999998 110.58 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.14 -37.44 10.63 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.485 2.123 . . . . 72.230000000000004 112.691 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.1 107.54 5.04 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.466 0.706 . . . . 74.310000000000002 111.014 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' THR . 18.0 p -79.01 89.48 4.77 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.421 1.088 . . . . 71.439999999999998 111.704 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -78.78 163.27 61.64 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 123.401 0.68 . . . . 72.230000000000004 111.092 177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -61.85 -14.66 37.98 Favored 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.399 2.066 . . . . 74.420000000000002 112.884 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.2 t -53.16 -47.86 68.44 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.556 1.143 . . . . 32.439999999999998 112.051 166.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.453 ' HA ' ' HE2' ' A' ' 40' ' ' LYS . 15.7 m-20 -105.02 25.93 9.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.422 0.689 . . . . 71.299999999999997 112.026 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.22 135.92 14.47 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 116.205 -0.452 . . . . 34.350000000000001 113.074 169.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.16 -165.16 22.59 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.441 -0.663 . . . . 70.239999999999995 111.441 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -93.13 148.67 21.82 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.926 0.49 . . . . 55.420000000000002 111.117 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.78 146.4 43.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.255 1.022 . . . . 73.340000000000003 110.141 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -131.07 111.62 12.16 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.097 0.559 . . . . 63.43 111.293 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 59.3 m -85.25 117.93 24.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.107 0.563 . . . . 43.130000000000003 110.154 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -107.22 111.07 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-N 118.495 0.589 . . . . 75.25 110.994 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -86.77 -36.89 18.33 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.528 0.731 . . . . 73.209999999999994 112.039 176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.99 -58.18 0.67 Allowed Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.399 -0.68 . . . . 74.209999999999994 111.399 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -71.57 -53.95 12.09 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.942 0.897 . . . . 72.120000000000005 109.911 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -130.98 173.55 10.88 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.773 0.797 . . . . 62.329999999999998 112.547 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 66.3 m -135.32 129.9 34.18 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.776 -1.102 . . . . 71.430000000000007 110.979 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -93.87 153.47 18.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.991 0.916 . . . . 61.340000000000003 110.627 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -128.86 138.92 52.31 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.615 0.721 . . . . 74.409999999999997 111.603 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -121.66 150.73 41.32 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.955 1.302 . . . . 63.43 107.83 170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.3 m -132.52 99.55 4.69 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.441 -0.578 . . . . 52.329999999999998 109.441 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.83 101.31 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.068 0.461 . . . . 42.5 110.406 -173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.3 m -82.42 109.73 16.92 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.569 -0.53 . . . . 75.409999999999997 109.569 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.046 0.538 . . . . 71.340000000000003 110.817 179.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 111.816 0.302 . . . . 75.109999999999999 111.816 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 ptp 40.43 64.52 4.65 Favored Pre-proline 0 N--CA 1.509 2.491 0 C-N-CA 125.669 1.588 . . . . 63.509999999999998 114.689 -176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.64 76.82 1.48 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.917 2.411 . . . . 62.009999999999998 111.892 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -146.76 120.29 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 CA-C-O 121.82 0.819 . . . . 71.230000000000004 112.543 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -88.68 166.17 14.26 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.042 -0.981 . . . . 44.149999999999999 110.772 171.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 84' ' ' ALA . 53.3 mt -103.32 87.47 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.106 0.479 . . . . 72.400000000000006 109.849 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -61.43 -25.64 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 112.976 0.732 . . . . 73.439999999999998 112.976 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.762 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 16.4 t70 -143.12 120.93 7.04 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 124.204 1.002 . . . . 53.109999999999999 109.395 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 61.0 Cg_endo -83.72 167.12 62.5 Favored 'Cis proline' 0 CA--C 1.558 1.713 0 CA-C-N 120.13 1.082 . . . . 73.049999999999997 113.631 -4.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mmp_? -104.52 26.14 9.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.143 0.977 . . . . 71.25 110.728 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -154.99 179.88 8.71 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.25 1.02 . . . . 75.510000000000005 110.866 -170.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -104.37 99.72 9.42 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.122 0.969 . . . . 74.010000000000005 108.78 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.37 119.45 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 72.340000000000003 112.01 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -86.02 108.58 18.3 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 109.677 -0.49 . . . . 62.32 109.677 175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 61.7 t -98.86 104.06 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.959 0.904 . . . . 74.25 109.72 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -77.31 132.67 38.73 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.155 0.582 . . . . 73.329999999999998 110.763 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.3 164.37 32.55 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.5 0.667 . . . . 61.420000000000002 112.208 -170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 55.9 mt -128.71 158.59 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.182 0.993 . . . . 73.420000000000002 108.992 177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.8 p -59.83 140.73 56.38 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.304 0.641 . . . . 70.150000000000006 111.431 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m 66.36 15.05 9.97 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.531 1.132 . . . . 43.229999999999997 113.845 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 63.8 mm-40 -102.44 178.73 4.5 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.16 0.584 . . . . 72.530000000000001 111.578 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.4 m -106.74 124.38 49.52 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.187 0.595 . . . . 65.010000000000005 111.99 -176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 67.1 t -112.11 130.91 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.193 0.997 . . . . 64.25 110.624 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.58 ' HG3' HG22 ' A' ' 63' ' ' VAL . 50.1 ttm -126.68 98.54 5.42 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.239 0.542 . . . . 70.409999999999997 110.629 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.73 99.14 8.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.179 0.992 . . . . 73.299999999999997 111.048 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.02 120.75 31.49 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.004 0.522 . . . . 53.100000000000001 110.651 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.2 t -133.79 114.62 13.58 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.209 0.604 . . . . 72.120000000000005 110.482 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.762 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 46.4 tt0 -98.05 135.65 39.43 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.281 0.562 . . . . 73.0 110.471 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -111.7 165.24 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.89 0.876 . . . . 74.150000000000006 111.415 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -74.47 -33.71 62.95 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 123.518 0.727 . . . . 64.120000000000005 112.468 -172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -103.28 136.49 42.94 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.534 0.733 . . . . 63.009999999999998 109.987 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.42 -43.76 96.56 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.036 0.446 . . . . 73.319999999999993 110.658 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -89.21 59.79 5.06 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 121.936 0.874 . . . . 45.200000000000003 109.805 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.54 102.67 49.78 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.401 0.68 . . . . 62.340000000000003 111.153 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.6 100.15 1.34 Allowed 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.477 2.118 . . . . 71.010000000000005 112.207 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 m -77.99 153.61 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.165 0.507 . . . . 75.120000000000005 111.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -110.1 156.97 19.85 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.714 0.805 . . . . 72.430000000000007 109.034 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -128.37 132.54 48.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.093 0.557 . . . . 64.340000000000003 109.566 177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 95.1 m-85 -129.35 177.85 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.815 0.846 . . . . 75.510000000000005 109.912 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -161.98 -70.33 0.06 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.532 0.682 . . . . 70.25 110.512 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.14 14.45 30.74 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.474 1.11 . . . . 61.210000000000001 111.838 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.51 -26.89 20.11 Favored Glycine 0 N--CA 1.477 1.388 0 C-N-CA 123.275 0.464 . . . . 41.130000000000003 112.037 -168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -68.94 131.5 45.2 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.092 0.957 . . . . 71.439999999999998 111.986 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -66.27 115.79 6.62 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 109.288 -0.634 . . . . 73.430000000000007 109.288 165.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.0 t -83.15 92.33 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.471 0.653 . . . . 75.109999999999999 110.228 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -89.39 159.37 17.35 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.365 1.066 . . . . 71.400000000000006 110.445 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -76.15 67.23 2.42 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.871 0.868 . . . . 73.530000000000001 110.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -71.36 -45.96 61.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.014 0.925 . . . . 75.430000000000007 111.808 -174.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -160.3 -63.95 0.07 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.658 0.783 . . . . 63.130000000000003 109.553 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -71.05 -59.21 2.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.599 -0.728 . . . . 72.540000000000006 111.44 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.99 123.17 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.832 0.853 . . . . 73.129999999999995 112.022 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 63' ' ' VAL . 10.6 m -126.46 117.17 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 CA-C-O 121.65 0.738 . . . . 71.450000000000003 110.211 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.26 98.94 11.28 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.132 0.973 . . . . 74.129999999999995 109.286 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -96.23 112.22 24.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.236 0.614 . . . . 74.430000000000007 109.363 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -115.64 112.66 22.45 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.06 0.544 . . . . 72.400000000000006 110.839 -172.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -113.83 92.09 3.86 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.466 1.107 . . . . 73.310000000000002 109.484 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.85 -112.27 3.68 Favored Glycine 0 CA--C 1.547 2.074 0 CA-C-O 119.63 -0.539 . . . . 63.130000000000003 113.738 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.6 -29.21 20.2 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.992 2.461 . . . . 61.219999999999999 113.516 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -72.19 121.06 18.69 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.284 0.634 . . . . 74.319999999999993 111.199 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -128.24 101.74 6.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.417 1.087 . . . . 73.010000000000005 109.618 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.457 ' NH1' ' SD ' ' A' ' 24' ' ' MET . 12.6 ptp180 -119.99 130.58 54.81 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 -174.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tt -92.07 116.38 28.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.683 1.193 . . . . 70.519999999999996 108.991 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 24' ' ' MET . 12.9 t -111.06 142.55 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-O 121.04 0.448 . . . . 64.319999999999993 110.545 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.26 115.72 18.63 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 124.216 1.006 . . . . 72.349999999999994 109.878 -174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.22 -55.89 1.35 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.593 2.862 . . . . 74.230000000000004 113.653 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.73 112.94 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.761 0.824 . . . . 52.240000000000002 109.36 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 m -47.3 -39.1 13.9 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 124.85 1.26 . . . . 74.540000000000006 113.593 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 15.6 mm-40 67.23 139.07 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 125.295 1.438 . . . . 71.530000000000001 113.013 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 7.6 Cg_exo -74.96 48.45 1.99 Allowed 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.376 2.718 . . . . 64.340000000000003 112.653 174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.8 t -167.23 -52.76 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.22 1.008 . . . . 71.310000000000002 109.638 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -75.74 -30.72 59.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 113.126 0.787 . . . . 74.530000000000001 113.126 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.81 92.79 0.17 Allowed Glycine 0 CA--C 1.537 1.417 0 N-CA-C 112.412 -0.275 . . . . 70.540000000000006 112.412 172.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.08 -156.29 7.51 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 113.639 0.216 . . . . 62.210000000000001 113.639 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 40' ' ' LYS . 41.0 mt-10 -90.81 98.24 11.66 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.217 0.607 . . . . 63.329999999999998 111.482 -174.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.2 m-85 -88.3 152.1 22.17 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 73.409999999999997 112.056 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -129.67 111.18 12.42 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.883 0.873 . . . . 70.340000000000003 110.719 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.0 t -86.08 101.71 13.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.742 0.417 . . . . 53.420000000000002 109.959 172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.87 101.08 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 C-N-CA 123.026 0.531 . . . . 71.200000000000003 110.402 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.83 -52.03 8.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.077 0.551 . . . . 61.450000000000003 112.019 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.07 -71.2 0.07 OUTLIER Glycine 0 N--CA 1.468 0.787 0 CA-C-N 115.658 -0.701 . . . . 64.340000000000003 111.596 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.45 -48.91 29.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.096 0.558 . . . . 74.540000000000006 111.749 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.1 171.22 8.25 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.934 0.716 . . . . 75.530000000000001 112.934 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -135.48 124.12 23.71 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 55.32 110.261 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.52 123.16 37.78 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.619 0.768 . . . . 53.340000000000003 111.278 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -90.76 124.83 35.43 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.393 0.677 . . . . 61.219999999999999 111.638 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -118.18 108.17 14.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.972 0.909 . . . . 74.120000000000005 108.814 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 88.2 m -91.72 101.16 13.77 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.83 -0.433 . . . . 62.43 109.83 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 63.7 t -89.35 110.52 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.948 0.499 . . . . 72.239999999999995 109.748 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.2 p -97.69 126.07 42.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.069 0.948 . . . . 74.340000000000003 110.121 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.569 0.7 . . . . 71.530000000000001 111.118 -179.261 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.459 0.171 . . . . 64.400000000000006 110.741 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -120.99 83.79 38.23 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 123.393 0.677 . . . . 72.140000000000001 110.765 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 58.5 Cg_endo -92.97 172.55 2.05 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.525 2.817 . . . . 74.409999999999997 113.762 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HB3' ' A' ' 31' ' ' ARG . 5.2 p -76.08 127.98 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-O 121.697 0.76 . . . . 73.310000000000002 112.88 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -114.8 150.96 34.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.458 1.103 . . . . 65.129999999999995 110.742 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 79.6 mt -95.17 112.81 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.505 0.722 . . . . 70.099999999999994 109.787 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -80.53 -19.37 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.244 0.617 . . . . 74.219999999999999 112.091 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 24.4 t70 -163.09 120.91 1.26 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.626 0.771 . . . . 71.239999999999995 111.094 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HG2' ' HB1' ' A' ' 84' ' ' ALA . 68.1 Cg_endo -88.2 128.73 9.19 Favored 'Cis proline' 0 C--N 1.374 1.874 0 CA-C-N 120.321 1.15 . . . . 43.140000000000001 113.22 -5.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -72.71 -16.35 61.67 Favored 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 123.547 0.739 . . . . 71.430000000000007 110.549 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -113.02 -179.87 3.77 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.37 1.068 . . . . 71.299999999999997 112.384 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -94.14 116.16 28.53 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.175 0.99 . . . . 72.450000000000003 110.062 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.96 126.38 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.765 0.826 . . . . 74.209999999999994 111.02 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -87.28 141.37 28.69 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.63 -0.507 . . . . 72.319999999999993 109.63 171.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.39 126.03 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 C-N-CA 123.961 0.904 . . . . 72.109999999999999 111.135 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -83.6 130.86 35.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.621 0.768 . . . . 75.439999999999998 109.28 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -143.06 133.57 24.93 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.367 0.506 . . . . 75.030000000000001 112.367 -176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' HB ' ' HG3' ' A' ' 21' ' ' GLU . 68.0 mt -123.95 156.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.439 1.096 . . . . 72.099999999999994 108.271 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.6 p -55.62 -24.56 34.05 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.832 0.853 . . . . 75.510000000000005 113.235 175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.497 ' H ' HG22 ' A' ' 18' ' ' ILE . 80.5 p -94.75 -4.91 46.5 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.776 0.831 . . . . 75.329999999999998 113.119 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.6 ' HG3' ' HB ' ' A' ' 18' ' ' ILE . 57.9 mt-10 -95.21 149.37 21.39 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 112.632 0.605 . . . . 74.099999999999994 112.632 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -95.76 112.43 24.15 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.297 -0.865 . . . . 63.409999999999997 110.14 171.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -111.43 110.12 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.681 0.793 . . . . 71.530000000000001 110.731 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.488 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 52.6 ttm -105.02 103.71 13.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.029 0.532 . . . . 55.32 110.199 174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.0 mt -82.61 122.82 28.6 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.535 0.734 . . . . 73.510000000000005 109.588 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.3 131.98 56.33 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.362 0.528 . . . . 72.329999999999998 111.772 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -130.41 141.99 50.52 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.114 0.966 . . . . 75.230000000000004 110.498 175.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.42 136.98 30.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.609 0.763 . . . . 74.129999999999995 110.781 -169.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.39 160.0 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.922 0.889 . . . . 74.25 112.244 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.91 -25.43 37.53 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.531 0.732 . . . . 73.450000000000003 110.952 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB3' HG23 ' A' ' 4' ' ' VAL . 30.2 tpt180 -108.9 91.44 3.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.696 1.198 . . . . 75.310000000000002 109.367 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -20.64 65.93 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 112.401 0.519 . . . . 70.010000000000005 112.401 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -61.91 -28.28 69.41 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.092 0.957 . . . . 72.200000000000003 111.812 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.31 96.07 49.34 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.583 0.753 . . . . 54.450000000000003 110.306 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.64 165.83 26.43 Favored 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.72 2.28 . . . . 63.329999999999998 113.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 HG11 ' SG ' ' A' ' 27' ' ' CYS . 5.0 m -81.98 159.1 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.399 0.619 . . . . 73.239999999999995 110.854 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HG3' ' HE1' ' A' ' 39' ' ' TYR . 6.7 ptp85 -128.25 127.1 42.2 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 108.111 -1.07 . . . . 74.439999999999998 108.111 172.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.41 ' CZ3' ' SG ' ' A' ' 77' ' ' CYS . 90.5 m95 -85.54 128.7 34.83 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.267 0.627 . . . . 75.040000000000006 110.407 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 27.6 m-85 -115.38 129.53 56.61 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 72.019999999999996 109.862 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.0 ttmt -79.78 -43.59 22.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.634 0.374 . . . . 72.329999999999998 111.242 -178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.3 88.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.634 1.174 . . . . 61.100000000000001 109.082 174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.69 -43.09 3.19 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 116.639 -0.255 . . . . 44.229999999999997 113.658 -177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -106.59 148.59 28.11 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.676 0.791 . . . . 73.140000000000001 110.409 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 1.8 pm0 -71.37 152.37 43.23 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.731 0.812 . . . . 71.450000000000003 112.52 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 40' ' ' LYS . 25.2 t -78.7 121.88 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.116 0.967 . . . . 71.349999999999994 110.627 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.81 144.75 27.55 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.18 0.592 . . . . 74.219999999999999 110.612 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -74.2 87.84 1.96 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.014 0.526 . . . . 75.219999999999999 110.024 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.621 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 32.5 t -80.9 -172.63 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.393 1.077 . . . . 54.450000000000003 111.416 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -55.68 -39.26 70.73 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.151 0.98 . . . . 53.049999999999997 112.446 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -115.63 20.24 14.79 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.498 0.719 . . . . 73.540000000000006 111.579 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.621 ' HB ' ' H ' ' A' ' 48' ' ' SER . 47.5 t -128.75 123.46 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.167 0.587 . . . . 74.439999999999998 109.827 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG23 ' HB ' ' A' ' 63' ' ' VAL . 12.4 m -134.03 131.78 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.315 0.646 . . . . 74.239999999999995 110.963 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.56 104.07 16.08 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 109.2 -0.667 . . . . 74.040000000000006 109.2 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -97.87 113.27 25.04 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.239 0.616 . . . . 74.230000000000004 110.403 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -112.84 147.5 36.83 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.362 0.665 . . . . 75.239999999999995 111.674 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -160.21 106.21 1.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.044 0.938 . . . . 72.109999999999999 109.662 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.64 -123.94 34.8 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-O 119.585 -0.564 . . . . 73.120000000000005 113.985 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.05 -22.69 14.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.189 1.926 . . . . 70.329999999999998 113.211 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -79.93 121.77 25.86 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.49 0.716 . . . . 73.010000000000005 110.839 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -127.32 105.86 8.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.805 0.842 . . . . 75.140000000000001 110.228 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 96.4 mtt180 -102.87 120.47 40.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.722 0.809 . . . . 75.420000000000002 112.216 -173.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tt -87.1 107.05 18.28 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.479 -0.934 . . . . 73.409999999999997 108.479 162.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' HB ' HG23 ' A' ' 52' ' ' VAL . 34.6 t -104.48 122.74 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.249 0.62 . . . . 64.340000000000003 111.087 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.51 99.08 52.37 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 123.908 0.883 . . . . 64.5 109.792 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.47 -43.19 53.62 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 123.293 2.662 . . . . 71.150000000000006 113.12 174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.4 99.62 4.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.777 0.831 . . . . 74.019999999999996 108.778 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 m -70.78 87.77 0.71 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.576 0.703 . . . . 74.420000000000002 111.906 -171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -72.92 153.3 91.05 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.927 0.891 . . . . 63.420000000000002 111.849 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.2 -27.97 24.42 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.768 2.979 . . . . 71.5 114.499 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.6 p -58.82 -39.18 80.43 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.818 0.847 . . . . 65.519999999999996 112.135 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.08 18.09 8.53 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.185 0.994 . . . . 71.319999999999993 112.741 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.57 111.32 4.05 Favored Glycine 0 N--CA 1.477 1.424 0 N-CA-C 112.02 -0.432 . . . . 71.120000000000005 112.02 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.47 -165.87 35.93 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 117.177 0.489 . . . . 70.349999999999994 113.76 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -99.74 104.8 16.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.493 0.717 . . . . 74.340000000000003 111.062 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 57.8 m-85 -89.67 114.77 26.45 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.392 0.615 . . . . 54.43 111.719 -173.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 57.5 tt0 -101.03 107.22 18.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.444 1.098 . . . . 73.519999999999996 110.241 -177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.41 ' SG ' ' CZ3' ' A' ' 38' ' ' TRP . 4.4 m -79.49 97.89 6.6 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.343 0.657 . . . . 41.450000000000003 109.501 175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.0 t -91.54 101.94 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 122.622 0.369 . . . . 71.329999999999998 110.75 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.85 -55.59 6.01 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.393 0.616 . . . . 72.340000000000003 110.037 173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.77 -62.51 0.23 Allowed Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.118 -0.946 . . . . 72.420000000000002 111.067 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 3' ' ' PRO . 21.1 t70 -83.33 -49.84 8.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.154 0.582 . . . . 64.299999999999997 109.482 169.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 21.0 mm-40 -93.14 155.55 17.41 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.218 0.822 . . . . 72.049999999999997 113.218 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.2 p -144.8 116.52 8.18 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.287 -1.324 . . . . 62.439999999999998 109.92 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB1' ' HG2' ' A' ' 9' ' ' PRO . . . -94.28 154.61 17.43 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.797 0.839 . . . . 65.439999999999998 110.475 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -129.94 124.45 33.1 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.406 0.521 . . . . 70.030000000000001 112.406 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -111.73 139.25 47.35 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.641 1.177 . . . . 73.239999999999995 109.38 171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.3 m -110.58 100.89 9.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 109.773 -0.455 . . . . 71.310000000000002 109.773 172.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.15 102.61 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.502 0.721 . . . . 71.200000000000003 109.728 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.7 m -100.5 117.13 34.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.585 -0.734 . . . . 62.420000000000002 110.579 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 38.7 mt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.989 0.899 . . . . 72.530000000000001 111.018 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 p-80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.563 -0.162 . . . . 75.349999999999994 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 43.9 ttm -167.47 121.65 0.8 Allowed Pre-proline 0 N--CA 1.482 1.156 0 C-N-CA 123.376 0.67 . . . . 71.319999999999993 110.727 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.92 99.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.971 2.448 . . . . 75.319999999999993 112.99 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG23 ' H ' ' A' ' 31' ' ' ARG . 3.4 p -72.0 96.54 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.071 0.939 . . . . 74.430000000000007 112.036 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -83.56 130.58 35.0 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.461 -0.791 . . . . 74.430000000000007 111.306 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 64.3 mt -73.0 95.41 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.713 0.768 . . . . 71.349999999999994 109.138 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.66 -34.99 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-N 113.939 -1.482 . . . . 42.119999999999997 113.069 -175.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -165.07 133.39 2.55 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 123.47 0.708 . . . . 75.349999999999994 110.034 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.96 122.5 8.74 Favored 'Cis proline' 0 C--N 1.381 2.251 0 CA-C-N 120.841 1.336 . . . . 71.349999999999994 113.368 -0.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.74 42.65 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.575 -1.193 . . . . 74.140000000000001 110.83 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.35 -172.85 4.31 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.129 0.972 . . . . 44.420000000000002 111.069 -174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -111.3 101.95 10.39 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.956 0.902 . . . . 71.409999999999997 109.445 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 57.6 t -93.75 108.66 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.14 0.576 . . . . 71.230000000000004 111.754 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.31 109.68 13.88 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.766 -0.457 . . . . 73.519999999999996 109.766 170.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 94.3 t -88.12 139.58 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.962 -0.755 . . . . 65.319999999999993 108.962 173.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.38 122.29 42.46 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.638 -0.664 . . . . 73.349999999999994 109.969 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.01 172.33 10.05 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.181 0.592 . . . . 72.450000000000003 112.255 -173.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.96 161.52 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.215 0 C-N-CA 124.672 1.189 . . . . 60.109999999999999 108.773 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.58 HG22 ' HD3' ' A' ' 69' ' ' PRO . 81.4 p -54.83 124.09 15.47 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.283 0.633 . . . . 45.020000000000003 111.142 172.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 m 69.49 13.14 8.34 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.599 1.16 . . . . 70.150000000000006 113.502 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -99.51 129.15 45.66 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.322 0.649 . . . . 75.420000000000002 109.549 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.1 p -67.29 132.39 47.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.453 0.909 . . . . 64.409999999999997 113.453 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 15' ' ' VAL . 86.9 t -109.64 146.87 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.632 1.173 . . . . 51.25 110.746 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 49.6 ttm -137.87 109.07 6.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.229 0.612 . . . . 74.340000000000003 109.941 170.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 28.5 mt -86.84 104.61 16.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.928 0.891 . . . . 73.430000000000007 110.423 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.78 125.04 34.21 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.001 0.52 . . . . 71.019999999999996 111.599 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.11 116.97 7.7 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.688 0.795 . . . . 64.140000000000001 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -99.04 140.15 33.62 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.677 0.791 . . . . 73.140000000000001 111.699 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -111.92 156.67 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.366 1.067 . . . . 73.450000000000003 111.267 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.2 -34.02 65.72 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.321 0.649 . . . . 71.349999999999994 111.686 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' H ' HG23 ' A' ' 4' ' ' VAL . 3.7 tpp180 -125.13 116.67 22.41 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.149 0.579 . . . . 75.109999999999999 109.998 -172.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -71.18 -40.57 71.15 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.95 0.9 . . . . 71.25 110.758 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.89 -20.86 66.15 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 112.176 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.93 112.79 12.61 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.113 0.565 . . . . 75.150000000000006 110.895 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.93 110.53 3.06 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.437 2.091 . . . . 73.340000000000003 112.721 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.624 HG11 ' HG3' ' A' ' 60' ' ' ARG . 29.4 m -73.45 151.19 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.035 0.534 . . . . 72.549999999999997 111.942 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -132.87 113.33 12.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.002 0.921 . . . . 74.25 110.089 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -86.86 145.18 26.68 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.884 0.873 . . . . 61.439999999999998 109.48 174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 93.6 m-85 -127.94 127.16 42.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.059 0.544 . . . . 73.329999999999998 110.677 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -93.83 101.44 13.54 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.019 0.928 . . . . 43.420000000000002 108.783 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.3 t70 66.32 -72.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.27 1.428 . . . . 62.119999999999997 112.366 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 6.72 1.27 Allowed Glycine 0 N--CA 1.476 1.334 0 CA-C-O 120.201 -0.221 . . . . 74.349999999999994 113.25 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -118.26 152.41 35.78 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.051 0.94 . . . . 61.439999999999998 109.903 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.4 150.12 33.19 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.312 0.577 . . . . 74.299999999999997 112.077 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.3 t -102.71 141.59 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 111.82 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -134.74 176.1 8.95 Favored 'General case' 0 CA--C 1.562 1.412 0 C-N-CA 124.391 1.076 . . . . 62.439999999999998 108.672 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -74.68 72.55 1.98 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 121.54 0.686 . . . . 71.099999999999994 109.412 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.2 m -67.83 -49.06 64.28 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.166 -0.924 . . . . 53.030000000000001 111.83 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -178.68 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.896 1.278 . . . . 74.010000000000005 108.968 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -71.92 -40.51 68.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.752 -0.658 . . . . 53.229999999999997 110.496 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG22 HD21 ' A' ' 64' ' ' LEU . 7.9 t -76.63 122.82 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.875 -0.602 . . . . 64.310000000000002 110.257 178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.68 132.12 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.036 0.534 . . . . 51.409999999999997 110.679 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.0 mt -106.37 111.37 23.92 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.709 0.804 . . . . 71.010000000000005 109.92 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.517 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 28.7 mm-40 -97.88 116.31 29.83 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.25 0.62 . . . . 74.239999999999995 111.519 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -100.45 113.08 25.56 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.402 0.681 . . . . 75.209999999999994 109.846 176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.6 82.49 2.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.685 0.794 . . . . 74.019999999999996 109.037 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -122.37 23.54 Favored Glycine 0 CA--C 1.544 1.862 0 CA-C-O 119.126 -0.819 . . . . 54.229999999999997 112.599 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.12 -5.13 11.23 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.674 2.25 . . . . 73.239999999999995 113.569 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -87.29 109.6 19.62 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.282 0.633 . . . . 75.109999999999999 110.314 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' HG3' HG11 ' A' ' 36' ' ' VAL . 25.4 mmt180 -107.4 126.6 52.69 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.885 0.874 . . . . 74.409999999999997 109.284 178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 8.8 ptp85 -142.34 123.97 15.0 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.269 0.557 . . . . 65.340000000000003 112.324 -176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 25' ' ' LEU . 7.5 tt -87.08 112.94 22.4 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.879 0.871 . . . . 71.200000000000003 108.768 174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.0 t -101.49 133.45 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 122.913 0.485 . . . . 64.349999999999994 110.241 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -128.87 101.45 20.11 Favored Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 123.819 0.848 . . . . 73.340000000000003 109.436 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.77 -70.36 0.03 OUTLIER 'Trans proline' 0 CA--C 1.567 2.128 0 C-N-CA 122.747 2.298 . . . . 65.349999999999994 113.182 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.71 76.92 8.75 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.197 0.599 . . . . 52.25 109.912 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' HD12 ' A' ' 64' ' ' LEU . 85.6 m -60.99 -59.14 5.85 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.765 0.826 . . . . 62.130000000000003 112.187 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 63.09 174.3 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 C-N-CA 123.927 0.891 . . . . 64.340000000000003 111.74 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HD3' HG22 ' A' ' 19' ' ' THR . 18.6 Cg_endo -58.68 -14.17 20.63 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.078 1.852 . . . . 61.109999999999999 112.501 165.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -52.89 -53.3 51.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.918 1.287 . . . . 63.409999999999997 112.405 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -103.48 27.86 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.562 0.745 . . . . 75.519999999999996 112.719 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.95 55.53 4.34 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 116.459 -0.337 . . . . 64.549999999999997 112.638 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.27 -165.83 12.96 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 122.69 0.186 . . . . 71.25 113.013 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.62 151.99 30.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.522 0.729 . . . . 65.030000000000001 112.739 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 89.0 m-85 -137.95 133.51 33.81 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.339 1.056 . . . . 70.239999999999995 110.255 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 27.7 tt0 -123.45 116.46 23.26 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.284 0.634 . . . . 74.409999999999997 110.996 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -98.56 100.46 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.217 0.607 . . . . 50.520000000000003 110.954 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.79 110.15 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.199 0.6 . . . . 74.430000000000007 110.355 175.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.51 72.4 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.292 0.637 . . . . 61.530000000000001 111.357 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.97 -51.44 0.61 Allowed Glycine 0 N--CA 1.474 1.171 0 CA-C-N 115.69 -0.686 . . . . 50.049999999999997 111.772 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -94.43 -51.9 4.57 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.731 0.812 . . . . 71.230000000000004 110.081 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.88 163.12 12.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.305 0.642 . . . . 71.329999999999998 111.829 177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.1 p -137.96 121.97 17.85 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.012 0.925 . . . . 73.5 110.496 176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.89 144.36 25.52 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.942 0.897 . . . . 71.120000000000005 110.411 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.65 127.85 55.49 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.47 0.652 . . . . 74.540000000000006 111.579 -175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -121.01 157.58 29.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.415 1.486 . . . . 64.409999999999997 109.094 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.9 m -147.27 112.86 5.65 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.723 0.409 . . . . 72.420000000000002 110.475 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 86.1 t -88.02 124.73 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.213 -0.662 . . . . 62.039999999999999 109.213 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 m -125.74 122.77 37.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.927 0.891 . . . . 75.209999999999994 109.874 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 73.319999999999993 110.872 -176.149 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.5 ttt -142.07 121.07 7.81 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.133 0.973 . . . . 74.430000000000007 109.388 172.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.37 108.01 2.41 Favored 'Trans proline' 0 CA--C 1.561 1.841 0 C-N-CA 122.114 1.876 . . . . 74.200000000000003 112.864 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -64.07 117.39 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-O 121.559 0.695 . . . . 74.099999999999994 110.778 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.93 154.54 23.94 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.048 0.928 . . . . 71.349999999999994 112.67 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -85.31 108.03 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 114.124 -1.398 . . . . 74.340000000000003 109.608 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -82.88 -23.31 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 123.412 0.685 . . . . 74.409999999999997 111.999 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 24.0 t70 -150.78 133.77 8.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.202 1.001 . . . . 63.399999999999999 110.162 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.51 -2.39 28.72 Favored 'Cis proline' 0 C--N 1.375 1.96 0 CA-C-N 120.907 1.359 . . . . 61.530000000000001 112.551 -6.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 73.87 -69.66 0.18 Allowed 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.224 1.81 . . . . 72.030000000000001 112.525 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.57 179.48 4.08 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.369 1.068 . . . . 72.129999999999995 113.478 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -76.2 108.89 9.45 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 115.176 -0.92 . . . . 54.32 109.955 174.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.32 141.38 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.765 0.826 . . . . 71.409999999999997 111.184 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -101.32 138.15 38.71 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.957 0.903 . . . . 74.430000000000007 109.81 172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.3 t -129.98 122.38 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 123.821 0.849 . . . . 75.019999999999996 109.637 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -88.56 105.11 17.43 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.826 -0.435 . . . . 73.219999999999999 109.826 172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -88.19 156.33 19.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.067 0.947 . . . . 73.530000000000001 112.752 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 20' ' ' SER . 40.4 mm -128.16 144.03 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.81 1.244 . . . . 73.540000000000006 108.038 168.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 67' ' ' THR . 40.0 p -54.36 -41.78 69.55 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.896 0.878 . . . . 53.539999999999999 113.05 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 18' ' ' ILE . 32.6 t -80.97 -5.96 58.17 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 113.155 0.798 . . . . 72.530000000000001 113.155 -177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -110.86 154.43 24.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.042 0.537 . . . . 73.430000000000007 111.571 -176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 65' ' ' PRO . 60.8 m -94.52 123.13 37.76 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.961 0.905 . . . . 35.109999999999999 110.757 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.0 t -97.2 116.68 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.514 0.726 . . . . 60.329999999999998 110.994 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.414 ' HG2' HG22 ' A' ' 63' ' ' VAL . 74.4 mtp -107.07 95.34 5.64 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.756 0.822 . . . . 52.210000000000001 110.334 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -81.72 115.66 21.06 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.678 0.791 . . . . 64.120000000000005 110.09 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 145.11 25.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.38 0.537 . . . . 63.130000000000003 111.819 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 36' ' ' VAL . 51.0 t -143.3 143.14 31.58 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.87 0.868 . . . . 73.109999999999999 110.563 171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 58' ' ' PRO . 33.7 tt0 -146.72 129.59 16.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.61 1.164 . . . . 60.109999999999999 109.681 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 m -110.14 175.74 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.824 0.85 . . . . 64.230000000000004 110.813 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.45 -14.56 61.27 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 112.745 0.646 . . . . 72.400000000000006 112.745 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -121.99 119.85 32.69 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.874 0.87 . . . . 74.310000000000002 111.761 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.83 -36.47 70.0 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.438 0.637 . . . . 73.030000000000001 110.454 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -52.65 -27.35 16.84 Favored 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 125.565 1.546 . . . . 75.099999999999994 113.606 177.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.42 106.08 29.98 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 123.736 0.815 . . . . 74.239999999999995 111.88 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -85.77 118.82 1.83 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.357 2.705 . . . . 72.219999999999999 110.552 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 27' ' ' CYS . 19.7 m -69.75 154.82 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 112.128 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -95.43 109.01 21.26 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.096 -0.705 . . . . 72.0 109.096 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -85.25 120.96 27.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.887 0.475 . . . . 63.299999999999997 109.918 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 76' ' ' GLN . 90.5 m-85 -118.55 138.05 52.8 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.588 0.755 . . . . 64.239999999999995 111.546 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -93.58 171.67 8.75 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 124.742 1.217 . . . . 72.109999999999999 108.046 165.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.34 108.88 0.76 Allowed 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.83 -0.544 . . . . 72.349999999999994 110.988 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.48 -43.84 2.47 Favored Glycine 0 N--CA 1.48 1.606 0 CA-C-N 116.047 -0.524 . . . . 45.210000000000001 114.383 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.03 158.72 28.57 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.179 0.992 . . . . 74.409999999999997 109.964 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.4 pt-20 -81.81 152.9 26.71 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.815 -0.553 . . . . 65.099999999999994 111.158 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -72.89 107.89 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.226 0.61 . . . . 74.120000000000005 110.436 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.31 141.81 32.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.798 0.839 . . . . 72.219999999999999 109.967 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -73.36 145.19 46.12 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.238 0.542 . . . . 72.099999999999994 111.316 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.5 t -161.31 -166.25 1.5 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.624 1.17 . . . . 72.510000000000005 109.674 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.08 -39.91 90.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.364 0.666 . . . . 44.509999999999998 110.937 172.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -89.75 -7.43 54.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.705 0.802 . . . . 72.219999999999999 112.574 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.07 123.7 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 123.189 0.596 . . . . 63.030000000000001 110.778 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.1 m -133.41 127.61 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 118.326 0.512 . . . . 52.329999999999998 110.554 174.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.71 130.68 35.95 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.723 0.409 . . . . 62.530000000000001 110.142 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -97.39 149.96 21.54 Favored 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 108.714 -0.847 . . . . 71.120000000000005 108.714 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.586 HD22 ' H ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -134.91 135.3 41.47 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.167 0.587 . . . . 74.329999999999998 112.04 -172.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -161.73 82.97 0.59 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.414 0.685 . . . . 72.010000000000005 110.215 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.35 22.06 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 119.378 -0.679 . . . . 73.420000000000002 113.929 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' HB2' ' HG3' ' A' ' 28' ' ' GLU . 21.8 Cg_exo -66.77 -16.33 49.9 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.77 2.313 . . . . 52.240000000000002 113.014 174.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -83.35 117.13 22.8 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.421 0.688 . . . . 71.5 111.558 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -116.21 125.23 51.97 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.769 -1.197 . . . . 74.430000000000007 107.769 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 55.6 mtt180 -118.71 154.95 31.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.301 0.641 . . . . 72.439999999999998 111.351 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 tt -112.23 113.41 25.63 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.85 -1.167 . . . . 75.030000000000001 107.85 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' VAL . 42.9 t -108.59 110.57 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.243 0.617 . . . . 74.140000000000001 109.473 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -100.33 101.3 14.33 Favored Pre-proline 0 CA--C 1.56 1.349 0 N-CA-C 108.455 -0.943 . . . . 54.210000000000001 108.455 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 Cg_endo -54.01 -71.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 123.17 2.58 . . . . 70.430000000000007 113.598 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 89.73 4.85 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.118 -0.697 . . . . 71.019999999999996 109.118 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.628 ' HA ' HD12 ' A' ' 64' ' ' LEU . 19.0 m -65.28 100.0 0.43 Allowed 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.568 0.699 . . . . 52.340000000000003 112.081 -173.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -68.86 150.46 97.61 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 114.967 -1.015 . . . . 72.319999999999993 111.665 -173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 90' ' ' ILE . 85.1 Cg_exo -50.92 -35.59 50.13 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.137 2.558 . . . . 72.409999999999997 113.539 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.7 t -64.82 -27.15 68.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.097 0.959 . . . . 71.439999999999998 112.586 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -80.56 4.64 17.79 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 112.792 0.664 . . . . 62.149999999999999 112.792 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -81.84 127.83 8.14 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.694 -0.562 . . . . 12.35 111.694 170.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.59 -121.61 1.27 Allowed Glycine 0 C--N 1.338 0.664 0 CA-C-O 119.698 -0.501 . . . . 51.140000000000001 112.147 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -130.57 139.15 50.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 117.726 0.763 . . . . 65.310000000000002 112.067 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.73 138.08 54.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.434 1.094 . . . . 75.519999999999996 110.266 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mt-30 -111.71 152.73 27.42 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.459 0.703 . . . . 74.099999999999994 111.604 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.47 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 60.3 m -130.17 96.77 4.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.821 0.848 . . . . 73.200000000000003 109.311 168.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.11 121.23 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 118.541 0.609 . . . . 72.25 110.57 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.7 -70.08 0.82 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 35.520000000000003 110.9 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.77 98.78 0.16 Allowed Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.25 -0.74 . . . . 52.5 111.25 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 63.87 19.61 11.82 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.594 1.157 . . . . 70.400000000000006 112.375 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.12 143.92 18.38 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.035 0.534 . . . . 54.409999999999997 111.304 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 76' ' ' GLN . 42.7 t -136.4 140.18 43.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.722 0.809 . . . . 54.439999999999998 112.034 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.0 133.61 38.58 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.778 0.831 . . . . 74.030000000000001 109.299 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.18 127.17 55.77 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.941 0.496 . . . . 74.319999999999993 111.076 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.47 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 91.5 m-85 -120.74 110.9 16.92 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.606 0.762 . . . . 73.540000000000006 110.54 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.3 p -92.07 102.8 15.34 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.282 0.563 . . . . 73.239999999999995 110.941 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.3 t -94.69 126.7 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 124.611 1.164 . . . . 71.140000000000001 110.881 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -121.09 118.9 30.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.66 0.784 . . . . 51.140000000000001 110.161 176.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.615 HG13 ' HA ' ' A' ' 69' ' ' PRO . 29.8 mm . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 123.628 0.771 . . . . 62.530000000000001 111.623 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.459 0.171 . . . . 63.310000000000002 110.845 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -145.59 150.71 44.63 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 123.308 0.643 . . . . 61.329999999999998 110.4 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.52 137.97 57.5 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.162 2.575 . . . . 63.409999999999997 114.301 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.9 p -80.56 111.81 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 122.091 0.948 . . . . 61.119999999999997 112.142 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -108.4 164.87 11.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.213 1.005 . . . . 75.230000000000004 111.574 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -108.52 118.44 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.781 0.833 . . . . 73.510000000000005 109.787 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 30' ' ' ASP . 15.8 m -80.11 -26.26 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 112.171 0.434 . . . . 64.319999999999993 112.171 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.86 131.87 4.62 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 118.745 -0.645 . . . . 74.450000000000003 110.188 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.58 164.01 69.14 Favored 'Cis proline' 0 C--N 1.376 1.999 0 CA-C-N 121.001 1.393 . . . . 74.430000000000007 113.43 -1.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -102.69 13.37 34.62 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.103 -0.953 . . . . 71.340000000000003 111.158 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.6 -178.5 6.37 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.935 0.874 . . . . 75.450000000000003 113.19 -165.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -94.88 99.72 11.72 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 113.845 -1.525 . . . . 74.310000000000002 109.841 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.05 111.86 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 111.779 -173.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -82.1 116.71 21.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.261 0.624 . . . . 72.239999999999995 110.925 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.465 ' HB ' HG22 ' A' ' 88' ' ' VAL . 41.2 t -109.44 144.1 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 C-N-CA 124.331 1.053 . . . . 74.109999999999999 110.541 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -113.59 128.57 56.48 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.68 0.792 . . . . 63.130000000000003 110.718 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 90' ' ' ILE . . . -142.57 110.73 6.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.911 0.485 . . . . 62.43 111.64 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.59 73.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 109.539 -0.541 . . . . 75.099999999999994 109.539 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 56.62 -74.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 126.094 1.758 . . . . 70.219999999999999 113.919 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.1 m -64.07 -15.88 60.51 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.59 1.156 . . . . 74.519999999999996 113.164 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -68.25 129.54 40.23 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 113.26 0.837 . . . . 64.219999999999999 113.26 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 p -81.32 125.85 30.87 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.33 -0.85 . . . . 55.219999999999999 110.701 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -123.51 136.46 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.292 1.037 . . . . 52.32 110.925 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.414 ' SD ' ' HD3' ' A' ' 61' ' ' ARG . 47.1 ttm -127.49 103.64 7.46 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.006 0.522 . . . . 51.43 110.301 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.1 mt -78.72 103.05 8.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.06 0.944 . . . . 63.119999999999997 110.421 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.51 126.67 35.05 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.743 0.417 . . . . 20.399999999999999 111.896 -175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.2 m -133.05 112.98 12.25 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.058 0.943 . . . . 71.439999999999998 110.047 168.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 84.7 mt-10 -103.06 128.66 49.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.717 0.807 . . . . 74.099999999999994 110.517 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.2 m -95.09 146.72 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.871 0.868 . . . . 62.399999999999999 111.424 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB2' HG13 ' A' ' 7' ' ' VAL . 19.1 t70 -67.25 -48.06 68.88 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.543 0.737 . . . . 62.009999999999998 110.47 172.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.55 96.1 9.96 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 108.068 -1.086 . . . . 72.340000000000003 108.068 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.12 -53.23 28.8 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.471 1.108 . . . . 63.310000000000002 113.313 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.38 -9.41 41.18 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 113.765 1.024 . . . . 72.109999999999999 113.765 -171.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.33 131.24 27.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.042 0.537 . . . . 44.25 110.695 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.09 -179.96 4.76 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.975 2.45 . . . . 73.5 114.063 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 18.6 m -112.89 167.69 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-O 121.812 0.815 . . . . 73.019999999999996 111.756 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -131.67 104.91 7.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.861 1.264 . . . . 74.030000000000001 109.059 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -86.18 140.31 30.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.611 -0.515 . . . . 74.239999999999995 109.611 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.3 m-85 -133.03 153.4 51.52 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.841 0.856 . . . . 74.540000000000006 111.325 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -169.75 121.93 0.71 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.469 0.708 . . . . 63.5 111.369 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 53.11 61.88 2.95 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.306 1.442 . . . . 64.200000000000003 112.97 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.13 -27.6 2.71 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 115.24 0.856 . . . . 71.200000000000003 115.24 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -105.13 -177.12 3.27 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.874 0.87 . . . . 74.219999999999999 110.535 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 15.2 pt-20 -110.97 149.59 30.45 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.637 0.375 . . . . 74.349999999999994 110.341 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 62' ' ' LEU . 44.4 t -77.39 117.71 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 122.808 0.443 . . . . 71.239999999999995 110.832 -175.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -113.27 170.09 8.48 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.259 1.023 . . . . 71.230000000000004 109.449 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.4 122.45 20.38 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 122.343 -0.223 . . . . 72.430000000000007 110.938 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.1 m -146.24 -156.15 0.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.278 1.031 . . . . 63.43 110.595 -172.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -54.81 101.32 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.055 0.942 . . . . 63.409999999999997 112.529 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 92.1 m-85 65.7 13.27 8.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.84 1.256 . . . . 71.329999999999998 112.593 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 64' ' ' LEU . 47.3 t -109.96 121.01 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.976 0.91 . . . . 71.299999999999997 109.507 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -136.19 143.85 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.383 0.673 . . . . 71.019999999999996 110.734 176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.96 93.77 4.67 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.463 0.705 . . . . 71.129999999999995 109.522 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -98.82 111.61 23.95 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 74.439999999999998 110.195 -178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -134.65 126.14 28.54 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.746 0.818 . . . . 42.210000000000001 109.483 -171.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 132.04 27.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 122.871 0.468 . . . . 75.510000000000005 111.58 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.0 -138.15 39.15 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.778 -0.457 . . . . 73.239999999999995 113.107 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.6 -15.5 19.43 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.74 2.293 . . . . 62.039999999999999 112.51 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 33.9 m-70 -82.38 100.22 9.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.364 0.666 . . . . 70.420000000000002 110.585 -174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' HG13 ' A' ' 36' ' ' VAL . 31.3 mmt180 -99.64 143.99 29.25 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.542 -0.911 . . . . 74.010000000000005 108.542 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.414 ' HD3' ' SD ' ' A' ' 24' ' ' MET . 5.4 ptp180 -161.49 143.31 11.65 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.155 1.168 . . . . 72.239999999999995 114.155 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.491 HD11 HG11 ' A' ' 45' ' ' VAL . 9.8 tt -93.24 120.76 33.89 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.043 1.337 . . . . 75.439999999999998 108.78 174.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 52' ' ' VAL . 21.8 t -108.94 133.93 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 122.933 0.493 . . . . 73.310000000000002 110.685 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.15 91.48 23.45 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.987 0.915 . . . . 74.439999999999998 109.112 -179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 19.1 Cg_endo -53.39 -33.25 65.8 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.8 3.0 . . . . 61.409999999999997 114.279 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.03 97.98 3.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.658 0.783 . . . . 72.209999999999994 109.362 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.4 m -74.92 91.53 2.49 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.349 0.595 . . . . 74.510000000000005 111.487 -173.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.29 145.45 90.35 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.44 1.096 . . . . 72.219999999999999 111.537 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 90' ' ' ILE . 96.6 Cg_exo -43.19 -46.27 9.34 Favored 'Trans proline' 0 C--N 1.39 2.729 0 C-N-CA 123.378 2.719 . . . . 75.450000000000003 114.16 173.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.8 m -68.84 -29.98 68.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.374 0.67 . . . . 62.119999999999997 112.603 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -92.26 9.68 32.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.306 0.642 . . . . 71.439999999999998 112.524 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.1 -165.66 23.96 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 122.35 -0.219 . . . . 52.43 112.732 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.57 -81.1 0.43 Allowed Glycine 0 N--CA 1.475 1.291 0 O-C-N 122.819 -0.224 . . . . 44.350000000000001 113.559 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -133.44 138.68 46.31 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.265 0.626 . . . . 60.240000000000002 112.51 -172.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 96.5 m-85 -143.44 141.42 30.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.303 1.041 . . . . 75.230000000000004 110.077 172.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -142.21 124.27 15.38 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.278 0.631 . . . . 62.520000000000003 109.598 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 52.8 t -120.74 97.33 5.5 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.905 0.706 . . . . 73.109999999999999 112.905 -168.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -84.97 114.52 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.492 0.717 . . . . 73.340000000000003 111.486 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.87 -34.72 57.78 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.368 0.604 . . . . 53.310000000000002 110.765 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.25 -66.1 0.28 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.262 -0.881 . . . . 63.32 111.382 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.21 -58.56 3.16 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.243 0.617 . . . . 54.420000000000002 111.024 172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.07 165.41 11.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.257 0.623 . . . . 55.229999999999997 111.811 -176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 p -141.48 129.41 21.87 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.92 0.888 . . . . 51.109999999999999 111.435 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.59 127.5 41.68 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.081 0.953 . . . . 53.109999999999999 111.12 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.06 140.56 36.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.938 0.495 . . . . 73.430000000000007 111.793 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 97.0 m-85 -138.21 141.94 39.98 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.225 1.01 . . . . 71.400000000000006 110.193 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 96.6 m -134.91 106.34 6.81 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.27 0.628 . . . . 73.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 15' ' ' VAL . 44.2 t -96.89 102.42 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 C-N-CA 123.16 0.584 . . . . 51.140000000000001 110.969 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 87.7 m -77.25 115.58 17.14 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.909 0.484 . . . . 65.310000000000002 110.047 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 69' ' ' PRO . 34.4 mm . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 121.207 0.527 . . . . 73.140000000000001 111.113 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 43.5 m80 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 110.48 -0.193 . . . . 72.239999999999995 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.8 mtt -78.88 147.9 71.29 Favored Pre-proline 0 CA--C 1.57 1.731 0 C-N-CA 123.749 0.82 . . . . 72.140000000000001 111.654 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.8 143.6 29.27 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.937 3.092 . . . . 73.510000000000005 116.317 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 34' ' ' ALA . 9.9 p -93.74 148.38 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.94 0.896 . . . . 72.219999999999999 110.575 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.516 ' H ' ' HB3' ' A' ' 30' ' ' ASP . 75.5 m-70 -126.68 179.65 5.24 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.719 0.808 . . . . 64.400000000000006 110.92 -176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.91 113.97 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.252 0.621 . . . . 73.409999999999997 109.462 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.15 -35.07 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.329 0 C-N-CA 123.381 0.672 . . . . 63.119999999999997 111.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.16 132.38 5.54 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 123.647 0.779 . . . . 75.129999999999995 110.078 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.11 130.28 20.32 Favored 'Cis proline' 0 C--N 1.379 2.159 0 CA-C-N 120.636 1.263 . . . . 71.010000000000005 112.586 -3.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -77.36 -7.44 56.08 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 124.765 1.226 . . . . 71.040000000000006 111.827 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.61 -174.62 4.66 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.494 1.117 . . . . 72.129999999999995 111.313 -171.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -74.36 129.7 38.28 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.091 0.556 . . . . 74.049999999999997 110.643 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.9 t -109.84 142.66 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.084 0.953 . . . . 64.450000000000003 110.617 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -112.7 130.6 56.0 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.953 0.901 . . . . 61.030000000000001 109.312 170.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 64.7 t -123.53 111.38 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.601 0.76 . . . . 73.510000000000005 110.258 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -86.19 107.92 18.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 122.08 -0.387 . . . . 45.229999999999997 110.109 173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.04 167.28 10.82 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.42 0.629 . . . . 61.219999999999999 112.381 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 89.6 mt -107.82 150.54 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 124.697 1.199 . . . . 73.219999999999999 109.094 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.9 p -58.67 115.14 2.86 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 122.75 0.42 . . . . 51.329999999999998 111.056 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 8.5 t 71.03 29.71 2.89 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.943 1.297 . . . . 60.030000000000001 112.978 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 22.4 tt0 -79.22 163.62 24.83 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 111.151 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 21' ' ' GLU . 25.1 p -94.22 108.65 20.51 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 122.997 0.519 . . . . 63.130000000000003 110.001 166.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.33 138.83 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 123.901 0.88 . . . . 63.130000000000003 110.731 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 45.8 ttm -122.66 110.4 15.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 122.882 0.473 . . . . 74.230000000000004 110.825 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 74.8 mt -86.54 102.72 14.38 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.151 0.58 . . . . 73.219999999999999 110.028 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 113.17 22.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.99 0.516 . . . . 64.239999999999995 111.808 -172.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.9 t -127.57 141.65 51.58 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.857 0.863 . . . . 72.310000000000002 110.574 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 88.0 mt-10 -140.94 136.57 32.35 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.889 1.276 . . . . 65.510000000000005 110.284 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -98.34 162.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.067 0.947 . . . . 75.540000000000006 112.706 -173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 5' ' ' HIS . 6.0 t70 -72.13 -29.64 64.26 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.481 1.112 . . . . 72.109999999999999 112.68 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -130.7 134.72 47.16 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.149 0.58 . . . . 74.310000000000002 111.429 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -61.44 -31.41 71.36 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 123.708 0.803 . . . . 72.150000000000006 110.68 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.74 -31.9 62.93 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 125.111 1.364 . . . . 62.43 112.652 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.46 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -100.37 141.43 22.7 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.072 0.549 . . . . 74.099999999999994 112.008 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -92.21 -151.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.607 2.871 . . . . 75.140000000000001 112.253 173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.9 m -139.13 163.7 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.833 0.853 . . . . 73.530000000000001 111.023 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -124.16 100.7 6.84 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.252 1.021 . . . . 65.109999999999999 109.279 171.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -87.47 136.31 32.99 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.875 0.47 . . . . 75.219999999999999 110.28 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 87.1 m-85 -120.7 126.67 50.79 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.357 0.663 . . . . 55.119999999999997 110.101 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 1.3 tmtp? -97.46 98.87 10.3 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.949 -1.13 . . . . 73.109999999999999 107.949 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 64.63 21.46 12.42 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.842 0.857 . . . . 70.349999999999994 111.193 -174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.38 -0.27 88.49 Favored Glycine 0 CA--C 1.544 1.846 0 O-C-N 121.797 -0.565 . . . . 33.039999999999999 114.326 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -65.17 -24.74 67.47 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 124.513 1.125 . . . . 61.520000000000003 113.621 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 75.73 122.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 125.286 1.435 . . . . 70.409999999999997 110.182 -164.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.92 102.07 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.326 0.584 . . . . 52.030000000000001 110.534 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -102.47 46.19 0.93 Allowed 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 107.322 -1.362 . . . . 71.219999999999999 107.322 167.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.9 mp0 55.6 24.93 7.47 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.11 -1.859 . . . . 64.150000000000006 113.375 -172.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.6 m -68.55 143.37 54.93 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.092 0.957 . . . . 74.340000000000003 111.556 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 60.49 39.18 18.57 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.321 1.048 . . . . 75.140000000000001 112.799 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 69.72 4.42 4.72 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 124.866 1.267 . . . . 74.140000000000001 113.59 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG22 HD23 ' A' ' 64' ' ' LEU . 47.1 t -70.95 94.8 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 118.334 0.515 . . . . 72.239999999999995 111.06 -176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.84 131.34 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.147 0.579 . . . . 74.040000000000006 111.214 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.65 118.77 37.5 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.329 0.651 . . . . 75.109999999999999 110.468 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.45 114.25 26.07 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.77 0.828 . . . . 73.329999999999998 110.496 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -119.62 125.05 47.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.868 0.867 . . . . 73.099999999999994 110.264 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -153.11 90.86 1.47 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.822 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.14 -111.67 4.35 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-O 119.572 -0.571 . . . . 75.340000000000003 113.438 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.88 -12.15 8.62 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.683 2.255 . . . . 75.239999999999995 113.0 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.742 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 53.3 m-70 -82.17 110.33 17.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.131 0.572 . . . . 73.040000000000006 110.547 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -128.0 53.04 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.84 0.856 . . . . 51.299999999999997 111.06 -170.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -97.84 148.06 23.79 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.21 0.819 . . . . 44.539999999999999 113.21 -167.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 9.4 tt -90.88 127.14 36.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.575 1.15 . . . . 64.519999999999996 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -111.3 138.82 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.468 0.707 . . . . 74.310000000000002 109.534 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HD2' ' A' ' 65' ' ' PRO . 3.2 tm? -139.27 120.98 9.96 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.73 0.812 . . . . 33.420000000000002 108.993 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.597 ' HD2' HD22 ' A' ' 64' ' ' LEU . 48.8 Cg_endo -84.52 -37.05 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.084 0 C-N-CA 123.488 2.792 . . . . 75.530000000000001 115.915 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.0 101.51 4.75 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.644 0.778 . . . . 64.329999999999998 110.253 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' HD11 ' A' ' 64' ' ' LEU . 3.8 m -68.49 -22.08 64.56 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.298 0.851 . . . . 73.430000000000007 113.298 -171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 20' ' ' SER . 52.8 mt-30 56.2 -161.95 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.915 0 C-N-CA 123.487 0.715 . . . . 65.319999999999993 110.509 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' GLN . 72.7 Cg_endo -80.77 -16.8 10.06 Favored 'Trans proline' 0 CA--C 1.569 2.236 0 CA-C-N 121.339 1.514 . . . . 73.109999999999999 112.218 151.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.9 m -62.18 -48.92 77.89 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.245 1.418 . . . . 65.420000000000002 114.585 -172.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 3.6 m-20 -82.83 22.93 0.86 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.485 0.92 . . . . 53.409999999999997 113.485 -171.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -96.27 83.8 0.82 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.384 -0.286 . . . . 64.230000000000004 112.384 172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.45 -158.97 16.55 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.175 0.43 . . . . 43.210000000000001 114.175 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.84 108.47 15.39 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.983 0.913 . . . . 52.5 112.058 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 30.1 m-85 -101.86 115.28 30.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.402 0.681 . . . . 73.200000000000003 109.895 173.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -113.75 130.08 56.49 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.153 0.581 . . . . 63.549999999999997 111.045 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 42.5 t -119.05 106.36 12.34 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.436 0.694 . . . . 72.409999999999997 111.099 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.8 t -104.34 110.56 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.92 0.488 . . . . 63.43 110.577 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.63 -50.02 54.65 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.738 0.78 . . . . 74.310000000000002 111.85 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.55 -87.97 0.07 OUTLIER Glycine 0 C--N 1.337 0.621 0 CA-C-N 114.649 -1.16 . . . . 63.409999999999997 110.706 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.76 -33.4 64.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.647 0.779 . . . . 73.349999999999994 111.707 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -114.91 162.23 17.21 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.277 0.631 . . . . 72.109999999999999 112.251 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -142.22 137.05 30.47 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.374 1.07 . . . . 75.129999999999995 111.267 -176.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.05 151.93 27.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.977 0.911 . . . . 74.340000000000003 110.651 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.81 130.4 52.56 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.0 0.52 . . . . 63.109999999999999 111.879 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.72 129.67 56.56 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.573 1.149 . . . . 75.129999999999995 109.239 173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.6 m -108.93 101.48 10.57 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.036 -0.728 . . . . 53.450000000000003 109.036 170.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.92 119.8 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 122.989 0.515 . . . . 74.540000000000006 109.702 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.8 m -121.65 120.11 33.78 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.274 0.629 . . . . 72.219999999999999 109.672 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.465 0.706 . . . . 71.420000000000002 111.732 -178.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.6 t60 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.264 0.554 . . . . 73.530000000000001 109.932 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.65 123.6 20.36 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 123.222 0.609 . . . . 75.409999999999997 110.678 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -95.69 -166.28 0.11 Allowed 'Trans proline' 0 CA--C 1.559 1.736 0 C-N-CA 123.439 2.759 . . . . 73.329999999999998 112.183 167.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 31' ' ' ARG . 7.7 p -107.98 153.75 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.493 0.717 . . . . 54.43 109.984 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.787 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 22.8 t60 -136.0 153.4 51.39 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.234 0.614 . . . . 72.140000000000001 110.341 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.629 HG12 ' HB3' ' A' ' 82' ' ' GLU . 42.8 mm -94.38 128.96 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 123.19 0.596 . . . . 52.240000000000002 110.199 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 30' ' ' ASP . 12.7 m -98.79 -27.95 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 122.714 0.406 . . . . 72.340000000000003 111.946 172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.54 129.57 3.43 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 122.952 0.501 . . . . 61.530000000000001 110.598 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -83.55 128.92 14.09 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 124.323 -1.115 . . . . 73.430000000000007 113.187 -6.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -68.45 -39.45 81.45 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.426 -0.806 . . . . 73.310000000000002 109.68 173.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.19 167.46 21.12 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.343 -1.298 . . . . 63.119999999999997 112.052 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -97.08 101.84 13.5 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.327 -0.99 . . . . 73.120000000000005 108.327 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.38 127.04 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.075 0.55 . . . . 74.219999999999999 111.931 -166.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -106.16 112.06 24.93 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.022 0.929 . . . . 54.109999999999999 109.005 172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 91.4 t -107.39 131.81 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 123.742 0.817 . . . . 72.150000000000006 110.221 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -88.65 129.76 35.44 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.703 -0.48 . . . . 74.25 109.703 169.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -117.92 148.2 42.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.555 0.742 . . . . 62.409999999999997 111.115 175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 73.8 mt -106.66 146.5 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.005 0.922 . . . . 62.329999999999998 108.901 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.8 p -63.38 134.12 55.19 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.22 0.608 . . . . 73.310000000000002 111.173 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.2 m 66.13 15.11 9.96 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.741 1.216 . . . . 74.340000000000003 113.727 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.05 146.75 32.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.137 0.575 . . . . 74.310000000000002 110.143 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.4 p -73.03 123.01 22.68 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.522 0.729 . . . . 64.129999999999995 112.503 -177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.68 123.2 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.732 0.813 . . . . 52.130000000000003 110.944 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 86.9 mtp -108.21 102.32 11.46 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.049 0.94 . . . . 62.009999999999998 110.307 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 68.8 mt -91.04 139.09 31.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.202 0.601 . . . . 70.439999999999998 109.471 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.6 128.12 32.55 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.497 0.554 . . . . 74.400000000000006 112.497 -174.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 76.5 m -137.18 115.36 11.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.05 0.94 . . . . 75.129999999999995 110.093 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 95.7 mt-10 -122.07 129.32 52.29 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.068 0.947 . . . . 61.219999999999999 110.813 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 6' ' ' ILE . 28.5 m -89.74 169.04 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.124 0.97 . . . . 50.229999999999997 112.475 -174.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.624 ' HB2' HG13 ' A' ' 7' ' ' VAL . 35.0 t70 -82.54 -27.22 31.78 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.474 1.11 . . . . 75.299999999999997 111.322 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' HB3' HG23 ' A' ' 4' ' ' VAL . 79.9 ttt180 -117.64 112.66 20.81 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.249 0.62 . . . . 75.420000000000002 110.965 -173.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.16 -25.3 65.42 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.453 1.101 . . . . 63.350000000000001 113.325 -177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.22 -35.95 78.6 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.284 1.034 . . . . 31.210000000000001 112.45 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.98 86.51 53.71 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.336 0.654 . . . . 50.030000000000001 111.039 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.55 168.81 23.68 Favored 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.16 2.573 . . . . 73.540000000000006 111.895 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -80.86 151.06 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.491 0.662 . . . . 72.420000000000002 111.538 -173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -109.64 121.15 44.56 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.487 1.115 . . . . 73.010000000000005 108.046 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -84.76 134.63 34.32 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.666 -0.494 . . . . 72.409999999999997 109.666 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 75' ' ' PHE . 98.3 m-85 -130.38 127.56 39.6 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.841 0.856 . . . . 71.430000000000007 110.023 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.65 105.55 15.64 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.972 0.909 . . . . 64.030000000000001 108.711 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.36 20.86 2.9 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 124.506 1.122 . . . . 54.439999999999998 113.747 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.04 -49.41 0.93 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 123.064 0.364 . . . . 73.019999999999996 113.268 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -76.17 134.52 39.89 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.109 0.564 . . . . 73.540000000000006 111.448 -172.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.95 123.26 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 120.883 0.373 . . . . 74.239999999999995 110.717 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.3 129.26 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 123.928 0.891 . . . . 73.430000000000007 111.203 -176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -139.53 168.32 20.08 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.264 1.026 . . . . 74.200000000000003 109.058 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.64 74.5 4.2 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.447 0.641 . . . . 65.450000000000003 111.379 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 m -71.27 -50.85 28.5 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.49 -0.777 . . . . 61.130000000000003 111.247 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -160.55 -71.19 0.07 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 110.082 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -78.66 -45.45 21.39 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.637 -0.71 . . . . 54.130000000000003 111.43 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG22 HD21 ' A' ' 64' ' ' LEU . 20.9 t -70.01 129.54 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-N 115.597 -0.729 . . . . 72.010000000000005 111.364 -178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.84 135.34 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.421 0.689 . . . . 61.32 110.135 170.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -110.72 119.77 40.22 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.502 0.721 . . . . 70.420000000000002 110.754 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.51 118.76 32.15 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.436 0.694 . . . . 75.099999999999994 109.17 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.21 124.93 23.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.782 0.833 . . . . 70.340000000000003 111.521 -173.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.96 102.19 1.64 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.48 0.712 . . . . 72.239999999999995 110.311 175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 -114.84 7.16 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 119.517 -0.601 . . . . 74.519999999999996 113.679 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -74.06 -21.71 17.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.756 2.304 . . . . 73.150000000000006 113.478 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 34.2 m-70 -81.33 131.08 35.27 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.485 0.714 . . . . 74.319999999999993 112.804 -171.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' CYS . 13.0 mmt180 -144.68 119.61 9.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.877 1.271 . . . . 74.019999999999996 110.155 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -134.62 121.51 21.0 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.411 0.684 . . . . 64.450000000000003 111.094 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.79 106.1 15.22 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.734 -0.839 . . . . 61.229999999999997 108.734 171.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.3 t -100.13 131.64 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.122 0.569 . . . . 61.32 110.095 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -122.25 119.72 28.46 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.611 0.765 . . . . 72.329999999999998 109.062 178.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' HD2' HD13 ' A' ' 64' ' ' LEU . 30.4 Cg_endo -62.67 -48.94 6.21 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.498 2.132 . . . . 75.439999999999998 113.237 174.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.75 91.54 2.37 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.899 0.48 . . . . 61.329999999999998 111.002 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.5 m -66.02 118.31 9.61 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.734 0.814 . . . . 72.049999999999997 112.209 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -90.43 158.65 42.93 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.291 1.036 . . . . 71.109999999999999 109.83 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.38 -40.18 86.95 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.984 2.456 . . . . 70.349999999999994 114.0 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.2 t -88.84 -18.23 28.07 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.293 0.637 . . . . 74.010000000000005 111.943 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.8 -43.4 58.96 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.141 0.977 . . . . 62.219999999999999 111.232 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' HA3' HD11 ' A' ' 90' ' ' ILE . . . -92.91 154.57 22.04 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 115.935 -0.575 . . . . 71.430000000000007 112.112 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.64 -136.73 3.74 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.762 -0.535 . . . . 70.420000000000002 111.762 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -100.0 116.98 33.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 118.452 1.126 . . . . 73.230000000000004 110.885 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 77.6 m-85 -105.69 128.16 53.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.243 1.017 . . . . 64.209999999999994 111.384 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -112.41 122.13 46.83 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.332 1.053 . . . . 75.120000000000005 109.946 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.448 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 33.4 m -105.72 94.88 5.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.266 0.626 . . . . 62.130000000000003 110.356 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG22 ' SG ' ' A' ' 83' ' ' CYS . 51.4 t -93.52 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.102 0.561 . . . . 74.329999999999998 110.443 -175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.49 -31.79 71.32 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.418 0.627 . . . . 51.119999999999997 111.321 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.84 -87.82 0.14 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.417 -1.073 . . . . 75.200000000000003 110.417 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -69.76 -30.67 68.3 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.368 0.667 . . . . 71.010000000000005 110.868 170.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.787 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 5.4 mm-40 -113.29 158.98 19.84 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.399 1.08 . . . . 73.540000000000006 112.563 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 78' ' ' VAL . 76.0 m -148.97 130.22 14.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.758 0.823 . . . . 70.200000000000003 112.091 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.64 142.3 32.3 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.028 0.931 . . . . 54.409999999999997 109.862 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -117.77 127.86 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.126 0.489 . . . . 44.439999999999998 112.286 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' HE1' ' SG ' ' A' ' 27' ' ' CYS . 28.6 m-85 -121.71 123.73 42.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.803 1.241 . . . . 63.130000000000003 110.224 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.5 m -110.21 100.98 9.78 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.611 -0.885 . . . . 52.119999999999997 108.611 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 60.2 t -95.79 102.86 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.095 0.558 . . . . 61.119999999999997 110.715 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.8 m -87.05 106.47 17.88 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.647 1.179 . . . . 72.310000000000002 110.838 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 17' ' ' ALA . 41.4 mt . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 121.304 0.573 . . . . 63.399999999999999 110.372 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.0 m170 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 110.031 -0.359 . . . . 72.420000000000002 110.031 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.5 mpt? -80.49 126.28 78.93 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 123.556 0.742 . . . . 75.439999999999998 111.222 -174.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -62.08 -24.44 76.55 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.561 2.174 . . . . 72.349999999999994 111.897 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.5 p -116.77 87.14 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 124.328 1.051 . . . . 75.310000000000002 109.898 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -109.09 148.04 31.46 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.876 -0.602 . . . . 74.129999999999995 110.53 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 84' ' ' ALA . 2.0 mp -74.07 116.45 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 C-N-CA 122.893 0.477 . . . . 64.530000000000001 109.879 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -88.56 -22.39 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 C-N-CA 122.998 0.519 . . . . 72.409999999999997 111.357 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -149.35 128.69 6.32 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.211 1.004 . . . . 74.319999999999993 109.513 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.1 148.87 93.21 Favored 'Cis proline' 0 C--N 1.374 1.913 0 CA-C-N 120.37 1.168 . . . . 72.409999999999997 112.683 -4.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -23.77 55.88 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.42 -0.809 . . . . 74.010000000000005 110.72 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.65 -170.41 3.6 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.476 1.111 . . . . 70.019999999999996 110.651 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -59.88 141.02 56.21 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.976 0.91 . . . . 73.219999999999999 112.443 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.2 t -123.95 105.15 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.422 0.689 . . . . 63.240000000000002 110.757 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -91.5 113.12 25.3 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.571 0.748 . . . . 74.430000000000007 110.516 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.52 130.94 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.04 0.936 . . . . 62.32 110.229 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -103.1 105.42 15.72 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 109.022 -0.733 . . . . 73.310000000000002 109.022 173.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.66 164.71 13.95 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.65 0.78 . . . . 62.409999999999997 111.899 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 15.2 mm -116.21 161.34 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.497 0 N-CA-C 108.096 -1.076 . . . . 74.420000000000002 108.096 169.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.1 p -54.02 -36.67 63.25 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 114.884 1.439 . . . . 64.230000000000004 114.884 -174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -106.14 17.93 22.79 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.581 -0.699 . . . . 64.140000000000001 112.248 -175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 21.0 mm-40 -84.58 162.98 19.6 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.536 0.734 . . . . 73.5 112.727 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -105.8 105.05 14.91 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.841 0.857 . . . . 64.519999999999996 110.378 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.0 t -107.96 134.67 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 123.469 0.708 . . . . 64.530000000000001 111.203 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.575 ' HG3' HG22 ' A' ' 63' ' ' VAL . 52.3 ttm -124.59 104.54 8.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.535 0.734 . . . . 73.409999999999997 110.081 177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 87.0 mt -78.7 101.75 7.69 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.443 0.697 . . . . 53.43 110.032 175.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.71 132.3 35.89 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.373 0.669 . . . . 62.310000000000002 111.525 -176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.5 t -147.03 114.79 6.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.303 1.041 . . . . 75.129999999999995 110.05 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -113.88 140.0 48.71 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.678 0.751 . . . . 72.439999999999998 110.538 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 34' ' ' ALA . 22.3 m -110.71 155.52 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.757 0.823 . . . . 70.319999999999993 110.918 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.85 -36.56 79.45 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.955 0.902 . . . . 74.450000000000003 112.199 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -118.64 123.52 45.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.078 0.551 . . . . 75.109999999999999 110.476 -170.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.58 -16.28 63.81 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.386 0.674 . . . . 73.140000000000001 112.732 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.26 -15.08 62.91 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.356 1.062 . . . . 72.420000000000002 112.816 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' HG21 ' A' ' 29' ' ' VAL . . . -59.82 116.44 16.97 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.491 1.116 . . . . 63.399999999999999 113.821 -177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -94.36 85.87 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.975 2.45 . . . . 53.340000000000003 110.181 166.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.86 155.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.997 -171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -117.73 105.63 12.2 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.281 -0.872 . . . . 71.140000000000001 109.489 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 85.9 m95 -85.56 125.49 33.14 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.239 0.616 . . . . 70.310000000000002 109.483 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -115.64 136.08 53.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.228 0.611 . . . . 74.230000000000004 110.624 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 45' ' ' VAL . 1.2 tmtp? -115.58 92.66 3.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.994 -1.484 . . . . 72.540000000000006 106.994 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 52.27 23.54 2.43 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 114.579 1.326 . . . . 61.229999999999997 114.579 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.61 -72.5 0.42 Allowed Glycine 0 C--N 1.356 1.661 0 N-CA-C 114.768 0.667 . . . . 73.129999999999995 114.768 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -84.85 45.75 1.19 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.489 1.115 . . . . 70.140000000000001 113.425 -164.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 45' ' ' VAL . 18.9 tt0 59.28 -167.12 0.16 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.81 0.844 . . . . 75.319999999999993 109.594 -169.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 26.8 t -101.25 -41.87 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.188 -0.945 . . . . 62.329999999999998 111.857 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 64.72 154.24 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.113 1.365 . . . . 64.140000000000001 112.927 -172.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.12 44.31 1.03 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.68 0.752 . . . . 64.319999999999993 111.614 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 77.8 p -119.26 176.58 5.26 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.534 1.133 . . . . 73.409999999999997 110.254 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 57.9 34.58 24.49 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 124.018 0.927 . . . . 63.149999999999999 112.787 177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 73.02 -3.65 2.38 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 125.711 1.605 . . . . 71.109999999999999 113.135 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 64' ' ' LEU . 47.6 t -75.07 126.8 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.448 0.699 . . . . 74.120000000000005 110.349 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 63' ' ' VAL . 28.8 m -118.09 130.13 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-O 121.159 0.504 . . . . 63.340000000000003 111.191 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.42 103.47 13.88 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.432 0.693 . . . . 73.430000000000007 109.573 177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.566 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 31.8 mt-10 -98.39 117.51 32.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.262 0.625 . . . . 73.150000000000006 110.528 -176.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -130.11 133.83 46.93 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.666 0.786 . . . . 63.340000000000003 110.342 -174.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.82 96.0 2.17 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.686 0.795 . . . . 75.319999999999993 110.198 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.48 -113.93 5.99 Favored Glycine 0 CA--C 1.546 1.974 0 CA-C-O 119.373 -0.682 . . . . 75.25 113.943 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.91 -10.56 9.3 Favored 'Trans proline' 0 CA--C 1.56 1.811 0 C-N-CA 122.868 2.379 . . . . 63.119999999999997 113.955 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -89.76 119.22 29.97 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.287 0.635 . . . . 70.409999999999997 110.151 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 14.0 mmt180 -128.07 125.42 39.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.62 0.768 . . . . 63.229999999999997 109.61 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 7.3 ptp85 -142.73 122.7 13.59 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.563 0.697 . . . . 71.25 112.491 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 6.8 tt -84.47 109.03 17.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.49 1.116 . . . . 74.319999999999993 108.105 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 24' ' ' MET . 46.5 t -109.81 132.75 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.798 0.808 . . . . 54.310000000000002 111.507 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 66' ' ' ALA . 1.4 mm? -117.92 116.7 36.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.866 1.266 . . . . 24.210000000000001 109.806 175.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.1 -46.13 6.59 Favored 'Trans proline' 0 CA--C 1.56 1.8 0 C-N-CA 122.54 2.16 . . . . 72.109999999999999 112.162 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 64' ' ' LEU . . . -127.76 110.89 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.0 -1.111 . . . . 53.210000000000001 108.0 171.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -38.79 81.29 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 123.807 0.843 . . . . 61.509999999999998 113.11 -168.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 67.8 163.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.766 0 C-N-CA 124.46 1.104 . . . . 62.439999999999998 112.54 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -18.49 49.11 Favored 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 121.795 1.663 . . . . 71.530000000000001 111.308 164.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -52.17 -64.85 0.68 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.611 1.164 . . . . 64.329999999999998 112.15 171.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 7.7 m-20 -92.24 25.54 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 112.867 0.691 . . . . 73.340000000000003 112.867 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA3' HG12 ' A' ' 90' ' ' ILE . . . -97.42 82.62 0.7 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 111.552 -0.619 . . . . 53.219999999999999 111.552 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.42 -145.46 4.34 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 113.827 0.291 . . . . 50.32 113.827 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.69 133.59 52.58 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.099 0.96 . . . . 64.409999999999997 111.31 -174.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.8 m-85 -126.97 148.16 50.09 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.481 1.112 . . . . 71.140000000000001 110.826 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -139.18 139.08 37.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.449 0.699 . . . . 74.299999999999997 111.112 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' HE2' ' A' ' 86' ' ' PHE . 23.2 m -122.55 97.69 5.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.366 0.666 . . . . 64.430000000000007 111.054 -177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 83' ' ' CYS . 65.7 t -94.71 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 122.602 0.361 . . . . 70.340000000000003 111.212 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.79 -33.62 34.72 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.086 0.555 . . . . 72.310000000000002 111.694 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.56 -101.61 0.16 Allowed Glycine 0 C--N 1.341 0.818 0 CA-C-N 115.483 -0.781 . . . . 61.240000000000002 111.341 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -88.85 -21.96 23.43 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 122.807 0.443 . . . . 75.310000000000002 110.776 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -96.6 148.4 22.89 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.583 0.753 . . . . 64.299999999999997 111.392 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.43 ' HB3' HG22 ' A' ' 78' ' ' VAL . 25.0 p -139.75 135.3 32.97 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 111.729 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.31 160.23 14.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.628 0.771 . . . . 62.509999999999998 110.844 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -133.39 134.19 43.36 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 112.676 0.621 . . . . 65.239999999999995 112.676 -175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.557 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 82.1 m-85 -126.52 139.33 53.3 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.635 1.174 . . . . 71.400000000000006 109.263 174.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.8 m -126.41 101.76 6.84 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.913 0.485 . . . . 61.409999999999997 109.864 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.33 128.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.462 0.705 . . . . 63.009999999999998 109.961 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.9 p -124.33 123.24 39.77 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.008 0.923 . . . . 70.329999999999998 109.503 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG12 ' HA3' ' A' ' 72' ' ' GLY . 41.3 mm . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 122.189 0.995 . . . . 64.109999999999999 112.027 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 74.5 m80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.999 0.428 . . . . 75.040000000000006 111.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 1.7 mpp? -73.65 122.74 88.34 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 110.88 -175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 2' ' ' MET . 2.5 Cg_endo -82.66 21.13 1.03 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.959 2.439 . . . . 74.439999999999998 113.38 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.545 HG13 ' HA3' ' A' ' 80' ' ' GLY . 3.0 p -73.52 92.15 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 CA-C-O 122.441 1.115 . . . . 71.430000000000007 111.207 178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -115.21 140.48 49.05 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.598 -1.183 . . . . 52.439999999999998 109.216 173.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.3 mt -71.96 110.36 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.103 0.561 . . . . 70.510000000000005 110.622 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.71 -30.64 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 CA-C-N 115.57 -0.741 . . . . 62.149999999999999 112.317 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -166.59 130.6 1.6 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 123.103 0.561 . . . . 64.010000000000005 110.85 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -89.27 142.11 16.93 Favored 'Cis proline' 0 C--N 1.377 2.07 0 CA-C-N 120.189 1.103 . . . . 71.420000000000002 112.803 -5.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.53 -24.67 21.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.799 0.84 . . . . 74.340000000000003 109.362 173.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -80.57 151.78 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.696 1.198 . . . . 72.409999999999997 111.863 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -78.43 103.84 8.63 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 123.298 0.639 . . . . 61.310000000000002 110.597 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.7 t -86.19 109.02 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.512 0.725 . . . . 63.439999999999998 111.489 -173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -80.74 112.89 18.54 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.038 0.535 . . . . 71.420000000000002 110.427 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.58 140.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.612 1.165 . . . . 70.239999999999995 111.258 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -115.38 110.14 18.92 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.199 0.6 . . . . 71.420000000000002 109.691 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -123.49 164.29 19.23 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.12 0.568 . . . . 22.309999999999999 112.397 -175.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.5 168.2 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 125.622 1.569 . . . . 71.319999999999993 107.119 172.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.7 p -50.94 -34.16 27.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 114.137 1.162 . . . . 73.239999999999995 114.137 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.9 t -93.98 -4.59 49.39 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.707 0.632 . . . . 63.200000000000003 112.707 -177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -81.39 128.2 33.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.082 0.553 . . . . 75.049999999999997 112.073 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 26.0 p -87.25 113.11 22.69 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.457 -0.792 . . . . 54.509999999999998 109.678 170.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.49 128.83 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.866 0.866 . . . . 75.109999999999999 111.502 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -116.95 100.02 7.47 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 63.520000000000003 110.981 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.647 HD12 HD13 ' A' ' 62' ' ' LEU . 63.1 mt -78.92 112.96 16.62 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.902 0.881 . . . . 72.540000000000006 109.077 172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.29 145.4 28.92 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.349 0.522 . . . . 41.299999999999997 111.617 -177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' A' ' 36' ' ' VAL . 42.5 t -150.74 139.06 20.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.022 0.929 . . . . 52.210000000000001 110.608 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -143.15 141.14 31.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.701 0.8 . . . . 74.329999999999998 110.415 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 20.4 m -121.96 168.5 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-O 121.709 0.766 . . . . 71.140000000000001 112.177 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -68.44 -37.66 80.46 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 114.448 -1.251 . . . . 75.209999999999994 112.186 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.441 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 7.2 mmm-85 -93.56 121.62 35.15 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.431 0.692 . . . . 74.540000000000006 111.465 -173.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -71.12 -39.15 72.22 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 111.124 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -73.54 -16.34 61.27 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.825 0.85 . . . . 60.219999999999999 111.938 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.09 97.93 49.17 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 123.203 0.601 . . . . 71.519999999999996 111.597 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.01 173.33 14.69 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.527 2.151 . . . . 72.530000000000001 113.395 173.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' A' ' 27' ' ' CYS . 4.0 m -91.73 157.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 116.137 -0.483 . . . . 75.400000000000006 111.01 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -102.69 113.21 26.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.484 0.714 . . . . 71.349999999999994 109.076 174.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.531 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 91.3 m95 -86.04 117.04 24.63 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.905 0.482 . . . . 71.129999999999995 110.437 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -115.32 131.56 56.89 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.723 0.638 . . . . 63.539999999999999 112.723 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 45' ' ' VAL . 33.4 ttmt -93.94 -175.93 3.86 Favored 'General case' 0 CA--C 1.568 1.653 0 C-N-CA 125.057 1.343 . . . . 72.120000000000005 109.115 170.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -48.72 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.721 0 C-N-CA 124.3 1.04 . . . . 72.109999999999999 113.277 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.26 26.76 70.77 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 115.325 0.89 . . . . 73.150000000000006 115.325 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -165.17 -175.7 3.77 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.294 0.638 . . . . 74.109999999999999 111.278 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -71.72 163.93 26.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.22 0.608 . . . . 70.109999999999999 109.728 170.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 40' ' ' LYS . 47.2 t -66.68 -22.31 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 113.051 0.76 . . . . 54.109999999999999 113.051 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 62.08 91.97 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.418 1.087 . . . . 73.340000000000003 112.285 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.35 84.34 0.57 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.246 0.546 . . . . 74.409999999999997 110.921 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.589 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 46.4 m -116.33 97.82 6.25 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.069 0.948 . . . . 71.0 110.979 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 57.17 -77.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 125.263 1.425 . . . . 40.140000000000001 113.164 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -70.09 -43.32 71.35 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.858 0.863 . . . . 74.129999999999995 110.344 178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' A' ' 48' ' ' SER . 32.6 t -73.68 119.07 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.808 -0.633 . . . . 74.319999999999993 111.252 -176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.508 HG23 ' HB ' ' A' ' 63' ' ' VAL . 34.5 m -131.44 142.8 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.381 0.673 . . . . 33.030000000000001 110.593 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.42 122.05 43.68 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.454 0.702 . . . . 73.25 110.508 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 34.0 mm-40 -97.82 147.85 23.99 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.824 0.849 . . . . 71.219999999999999 111.319 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.518 ' H ' HD22 ' A' ' 55' ' ' ASN . 0.1 OUTLIER -135.25 148.99 49.75 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.69 0.796 . . . . 73.230000000000004 111.915 -173.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 12.2 tp10 -166.88 75.3 0.16 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.671 0.788 . . . . 75.519999999999996 110.433 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.35 -114.27 6.52 Favored Glycine 0 CA--C 1.549 2.182 0 CA-C-O 119.566 -0.575 . . . . 71.120000000000005 114.204 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.48 -12.67 13.84 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.707 2.272 . . . . 74.540000000000006 113.008 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 43.0 m-70 -86.12 128.85 34.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.881 0.872 . . . . 63.32 109.686 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HB3' ' HE1' ' A' ' 38' ' ' TRP . 16.9 mmt180 -137.11 150.29 47.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.842 1.257 . . . . 74.140000000000001 109.191 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.5 ptp180 -158.24 129.59 6.57 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.155 0.798 . . . . 75.230000000000004 113.155 174.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 HD12 ' A' ' 25' ' ' LEU . 5.9 tt -79.53 118.58 21.52 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.915 1.286 . . . . 70.540000000000006 109.024 171.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.508 ' HB ' HG23 ' A' ' 52' ' ' VAL . 66.4 t -111.51 131.98 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 122.787 0.435 . . . . 72.049999999999997 110.416 176.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -134.04 95.28 17.14 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 123.612 0.765 . . . . 71.5 109.531 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.9 -37.6 92.73 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.357 2.704 . . . . 74.200000000000003 113.703 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.55 88.69 2.87 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.372 0.669 . . . . 43.32 110.23 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -81.59 95.25 7.1 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.297 0.57 . . . . 72.120000000000005 111.381 -173.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -75.43 143.79 76.74 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.045 0.938 . . . . 64.239999999999995 111.952 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.42 62.72 2.15 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.906 3.07 . . . . 74.540000000000006 113.081 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 p -177.81 -41.71 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.134 1.373 . . . . 64.530000000000001 108.245 -170.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -77.26 -49.93 13.99 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.797 -1.092 . . . . 73.150000000000006 109.494 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.78 150.38 49.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-N 115.301 -0.863 . . . . 74.349999999999994 113.697 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.72 -154.31 20.67 Favored Glycine 0 N--CA 1.471 1.028 0 CA-C-O 120.145 -0.253 . . . . 63.149999999999999 112.84 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 97.19 11.05 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.227 0.537 . . . . 74.450000000000003 110.459 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -89.66 146.66 24.38 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.806 0.843 . . . . 74.439999999999998 111.182 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -135.55 121.65 20.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.18 0.592 . . . . 71.140000000000001 111.156 -174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 83' ' ' CYS . 84.5 m -97.57 96.82 8.56 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.634 0.774 . . . . 72.5 110.695 176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.56 123.67 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 110.17 -0.307 . . . . 61.240000000000002 110.17 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.67 90.12 2.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.28 0.632 . . . . 51.509999999999998 110.766 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 74.39 -82.83 0.78 Allowed Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.552 -0.749 . . . . 74.420000000000002 113.173 174.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.51 -29.68 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.144 0.578 . . . . 70.219999999999999 111.82 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -114.84 177.19 4.74 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.691 0.626 . . . . 63.229999999999997 112.691 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 25.6 p -155.66 126.87 7.13 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.625 0.77 . . . . 74.109999999999999 111.484 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.79 138.29 32.13 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.514 0.726 . . . . 62.299999999999997 110.819 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -108.43 137.18 46.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.026 0.531 . . . . 71.209999999999994 111.662 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' HE2' ' SG ' ' A' ' 77' ' ' CYS . 74.0 m-85 -133.54 109.99 9.62 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.042 0.937 . . . . 64.530000000000001 109.152 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 40.9 m -104.13 100.41 10.16 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.174 0.511 . . . . 61.109999999999999 110.38 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -92.92 101.75 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.461 0.704 . . . . 73.530000000000001 110.467 -174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.0 m -91.71 117.68 29.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.215 1.006 . . . . 74.310000000000002 110.414 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG12 ' HB3' ' A' ' 17' ' ' ALA . 48.9 mt . . . . . 0 N--CA 1.483 1.193 0 C-N-CA 123.402 0.681 . . . . 73.25 110.846 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.701 -0.481 . . . . 62.420000000000002 109.701 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -150.08 152.89 34.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.53 0.732 . . . . 74.030000000000001 111.251 -175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -80.52 -178.23 4.3 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 122.88 2.387 . . . . 61.109999999999999 113.892 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 34' ' ' ALA . 2.6 p -120.27 138.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.007 0.923 . . . . 72.519999999999996 110.804 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.415 ' HB3' ' HG3' ' A' ' 82' ' ' GLU . 86.6 m-70 -144.77 -163.33 1.68 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.604 1.162 . . . . 75.209999999999994 110.184 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 82' ' ' GLU . 73.5 mt -123.7 122.21 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 123.83 0.852 . . . . 75.019999999999996 109.675 172.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.0 -27.63 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.228 0.611 . . . . 70.219999999999999 112.1 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 26.1 t70 -135.09 115.26 11.93 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 123.532 0.733 . . . . 71.099999999999994 110.092 -170.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 94.0 Cg_endo -78.71 172.04 62.9 Favored 'Cis proline' 0 C--N 1.378 2.086 0 CA-C-N 120.546 1.231 . . . . 34.329999999999998 112.985 -10.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -123.66 10.07 9.01 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 123.343 0.657 . . . . 74.129999999999995 111.911 -174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.93 -178.45 6.76 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 122.914 0.485 . . . . 71.209999999999994 112.117 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -67.04 112.08 4.19 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.658 -0.701 . . . . 71.409999999999997 111.272 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.5 t -96.51 117.84 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.165 0.586 . . . . 63.229999999999997 110.092 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -109.05 111.65 23.41 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.184 0.593 . . . . 72.409999999999997 110.304 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 88' ' ' VAL . 65.8 t -108.35 129.74 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.752 0.821 . . . . 74.340000000000003 109.787 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -92.79 134.03 35.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.491 0.316 . . . . 72.239999999999995 110.46 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -141.58 168.7 19.14 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.637 0.732 . . . . 71.140000000000001 111.965 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 47.4 mm -127.09 165.3 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 125.079 1.352 . . . . 72.319999999999993 108.342 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.4 p -52.37 127.14 21.34 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.089 0.556 . . . . 73.319999999999993 111.642 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.5 t 66.93 31.91 6.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.497 1.119 . . . . 63.25 112.762 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -83.76 161.52 20.96 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 123.381 0.672 . . . . 72.129999999999995 110.354 178.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -103.31 92.77 4.64 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.234 0.613 . . . . 54.450000000000003 110.745 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.81 124.03 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.568 0.747 . . . . 73.200000000000003 111.744 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.4 ' HG2' HG22 ' A' ' 63' ' ' VAL . 55.4 mtt -110.02 121.21 44.71 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.179 0.591 . . . . 72.239999999999995 110.659 173.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -107.89 102.45 11.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.052 0.941 . . . . 75.25 109.672 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.34 144.4 25.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.137 0.575 . . . . 74.430000000000007 111.359 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' CB ' ' HG ' ' A' ' 77' ' ' CYS . 41.4 t -153.37 113.49 3.94 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.011 0.924 . . . . 63.530000000000001 109.869 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 59' ' ' HIS . 2.7 mp0 -106.63 130.66 54.34 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.493 0.663 . . . . 65.409999999999997 110.222 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.64 170.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 115.38 -0.827 . . . . 52.350000000000001 112.827 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -79.95 -35.51 37.55 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.925 0.89 . . . . 74.129999999999995 110.807 174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -123.08 116.17 23.05 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.712 0.805 . . . . 75.150000000000006 110.463 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.73 -29.97 60.41 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.625 1.17 . . . . 62.32 113.465 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -63.1 -20.93 65.82 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.733 1.213 . . . . 71.319999999999993 113.563 -177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -134.68 97.92 13.82 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.116 0.566 . . . . 70.019999999999996 111.854 -176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 167.17 22.22 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.588 2.858 . . . . 72.439999999999998 112.612 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.52 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 2.1 m -77.43 163.2 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 113.106 0.78 . . . . 74.430000000000007 113.106 -172.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.8 124.15 51.02 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.756 1.222 . . . . 74.409999999999997 108.376 165.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -87.19 129.75 34.83 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.998 0.519 . . . . 72.329999999999998 111.622 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 79.8 m-85 -126.09 166.11 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.201 1.4 . . . . 70.239999999999995 109.944 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -174.65 131.07 0.34 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.862 0.865 . . . . 73.420000000000002 111.17 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 55.65 24.93 7.56 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.967 1.099 . . . . 74.209999999999994 113.967 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.78 -17.8 38.33 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 114.764 0.666 . . . . 52.049999999999997 114.764 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -125.5 162.65 24.42 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.946 0.899 . . . . 73.409999999999997 110.361 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 13.6 pt-20 -69.4 142.64 53.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.583 -0.698 . . . . 63.420000000000002 110.895 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.6 t -60.94 -58.61 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.566 0.747 . . . . 52.109999999999999 112.339 -169.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 65.82 167.35 0.2 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.096 1.358 . . . . 62.119999999999997 113.488 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -100.9 157.19 16.92 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.579 -0.737 . . . . 72.439999999999998 111.206 175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.1 m -156.58 -65.03 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.212 0.605 . . . . 54.340000000000003 110.517 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -174.06 -58.13 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.885 -1.052 . . . . 74.219999999999999 108.853 -172.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.457 ' O ' HD13 ' A' ' 64' ' ' LEU . 97.7 m-85 -65.36 -32.54 74.23 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.385 -0.825 . . . . 72.439999999999998 110.972 172.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.81 135.39 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.002 0.521 . . . . 74.420000000000002 111.007 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 63' ' ' VAL . 17.3 m -133.97 139.68 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.983 0.913 . . . . 73.329999999999998 110.242 168.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.2 mt -110.61 123.12 49.37 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 73.239999999999995 109.97 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -99.11 138.94 35.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.476 0.71 . . . . 75.109999999999999 111.493 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -134.67 135.58 42.17 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.83 0.852 . . . . 75.329999999999998 110.886 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 59' ' ' HIS . 35.7 tt0 -144.19 78.34 1.58 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.054 -1.091 . . . . 74.209999999999994 108.054 172.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.11 -107.59 1.53 Allowed Glycine 0 CA--C 1.547 2.033 0 CA-C-O 119.29 -0.728 . . . . 73.340000000000003 113.461 -173.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.66 -17.8 25.89 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.856 2.371 . . . . 51.240000000000002 114.063 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 56' ' ' GLU . 17.2 m-70 -75.56 129.12 36.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 122.966 0.506 . . . . 74.129999999999995 111.186 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 36' ' ' VAL . 12.1 mmt180 -143.81 112.25 6.43 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.215 1.006 . . . . 71.0 110.289 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -141.1 124.86 16.95 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.38 0.881 . . . . 71.209999999999994 113.38 -177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 tt -81.57 107.21 14.13 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.102 1.361 . . . . 72.540000000000006 109.942 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.5 t -95.95 133.56 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 122.799 0.44 . . . . 74.530000000000001 110.361 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -125.59 89.87 51.67 Favored Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 123.678 0.791 . . . . 61.140000000000001 109.512 -177.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.58 -47.07 23.18 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.714 2.943 . . . . 73.549999999999997 114.817 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.37 83.65 2.05 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.155 0.582 . . . . 55.100000000000001 110.303 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 m -76.19 91.84 3.21 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.475 0.655 . . . . 65.310000000000002 111.257 -175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -80.78 160.53 66.39 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 124.409 1.084 . . . . 75.310000000000002 109.813 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -52.23 -25.45 23.66 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.175 2.583 . . . . 72.409999999999997 114.204 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -75.18 -35.91 61.51 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.945 0.498 . . . . 74.129999999999995 111.894 173.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.31 -2.88 30.34 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.682 0.793 . . . . 65.25 113.014 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.75 179.44 41.47 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 122.47 -0.144 . . . . 54.219999999999999 112.916 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.85 -146.06 16.27 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 116.609 0.205 . . . . 41.399999999999999 113.539 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -95.31 129.1 42.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.864 0.866 . . . . 74.540000000000006 112.107 -172.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 22.6 m-85 -117.32 128.42 55.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.233 1.013 . . . . 75.340000000000003 110.225 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 7.3 tp60 -107.34 100.84 10.25 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.38 1.072 . . . . 73.200000000000003 110.613 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . 37.0 t -98.67 105.11 17.21 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.634 0.774 . . . . 72.349999999999994 110.706 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.76 130.13 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 112.869 0.692 . . . . 70.439999999999998 112.869 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.77 108.65 2.23 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.047 0.539 . . . . 62.219999999999999 111.855 172.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 4' ' ' VAL . . . 64.39 67.72 1.93 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 115.798 -0.637 . . . . 72.010000000000005 114.131 173.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.8 t70 69.05 -10.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.724 1.21 . . . . 53.329999999999998 112.906 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 65.3 mm-40 -102.73 160.5 14.53 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.907 0.86 . . . . 75.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 18.2 p -143.2 128.06 18.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.149 -1.387 . . . . 71.030000000000001 109.764 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.48 127.45 40.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.43 1.092 . . . . 73.209999999999994 109.3 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -95.23 122.0 37.47 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.293 0.637 . . . . 73.430000000000007 110.82 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 88.3 m-85 -130.07 140.27 50.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.892 0.877 . . . . 71.409999999999997 110.337 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.5 m -144.71 103.51 3.93 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.01 0.924 . . . . 75.430000000000007 109.165 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 15' ' ' VAL . 93.9 t -95.05 104.61 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 123.386 0.674 . . . . 72.310000000000002 110.727 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -87.4 116.49 25.54 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.564 0.745 . . . . 73.239999999999995 110.623 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 17' ' ' ALA . 67.4 mt . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 121.516 0.674 . . . . 62.219999999999999 111.243 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 53.8 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 110.235 -0.283 . . . . 62.030000000000001 110.235 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -81.01 151.18 70.03 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 122.708 0.403 . . . . 74.430000000000007 110.642 176.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.08 128.78 31.2 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.227 1.951 . . . . 63.450000000000003 110.303 165.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 34' ' ' ALA . 3.7 p -65.71 104.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 122.203 1.001 . . . . 63.210000000000001 111.919 -173.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -99.97 169.65 9.05 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.09 -0.959 . . . . 71.519999999999996 110.518 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . 63.6 mt -104.97 123.74 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.715 0.406 . . . . 74.230000000000004 111.087 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.93 -41.56 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.527 0.731 . . . . 64.129999999999995 112.29 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -160.59 120.09 1.59 Allowed Pre-proline 0 CA--C 1.558 1.265 0 C-N-CA 123.535 0.734 . . . . 75.329999999999998 109.706 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 27' ' ' CYS . 86.6 Cg_endo -77.64 123.56 9.67 Favored 'Cis proline' 0 C--N 1.379 2.177 0 CA-C-N 120.031 1.047 . . . . 63.210000000000001 113.842 1.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 1.6 tmm_? -82.07 5.25 20.06 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 123.916 0.886 . . . . 75.230000000000004 110.68 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -136.23 -173.2 3.33 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.914 0.886 . . . . 62.509999999999998 111.908 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -87.56 114.5 24.22 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.053 0.941 . . . . 72.25 110.333 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.73 128.61 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.979 0.512 . . . . 51.520000000000003 110.539 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -105.13 111.28 23.98 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.239 0.616 . . . . 74.299999999999997 109.836 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.3 t -109.81 119.4 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.282 1.033 . . . . 75.319999999999993 110.837 -174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -96.49 108.84 21.46 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.004 0.521 . . . . 74.0 110.335 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.39 142.56 43.47 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.658 0.783 . . . . 40.109999999999999 112.413 -173.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 54.6 mt -105.74 155.76 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 N-CA-C 108.179 -1.045 . . . . 51.439999999999998 108.179 168.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.2 p -66.09 149.46 50.25 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.165 0.432 . . . . 73.340000000000003 112.165 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.9 t 74.38 1.11 3.77 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 125.502 1.521 . . . . 54.219999999999999 113.199 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -86.06 165.61 16.5 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.414 0.686 . . . . 74.109999999999999 112.224 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.4 m -101.51 99.09 9.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.657 0.783 . . . . 73.540000000000006 110.895 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.0 t -97.39 118.68 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 123.679 0.792 . . . . 72.510000000000005 110.832 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 75.5 mtp -113.52 100.18 8.32 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.4 0.68 . . . . 74.420000000000002 111.072 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.87 99.65 11.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.781 0.832 . . . . 64.319999999999993 110.514 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.48 125.91 48.19 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.152 0.581 . . . . 51.509999999999998 111.76 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 52.0 t -132.6 130.51 40.34 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.283 1.033 . . . . 73.010000000000005 111.063 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -123.05 131.35 53.66 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.393 0.677 . . . . 73.329999999999998 111.636 176.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . 27.1 m -95.99 -178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.224 1.01 . . . . 75.019999999999996 111.68 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -88.54 -28.49 20.73 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.766 0.426 . . . . 75.120000000000005 111.737 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -115.31 114.6 25.38 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.321 0.648 . . . . 62.009999999999998 111.956 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG3' ' HA2' ' A' ' 57' ' ' GLY . 35.8 tt0 -58.03 -28.53 64.57 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.493 1.117 . . . . 65.319999999999993 112.1 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.59 -33.59 64.08 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.591 1.156 . . . . 61.509999999999998 113.022 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 4' ' ' VAL . . . -104.85 109.66 63.4 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.82 0.848 . . . . 75.200000000000003 112.622 -168.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HB3' ' NH2' ' A' ' 60' ' ' ARG . 24.2 Cg_exo -68.37 137.21 39.2 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.986 2.457 . . . . 73.239999999999995 112.431 169.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.9 m -78.39 157.39 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.435 0.636 . . . . 73.329999999999998 111.27 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 17.2 mmm180 -106.72 111.96 24.73 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.541 1.136 . . . . 74.510000000000005 109.043 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -85.65 122.07 29.23 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.936 0.398 . . . . 74.040000000000006 110.74 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 96.3 m-85 -125.53 178.12 5.83 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.641 1.177 . . . . 65.219999999999999 110.352 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HE2' ' HA3' ' A' ' 73' ' ' GLY . 60.9 tttt -137.36 -84.86 0.32 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.634 -0.506 . . . . 62.409999999999997 109.634 171.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -126.79 86.11 2.47 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.075 -0.713 . . . . 74.239999999999995 109.075 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.56 -52.63 4.75 Favored Glycine 0 CA--C 1.544 1.872 0 CA-C-N 115.506 -0.77 . . . . 74.510000000000005 113.27 -176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.35 155.25 20.13 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.5 0.72 . . . . 74.109999999999999 111.02 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -77.67 166.77 22.58 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.297 0.639 . . . . 72.230000000000004 111.46 174.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 62' ' ' LEU . 25.2 t -119.8 106.49 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 64.0 109.273 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -107.13 169.42 8.57 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.864 0.865 . . . . 64.049999999999997 110.085 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -67.56 126.98 31.05 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 122.694 0.398 . . . . 73.420000000000002 111.258 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.1 t -152.01 -150.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.283 0.633 . . . . 71.530000000000001 110.827 -167.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -59.06 88.28 0.01 OUTLIER 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.995 0.918 . . . . 61.210000000000001 110.811 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 86.08 -20.65 0.24 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.326 1.85 . . . . 74.099999999999994 111.917 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG22 HD21 ' A' ' 64' ' ' LEU . 25.5 t -67.49 114.99 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 122.897 0.479 . . . . 71.319999999999993 110.198 177.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.98 136.21 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.31 0.576 . . . . 63.25 110.768 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.91 112.32 21.72 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.056 0.943 . . . . 45.43 109.824 177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -97.31 122.63 40.55 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.231 0.539 . . . . 62.32 111.098 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -111.28 118.47 35.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.47 1.108 . . . . 64.329999999999998 109.838 -172.217 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -154.02 94.38 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.108 0.413 . . . . 70.349999999999994 110.946 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.505 ' HA2' ' HG3' ' A' ' 32' ' ' GLU . . . 61.48 -126.46 39.78 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 119.485 -0.619 . . . . 65.019999999999996 113.503 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 -18.66 24.98 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.135 1.89 . . . . 62.210000000000001 112.717 172.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -73.95 101.9 3.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.583 0.753 . . . . 75.299999999999997 110.725 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.459 ' NH2' ' HB3' ' A' ' 35' ' ' PRO . 13.1 mmt180 -122.09 112.88 18.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.579 1.152 . . . . 61.340000000000003 109.798 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -130.52 134.21 46.86 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.011 0.745 . . . . 62.310000000000002 113.011 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 45' ' ' VAL . 6.0 tt -96.58 111.4 23.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.557 1.143 . . . . 72.010000000000005 108.409 173.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.4 t -107.61 130.06 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 122.777 0.431 . . . . 52.140000000000001 110.716 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -120.18 94.0 48.38 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.849 0.86 . . . . 63.020000000000003 109.316 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.41 -43.04 49.51 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.702 2.935 . . . . 64.329999999999998 113.863 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.11 85.5 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.45 0.7 . . . . 71.239999999999995 109.171 173.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.5 m -65.02 125.88 26.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.294 0.638 . . . . 72.129999999999995 111.388 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -98.48 156.28 35.88 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.484 1.114 . . . . 74.219999999999999 110.2 -174.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.98 -35.08 93.92 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.711 2.274 . . . . 75.040000000000006 113.727 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -82.25 5.86 18.65 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 113.241 0.83 . . . . 71.230000000000004 113.241 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -89.42 0.25 56.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 122.062 -0.399 . . . . 71.099999999999994 111.18 165.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.89 107.62 2.12 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 119.986 -0.341 . . . . 75.230000000000004 112.835 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.405 ' HA3' ' HE2' ' A' ' 40' ' ' LYS . . . 164.65 -179.49 39.34 Favored Glycine 0 N--CA 1.475 1.284 0 CA-C-N 116.976 0.388 . . . . 74.510000000000005 113.724 177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.03 110.52 21.21 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.007 0.523 . . . . 62.030000000000001 112.107 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.73 121.85 32.28 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 71.310000000000002 110.256 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -107.45 111.64 24.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.214 1.006 . . . . 71.230000000000004 111.742 -169.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.8 m -84.61 95.3 8.83 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.32 -0.622 . . . . 75.239999999999995 109.32 172.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 37' ' ' ARG . 68.1 t -85.22 100.05 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.285 0.564 . . . . 65.239999999999995 109.652 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.96 -63.93 1.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.504 -0.771 . . . . 63.409999999999997 110.217 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.81 110.55 0.23 Allowed Glycine 0 C--N 1.34 0.799 0 N-CA-C 110.529 -1.028 . . . . 61.020000000000003 110.529 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.8 t70 76.82 -50.57 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.136 1.374 . . . . 75.049999999999997 111.992 -172.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -113.35 157.44 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.241 0.616 . . . . 72.519999999999996 111.753 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.4 p -145.77 143.29 29.61 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.934 0.894 . . . . 72.219999999999999 111.591 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.81 127.65 42.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.774 0.83 . . . . 65.530000000000001 111.341 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -102.97 123.95 47.55 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.537 0.735 . . . . 74.230000000000004 110.446 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -112.9 107.72 16.4 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.229 -0.656 . . . . 64.420000000000002 109.229 173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.3 m -88.7 101.69 14.24 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 110.208 -0.293 . . . . 64.549999999999997 110.208 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 95.1 t -90.5 108.81 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.278 0.631 . . . . 23.239999999999998 109.878 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.3 m -103.65 115.34 30.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.159 0.984 . . . . 74.140000000000001 110.24 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.906 0.86 . . . . 73.519999999999996 110.825 -174.722 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 35.7 t60 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.813 -0.44 . . . . 71.329999999999998 109.813 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -112.6 127.36 26.95 Favored Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 123.087 0.555 . . . . 62.140000000000001 111.828 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -91.37 90.82 0.25 Allowed 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 122.706 2.271 . . . . 72.109999999999999 112.151 170.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.82 100.51 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 122.102 0.953 . . . . 74.230000000000004 111.42 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -106.96 159.11 16.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.356 -0.838 . . . . 74.340000000000003 110.763 176.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.4 mt -89.95 111.7 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.571 -0.74 . . . . 71.099999999999994 110.868 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.7 -36.67 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.639 0.776 . . . . 72.519999999999996 111.935 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -128.61 134.1 25.91 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.349 -0.982 . . . . 73.340000000000003 108.349 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -95.61 19.69 32.66 Favored 'Cis proline' 0 CA--C 1.552 1.386 0 CA-C-N 121.19 1.461 . . . . 64.310000000000002 113.365 3.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? 59.23 40.16 21.82 Favored 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 124.295 1.038 . . . . 65.120000000000005 109.991 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 84' ' ' ALA . 2.1 mp0 64.6 -179.27 0.17 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 124.653 1.181 . . . . 74.439999999999998 113.646 171.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 45.2 80.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 126.283 1.833 . . . . 74.510000000000005 114.273 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.5 t -121.2 103.97 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.262 0.625 . . . . 61.439999999999998 110.442 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -98.26 112.52 24.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.165 0.586 . . . . 72.140000000000001 109.768 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 23' ' ' VAL . 14.4 t -109.4 111.37 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.702 0.801 . . . . 52.25 110.422 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -86.89 134.55 33.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.38 0.272 . . . . 72.420000000000002 110.427 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.15 168.59 21.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 73.230000000000004 111.205 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 55.4 mt -99.46 168.11 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.797 0.839 . . . . 75.200000000000003 108.891 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.491 HG22 ' HD3' ' A' ' 69' ' ' PRO . 63.2 p -52.79 124.55 14.27 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 123.245 0.618 . . . . 41.219999999999999 111.744 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.6 t 68.6 18.23 8.87 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.908 1.283 . . . . 52.039999999999999 113.419 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.15 152.64 20.5 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.18 0.592 . . . . 74.329999999999998 109.79 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.3 m -70.6 131.25 43.66 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.681 0.793 . . . . 63.229999999999997 112.692 -175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 15' ' ' VAL . 62.3 t -128.55 115.19 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.645 1.178 . . . . 65.340000000000003 109.762 173.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.454 ' HG3' HG22 ' A' ' 63' ' ' VAL . 26.9 ttt -107.49 100.41 9.83 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 122.005 -0.434 . . . . 61.310000000000002 110.554 175.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 68.4 mt -78.89 154.03 30.04 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.637 0.775 . . . . 61.539999999999999 110.054 173.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -148.13 129.85 15.09 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.84 0.456 . . . . 73.120000000000005 111.394 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 48.5 t -152.49 113.2 4.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.23 0.612 . . . . 70.430000000000007 111.289 174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.618 ' HG2' ' HA ' ' A' ' 59' ' ' HIS . 58.8 mt-10 -121.25 151.41 40.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.242 1.017 . . . . 72.019999999999996 110.865 178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.9 m -110.08 166.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.036 0.935 . . . . 72.540000000000006 112.334 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.71 -28.54 50.94 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.984 -1.007 . . . . 63.520000000000003 111.466 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -113.17 108.64 17.57 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.484 0.713 . . . . 75.340000000000003 109.971 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -28.74 68.47 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.235 1.014 . . . . 63.240000000000002 112.734 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.13 -19.69 64.84 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.064 0.946 . . . . 74.239999999999995 112.233 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.92 82.44 64.52 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.357 0.663 . . . . 54.439999999999998 111.282 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.11 176.51 9.89 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 123.42 2.747 . . . . 71.530000000000001 113.26 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 1.4 m -93.44 159.66 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.702 0.763 . . . . 75.430000000000007 112.056 -174.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -117.15 124.32 48.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.071 1.348 . . . . 62.409999999999997 108.951 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -87.04 136.89 32.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.11 0.564 . . . . 73.219999999999999 111.506 -175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 99.0 m-85 -137.59 130.28 29.94 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.594 1.157 . . . . 73.540000000000006 110.216 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -111.54 102.46 10.8 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.822 0.849 . . . . 73.25 110.864 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 55.77 24.07 6.97 Favored 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.266 1.427 . . . . 73.25 113.457 171.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 128.76 -38.74 1.99 Allowed Glycine 0 N--CA 1.476 1.357 0 O-C-N 122.061 -0.399 . . . . 34.539999999999999 113.2 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.02 160.0 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.378 0.671 . . . . 75.340000000000003 110.438 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -94.79 126.73 40.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.655 0.382 . . . . 73.5 110.077 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -78.37 118.87 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.045 0.538 . . . . 75.129999999999995 111.544 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -117.48 166.64 12.11 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.56 0.744 . . . . 75.209999999999994 110.483 172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.95 98.39 7.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.968 0.507 . . . . 35.210000000000001 110.521 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -153.57 154.85 35.03 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.811 0.844 . . . . 44.240000000000002 110.887 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 65.65 -75.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 125.053 1.341 . . . . 74.319999999999993 112.78 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -148.1 -8.43 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.422 1.089 . . . . 75.319999999999993 111.056 177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG22 HD21 ' A' ' 64' ' ' LEU . 23.8 t -76.44 126.25 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 123.748 0.819 . . . . 74.099999999999994 110.372 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -126.36 149.06 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 123.012 0.525 . . . . 74.409999999999997 111.154 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.52 115.9 24.35 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.922 0.889 . . . . 72.319999999999993 109.554 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -95.54 124.54 39.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.262 0.625 . . . . 72.530000000000001 109.463 -177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.46 HD22 ' H ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -133.01 147.95 52.25 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.722 0.409 . . . . 71.219999999999999 111.829 -174.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -169.97 88.97 0.16 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.205 1.002 . . . . 74.420000000000002 109.361 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.8 -108.1 2.23 Favored Glycine 0 CA--C 1.546 1.975 0 CA-C-O 119.226 -0.763 . . . . 60.140000000000001 113.111 -174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.79 -12.11 11.12 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.43 2.087 . . . . 71.25 113.164 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.618 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 m170 -69.9 121.54 17.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.483 0.713 . . . . 74.439999999999998 110.605 -177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -141.65 90.78 2.31 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.269 1.027 . . . . 72.340000000000003 109.003 173.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -121.63 116.91 25.45 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.035 0.534 . . . . 74.140000000000001 111.024 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 5.9 tt -80.16 117.46 20.98 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.622 0.769 . . . . 75.519999999999996 109.195 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 24' ' ' MET . 61.0 t -102.05 126.7 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-O 121.281 0.563 . . . . 70.519999999999996 109.809 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.406 HD21 HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -120.93 108.16 37.06 Favored Pre-proline 0 CA--C 1.56 1.354 0 N-CA-C 108.689 -0.856 . . . . 74.329999999999998 108.689 -179.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.89 -55.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.638 2.225 . . . . 53.219999999999999 113.836 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.43 87.97 2.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.312 0.645 . . . . 62.450000000000003 110.577 -177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 m -82.72 97.68 8.69 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.919 0.487 . . . . 54.539999999999999 111.471 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.3 165.15 47.04 Favored Pre-proline 0 CA--C 1.567 1.604 0 C-N-CA 123.609 0.764 . . . . 75.049999999999997 110.578 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.491 ' HD3' HG22 ' A' ' 19' ' ' THR . 26.3 Cg_endo -60.21 -17.56 46.92 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.15 1.9 . . . . 63.43 114.106 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.2 m -87.61 -12.4 45.73 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 112.479 0.548 . . . . 64.530000000000001 112.479 174.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -98.78 3.28 47.45 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 113.1 0.778 . . . . 71.219999999999999 113.1 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.55 -133.9 1.31 Allowed Glycine 0 CA--C 1.536 1.35 0 CA-C-O 120.22 -0.211 . . . . 54.229999999999997 112.67 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.62 -161.52 51.45 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 117.274 0.537 . . . . 52.039999999999999 114.267 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -91.84 129.15 37.86 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.486 0.714 . . . . 73.409999999999997 111.862 -177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 80.3 m-85 -112.47 162.47 15.57 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.992 0.917 . . . . 73.329999999999998 110.535 171.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.2 tt0 -147.79 144.17 28.03 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.996 0.919 . . . . 71.209999999999994 110.581 -175.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 97.0 m -129.59 96.76 4.34 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.4 0.68 . . . . 71.140000000000001 111.102 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -94.75 107.56 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.352 0.661 . . . . 72.030000000000001 110.528 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -77.59 -79.11 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.079 0.551 . . . . 72.310000000000002 111.402 -178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.5 28.38 0.06 OUTLIER Glycine 0 CA--C 1.533 1.174 0 CA-C-N 115.773 -0.649 . . . . 54.200000000000003 111.531 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.5 t70 177.33 -58.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.314 1.446 . . . . 64.420000000000002 108.892 -171.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.67 164.7 11.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.018 0.927 . . . . 75.329999999999998 111.498 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 27.6 p -146.62 131.1 17.7 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.162 0.585 . . . . 72.120000000000005 111.856 175.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 11' ' ' GLU . . . -93.52 157.02 16.41 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.725 0.81 . . . . 50.039999999999999 111.171 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.18 134.71 46.76 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.196 0.598 . . . . 75.129999999999995 111.815 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.751 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 25.7 m-85 -123.45 151.5 42.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.682 1.193 . . . . 74.409999999999997 109.48 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 53.7 m -139.57 102.43 4.46 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.698 0.799 . . . . 64.040000000000006 109.424 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.35 113.81 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.992 0.517 . . . . 72.349999999999994 109.888 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 47.8 m -105.59 118.75 37.37 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.204 0.602 . . . . 72.209999999999994 110.228 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.673 0.789 . . . . 61.439999999999998 111.044 -179.719 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 121.317 0.579 . . . . 61.32 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -91.5 139.36 25.14 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.635 0.774 . . . . 23.199999999999999 110.52 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.79 -160.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.908 2.405 . . . . 74.319999999999993 113.013 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 34' ' ' ALA . 2.7 p -126.81 97.95 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 122.004 0.907 . . . . 74.549999999999997 111.759 -176.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -84.18 125.03 31.8 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.495 -0.775 . . . . 72.420000000000002 110.064 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' HA ' HG12 ' A' ' 29' ' ' VAL . 55.2 mt -73.52 99.1 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.173 0.511 . . . . 72.340000000000003 109.747 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.9 m -83.44 -24.74 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 115.464 -0.789 . . . . 73.099999999999994 111.39 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 28' ' ' GLU . 19.0 t70 -142.03 125.29 9.59 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.547 1.139 . . . . 70.340000000000003 108.84 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.42 145.21 82.9 Favored 'Cis proline' 0 C--N 1.369 1.615 0 C-N-CA 124.021 -1.241 . . . . 71.349999999999994 113.017 -5.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -58.47 -30.0 66.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.119 0.968 . . . . 72.230000000000004 112.731 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -162.61 -167.37 1.54 Allowed 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.596 0.758 . . . . 54.420000000000002 111.464 -170.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -51.39 128.78 23.52 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.269 . . . . 74.019999999999996 112.814 174.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.6 t -119.84 109.9 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.655 0.782 . . . . 54.409999999999997 110.038 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -84.41 112.71 20.6 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.74 0.416 . . . . 74.209999999999994 109.926 175.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.484 ' HB ' HG22 ' A' ' 88' ' ' VAL . 60.5 t -107.95 113.25 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.936 0.894 . . . . 75.209999999999994 110.523 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -82.99 111.71 19.09 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.815 -0.439 . . . . 73.120000000000005 109.815 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -99.3 156.91 16.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.801 0.84 . . . . 65.420000000000002 110.909 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 21' ' ' GLU . 63.1 mt -112.38 158.48 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 74.340000000000003 108.579 171.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.446 HG22 ' HG3' ' A' ' 69' ' ' PRO . 72.5 p -58.37 126.12 26.18 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.098 0.559 . . . . 63.240000000000002 111.346 174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 t 67.69 14.19 9.44 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.061 1.344 . . . . 73.230000000000004 113.504 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.6 tm-20 -91.7 151.0 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.343 0.657 . . . . 64.219999999999999 110.365 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.64 115.84 21.77 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.759 0.824 . . . . 61.439999999999998 112.242 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 94.7 t -113.13 130.45 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.847 0.859 . . . . 71.540000000000006 110.185 175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.9 mtp -126.57 103.89 7.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.03 0.532 . . . . 72.400000000000006 110.064 175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.18 103.66 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.995 0.518 . . . . 72.319999999999993 110.072 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.32 141.84 28.18 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 122.852 0.461 . . . . 73.319999999999993 110.679 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -140.29 114.83 9.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.846 0.859 . . . . 72.040000000000006 109.437 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 8' ' ' ASP . 1.4 tm-20 -105.5 131.06 53.37 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.598 -1.26 . . . . 72.349999999999994 107.598 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 6' ' ' ILE . 16.8 m -127.4 156.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.237 0.615 . . . . 74.540000000000006 111.194 -171.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -59.33 -38.99 81.72 Favored 'General case' 0 CA--C 1.561 1.367 0 C-N-CA 123.924 0.89 . . . . 72.0 112.783 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.6 ttt85 -92.11 130.71 37.77 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.026 0.53 . . . . 62.229999999999997 111.051 -173.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -72.85 -38.75 66.95 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.871 0.468 . . . . 74.329999999999998 111.12 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -86.91 32.98 0.66 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.447 0.699 . . . . 74.049999999999997 111.303 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -71.66 115.46 37.9 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.422 1.089 . . . . 65.319999999999993 113.837 -174.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.71 136.05 14.92 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.881 1.721 . . . . 74.530000000000001 110.386 165.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.403 HG11 ' HG3' ' A' ' 60' ' ' ARG . 21.2 m -132.95 164.32 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 123.344 0.658 . . . . 63.439999999999998 111.135 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.0 ttm-85 -142.38 105.37 4.57 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.368 -0.833 . . . . 74.219999999999999 108.997 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -84.67 137.1 33.45 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 109.278 -0.638 . . . . 72.319999999999993 109.278 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' GLN . 55.8 m-85 -115.38 168.84 9.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.723 0.809 . . . . 74.129999999999995 109.736 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 12.8 tmtt? -151.29 -54.51 0.14 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 120.994 0.426 . . . . 71.129999999999995 111.471 -167.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -137.92 34.4 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.947 0.88 . . . . 53.219999999999999 110.188 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.68 -31.41 5.55 Favored Glycine 0 N--CA 1.479 1.547 0 CA-C-N 115.673 -0.694 . . . . 51.25 112.04 -169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -86.01 153.95 21.78 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 124.582 1.153 . . . . 73.510000000000005 109.731 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 8.0 pt-20 -80.98 168.21 18.95 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-O 121.005 0.431 . . . . 72.209999999999994 110.477 173.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.3 t -96.02 106.46 18.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.486 0.66 . . . . 54.149999999999999 110.463 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -112.05 37.13 3.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.426 1.09 . . . . 72.409999999999997 108.33 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 61.23 171.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.369 1.468 . . . . 73.329999999999998 112.705 -168.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.6 t -155.25 -73.03 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 120.921 0.391 . . . . 74.400000000000006 110.734 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.23 -60.92 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.127 0.971 . . . . 75.409999999999997 108.603 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 77.3 m-85 -96.79 -4.28 40.78 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.504 -0.771 . . . . 74.030000000000001 111.729 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.6 t -110.53 106.66 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.718 -0.614 . . . . 72.510000000000005 109.449 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -129.82 157.01 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 123.827 0.851 . . . . 74.439999999999998 111.104 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.4 mt -116.46 131.33 56.97 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 111.765 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -115.8 118.75 33.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.155 0.982 . . . . 71.420000000000002 109.117 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -133.78 114.75 13.73 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.945 0.498 . . . . 64.120000000000005 111.143 -172.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -140.02 119.08 12.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.18 0.592 . . . . 60.020000000000003 111.169 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.38 -131.84 47.65 Favored Glycine 0 CA--C 1.539 1.582 0 CA-C-N 115.72 -0.673 . . . . 53.509999999999998 113.871 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -84.93 5.84 6.04 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 113.135 173.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -102.33 108.07 19.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.588 0.755 . . . . 61.329999999999998 110.177 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HG3' HG11 ' A' ' 36' ' ' VAL . 29.9 mmt180 -114.51 123.24 48.9 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.737 1.215 . . . . 74.129999999999995 108.805 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -139.72 133.14 30.1 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.373 0.606 . . . . 74.329999999999998 112.244 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 tt -90.33 116.36 28.23 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.879 0.872 . . . . 75.219999999999999 108.952 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' HG23 ' A' ' 52' ' ' VAL . 60.3 t -98.17 129.31 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 123.149 0.58 . . . . 72.209999999999994 110.437 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.25 91.89 49.03 Favored Pre-proline 0 CA--C 1.562 1.423 0 N-CA-C 107.943 -1.132 . . . . 53.439999999999998 107.943 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 10.1 Cg_endo -49.22 -49.74 14.67 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 123.982 3.122 . . . . 74.450000000000003 114.649 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.08 99.32 3.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.92 0.488 . . . . 75.099999999999994 110.472 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.3 m -79.09 107.49 11.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.78 0.832 . . . . 54.109999999999999 112.247 -170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -80.22 154.0 74.52 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 123.958 0.903 . . . . 71.109999999999999 110.252 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HG3' HG22 ' A' ' 19' ' ' THR . 73.5 Cg_exo -50.76 -30.75 30.44 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 123.298 2.665 . . . . 71.340000000000003 114.673 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 t -69.66 -34.89 74.64 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.652 0.781 . . . . 74.140000000000001 112.569 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 40' ' ' LYS . 60.7 m-20 -67.38 -19.47 65.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.468 0.914 . . . . 75.430000000000007 113.468 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -79.43 86.47 1.22 Allowed Glycine 0 CA--C 1.533 1.206 0 CA-C-N 116.478 -0.328 . . . . 33.140000000000001 113.227 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -134.28 -148.41 5.78 Favored Glycine 0 N--CA 1.473 1.12 0 C-N-CA 122.855 0.264 . . . . 54.240000000000002 112.598 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -99.27 109.63 22.25 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.484 0.714 . . . . 74.510000000000005 110.323 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 9.4 m-85 -92.42 145.9 24.1 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.513 0.725 . . . . 75.439999999999998 109.815 175.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 53.6 tt0 -143.33 108.73 5.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.675 0.274 . . . . 71.200000000000003 111.327 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 54.1 t -87.06 99.27 11.79 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.976 0.51 . . . . 33.109999999999999 110.23 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -91.78 104.52 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.243 0.617 . . . . 75.530000000000001 109.919 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.85 -52.85 7.74 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.276 0.56 . . . . 74.310000000000002 110.544 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.14 -86.23 0.06 OUTLIER Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.783 -0.644 . . . . 71.540000000000006 111.906 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.52 -42.76 74.26 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.207 0.603 . . . . 75.030000000000001 110.778 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.54 154.7 18.61 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.145 0.578 . . . . 55.439999999999998 112.49 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -140.46 123.66 16.72 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.116 0.966 . . . . 74.329999999999998 109.823 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 6' ' ' ILE . . . -94.72 140.38 29.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.1 0.96 . . . . 65.409999999999997 111.175 -176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -110.74 131.95 54.61 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.377 0.671 . . . . 72.120000000000005 111.449 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.611 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 51.4 m-85 -123.75 113.15 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.438 1.095 . . . . 62.119999999999997 109.153 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.3 m -97.28 101.65 13.25 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.627 -0.509 . . . . 74.420000000000002 109.627 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG22 ' HB ' ' A' ' 15' ' ' VAL . 60.1 t -102.26 120.53 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.058 0.543 . . . . 73.340000000000003 111.224 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -121.44 133.05 55.06 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.206 1.002 . . . . 73.140000000000001 110.83 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.65 HG12 ' HB3' ' A' ' 17' ' ' ALA . 47.7 mt . . . . . 0 N--CA 1.489 1.488 0 C-N-CA 123.64 0.776 . . . . 73.329999999999998 111.21 -175.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.499 -0.556 . . . . 64.120000000000005 109.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 84.8 mtp -97.23 158.52 33.11 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.667 0.787 . . . . 75.109999999999999 112.096 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.55 147.43 38.74 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.22 2.613 . . . . 62.109999999999999 114.067 169.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 79' ' ' ALA . 5.0 p -97.8 120.13 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-O 121.575 0.702 . . . . 61.039999999999999 111.566 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.701 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 13.2 m-70 -125.65 134.0 52.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.54 0.736 . . . . 71.109999999999999 112.451 -177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.14 117.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.967 0.507 . . . . 72.549999999999997 109.757 173.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.97 -39.69 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 123.215 0.606 . . . . 65.239999999999995 111.345 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -158.7 125.58 2.58 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.619 0.768 . . . . 70.140000000000001 110.251 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HD3' ' HA ' ' A' ' 27' ' ' CYS . 6.3 Cg_exo -81.21 133.23 24.72 Favored 'Cis proline' 0 C--N 1.384 2.402 0 CA-C-N 120.328 1.153 . . . . 73.349999999999994 112.484 -1.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.15 8.5 42.82 Favored 'General case' 0 CA--C 1.567 1.614 0 C-N-CA 123.992 0.917 . . . . 74.430000000000007 110.723 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -144.24 -168.13 2.8 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.888 0.875 . . . . 74.0 112.372 -172.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.5 m170 -88.18 110.87 21.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.183 0.993 . . . . 74.099999999999994 111.214 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.6 t -99.52 110.95 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.804 0.841 . . . . 73.239999999999995 110.716 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -90.93 117.2 29.34 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.576 0.75 . . . . 70.230000000000004 110.614 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.98 112.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.984 0.914 . . . . 75.040000000000006 110.512 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -78.6 108.55 12.07 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.026 -0.731 . . . . 74.540000000000006 109.026 168.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.632 ' HB3' HD13 ' A' ' 90' ' ' ILE . . . -97.51 159.94 14.62 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.143 0.577 . . . . 64.329999999999998 111.708 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.4 mt -133.51 153.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 124.765 1.226 . . . . 73.120000000000005 108.901 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 67' ' ' THR . 81.6 p -77.56 50.12 0.79 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.788 0.835 . . . . 62.439999999999998 112.804 -178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -162.09 -50.17 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.339 1.056 . . . . 74.030000000000001 110.503 -175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -74.41 165.85 24.49 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.605 0.762 . . . . 62.530000000000001 112.01 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.82 133.98 40.72 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.365 0.666 . . . . 62.439999999999998 111.275 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.3 t -99.72 106.79 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.947 -0.39 . . . . 72.310000000000002 109.947 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.514 ' HG3' HG22 ' A' ' 63' ' ' VAL . 27.1 ttt -105.24 91.58 3.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.343 0.592 . . . . 74.450000000000003 109.867 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 70.7 mt -78.74 146.62 33.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.358 -0.837 . . . . 73.329999999999998 109.038 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -144.99 137.37 26.04 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.828 0.451 . . . . 61.329999999999998 110.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.548 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 t -138.97 140.11 38.13 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.967 0.907 . . . . 72.310000000000002 110.344 177.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -131.12 129.69 42.16 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.438 0.695 . . . . 72.109999999999999 110.515 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.97 167.39 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 123.571 0.748 . . . . 63.310000000000002 110.425 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.45 -27.48 19.23 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.993 0.917 . . . . 70.200000000000003 110.337 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD3' ' HB ' ' A' ' 4' ' ' VAL . 77.0 ttt180 -97.56 105.44 17.58 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.703 0.801 . . . . 74.409999999999997 110.271 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -58.03 -28.52 64.56 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.975 0.91 . . . . 74.319999999999993 113.027 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.48 -27.65 68.64 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.285 1.034 . . . . 73.209999999999994 112.152 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.91 91.6 17.37 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.34 0.656 . . . . 24.23 111.046 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.79 -176.12 2.99 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.284 1.99 . . . . 73.409999999999997 112.197 170.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 60' ' ' ARG . 5.8 m -86.29 159.39 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.722 -0.611 . . . . 52.149999999999999 112.451 -176.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.14 127.96 43.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.007 -1.109 . . . . 75.439999999999998 108.007 162.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.551 ' HE1' ' HB3' ' A' ' 60' ' ' ARG . 94.0 m95 -86.11 120.27 27.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.815 -0.439 . . . . 73.319999999999993 109.815 176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.41 142.19 46.18 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.295 1.038 . . . . 73.219999999999999 109.116 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -97.02 -33.49 11.53 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.663 0.385 . . . . 71.349999999999994 111.628 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -153.4 -70.32 0.14 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.694 0.798 . . . . 73.329999999999998 109.818 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.82 5.66 3.41 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-N 115.898 -0.592 . . . . 71.400000000000006 112.659 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.55 165.8 29.26 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 70.329999999999998 108.738 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.14 144.77 39.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.544 0.737 . . . . 71.209999999999994 111.784 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 62' ' ' LEU . 15.1 t -62.19 -28.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 123.278 0.631 . . . . 65.129999999999995 112.288 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 66.73 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.156 1.382 . . . . 72.319999999999993 112.065 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.95 82.21 2.2 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 109.123 -0.695 . . . . 75.140000000000001 109.123 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.507 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 19.3 t -94.13 -172.44 2.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.752 0.821 . . . . 70.049999999999997 111.254 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -60.35 -26.65 66.76 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 113.117 0.784 . . . . 73.420000000000002 113.117 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -116.16 2.2 13.31 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.63 0.772 . . . . 63.140000000000001 112.253 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' H ' ' A' ' 48' ' ' SER . 33.2 t -120.39 124.43 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.099 0.409 . . . . 55.340000000000003 110.781 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.2 m -121.69 115.06 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.404 0 CA-C-O 121.621 0.724 . . . . 65.310000000000002 110.403 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 83.1 mt -95.26 109.16 21.32 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.492 0.717 . . . . 74.109999999999999 109.531 175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.567 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 41.6 mt-10 -103.97 147.61 27.16 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.651 0.78 . . . . 72.439999999999998 111.488 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.45 ' HB2' HH11 ' A' ' 60' ' ' ARG . 7.0 t30 -134.84 150.26 50.46 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.675 0.79 . . . . 75.430000000000007 111.021 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -146.98 85.37 1.61 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.053 0.941 . . . . 75.430000000000007 108.639 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . 60.01 -107.25 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 119.243 -0.754 . . . . 75.450000000000003 114.028 -175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 1.0 OUTLIER -78.09 -13.51 15.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.898 2.399 . . . . 71.400000000000006 113.409 175.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -87.48 136.67 32.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.458 0.703 . . . . 71.239999999999995 111.083 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.729 ' HG3' HG22 ' A' ' 36' ' ' VAL . 8.4 mmt180 -133.79 146.16 50.44 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.755 1.222 . . . . 64.239999999999995 109.274 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 15.2 ptt180 -154.75 126.94 7.77 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.393 0.616 . . . . 74.310000000000002 112.077 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.1 tt -94.69 111.57 23.34 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.664 1.185 . . . . 62.140000000000001 108.622 170.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 24' ' ' MET . 39.8 t -107.1 115.75 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.722 -0.473 . . . . 71.150000000000006 109.722 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -104.66 95.0 8.0 Favored Pre-proline 0 CA--C 1.561 1.377 0 N-CA-C 108.002 -1.11 . . . . 74.319999999999993 108.002 175.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -56.51 -62.02 0.28 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.466 2.777 . . . . 53.240000000000002 113.541 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.07 93.76 4.67 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.849 -0.797 . . . . 62.210000000000001 108.849 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.535 ' HA ' HD12 ' A' ' 64' ' ' LEU . 13.4 m -65.44 122.04 16.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.54 0.336 . . . . 64.019999999999996 111.216 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -98.7 159.47 30.31 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.565 0.746 . . . . 53.439999999999998 109.769 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.7 -46.49 31.41 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.972 2.448 . . . . 70.150000000000006 113.869 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.9 m -88.24 -0.9 57.66 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 112.339 0.496 . . . . 71.310000000000002 112.339 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.18 -3.67 58.89 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.335 0.654 . . . . 73.219999999999999 112.024 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -91.39 -174.38 43.35 Favored Glycine 0 N--CA 1.475 1.285 0 C-N-CA 122.89 0.281 . . . . 53.219999999999999 112.685 173.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.27 -161.05 25.21 Favored Glycine 0 N--CA 1.477 1.421 0 O-C-N 122.613 -0.345 . . . . 70.129999999999995 112.956 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -99.48 102.31 13.83 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.284 0.542 . . . . 75.25 110.321 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 70.5 m-85 -89.04 148.39 23.76 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.148 0.979 . . . . 64.030000000000001 111.1 -177.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -138.74 130.72 28.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.271 0.628 . . . . 75.420000000000002 110.992 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.489 ' SG ' ' HE1' ' A' ' 86' ' ' PHE . 93.5 m -105.0 98.7 8.38 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.739 0.816 . . . . 72.120000000000005 110.798 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -92.88 107.6 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 122.007 -0.433 . . . . 74.120000000000005 111.047 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 4' ' ' VAL . . . -78.37 -38.16 42.55 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.696 0.799 . . . . 63.32 111.408 175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.21 -96.51 0.11 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 110.409 -1.076 . . . . 74.239999999999995 110.409 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -76.48 -26.82 55.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.047 0.539 . . . . 72.209999999999994 110.335 168.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.701 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 7.7 mm-40 -94.53 146.0 24.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.493 1.117 . . . . 53.399999999999999 111.868 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 77' ' ' CYS . 26.6 p -150.31 127.37 11.19 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.389 0.676 . . . . 74.230000000000004 111.296 176.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 77' ' ' CYS . . . -93.08 157.0 16.52 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.117 0.967 . . . . 62.43 110.31 177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -128.24 138.54 52.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.845 0.458 . . . . 73.439999999999998 111.343 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.489 ' HE1' ' SG ' ' A' ' 77' ' ' CYS . 69.5 m-85 -132.96 110.59 10.38 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.494 1.118 . . . . 73.209999999999994 109.044 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.2 m -92.54 98.61 11.56 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 118.615 0.643 . . . . 54.219999999999999 109.309 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.25 102.21 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.906 0.882 . . . . 52.409999999999997 109.491 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.0 m -106.0 118.44 36.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.094 0.558 . . . . 61.009999999999998 109.868 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.632 HD13 ' HB3' ' A' ' 17' ' ' ALA . 36.1 mm . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.321 0.581 . . . . 63.119999999999997 111.76 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.904 0.383 . . . . 73.319999999999993 109.974 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 60.5 mtt -111.92 159.97 31.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 124.139 0.975 . . . . 70.030000000000001 109.96 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.91 174.43 9.65 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.044 1.829 . . . . 73.209999999999994 112.678 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 31' ' ' ARG . 10.0 p -100.61 149.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 122.935 0.494 . . . . 72.230000000000004 111.512 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -148.76 134.67 19.01 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.228 0.611 . . . . 71.230000000000004 110.655 172.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.86 126.67 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.539 0.736 . . . . 73.329999999999998 110.43 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -91.31 -33.55 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 122.86 0.464 . . . . 74.25 111.603 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.85 120.91 2.49 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 122.818 0.447 . . . . 72.230000000000004 110.276 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.14 157.47 69.42 Favored 'Cis proline' 0 C--N 1.379 2.169 0 CA-C-N 120.227 1.117 . . . . 75.25 113.731 -1.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -68.07 -53.77 23.13 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.166 0.587 . . . . 62.240000000000002 111.898 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -81.3 0.63 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.297 0.639 . . . . 70.25 112.691 -172.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 p80 -144.31 139.72 28.73 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.249 0.62 . . . . 74.530000000000001 111.077 -171.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 71.9 t -127.03 122.39 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.606 0.762 . . . . 65.5 110.82 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -89.58 133.53 34.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.119 0.968 . . . . 75.109999999999999 110.608 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.576 HG21 HD21 ' A' ' 25' ' ' LEU . 96.0 t -133.25 141.72 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.547 1.139 . . . . 74.099999999999994 110.406 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -98.61 139.97 33.54 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.632 0.773 . . . . 75.439999999999998 110.016 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HG12 ' A' ' 90' ' ' ILE . . . -147.89 159.36 43.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.819 0.818 . . . . 63.229999999999997 112.152 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 80.9 mt -142.66 163.05 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 126.249 1.82 . . . . 75.420000000000002 106.685 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.403 HG22 ' HA ' ' A' ' 68' ' ' GLN . 63.3 p -55.52 -27.28 47.75 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 119.058 0.845 . . . . 61.100000000000001 112.289 173.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.493 ' H ' HG22 ' A' ' 18' ' ' ILE . 37.3 t -79.04 -14.76 58.97 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.365 1.066 . . . . 74.120000000000005 113.085 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 25.2 mm-40 -92.12 161.52 14.72 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.326 0.862 . . . . 64.109999999999999 113.326 -173.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.3 p -122.4 110.63 15.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.54 -1.209 . . . . 63.420000000000002 109.116 173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.14 119.43 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.191 0.596 . . . . 73.129999999999995 111.076 -177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.501 ' HG3' HG22 ' A' ' 63' ' ' VAL . 21.6 ttt -118.6 90.37 3.32 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.493 0.717 . . . . 73.409999999999997 109.151 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 HG21 ' A' ' 15' ' ' VAL . 96.8 mt -86.82 154.57 20.79 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.846 0.858 . . . . 54.409999999999997 110.989 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -139.68 139.46 36.62 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.846 0.458 . . . . 64.120000000000005 111.92 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -130.26 119.95 23.67 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.259 1.024 . . . . 63.009999999999998 109.022 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.91 129.15 49.81 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.62 0.768 . . . . 73.329999999999998 110.457 -170.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.47 161.98 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.006 0.922 . . . . 73.030000000000001 110.006 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -89.81 -8.9 51.04 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.03 0.443 . . . . 74.230000000000004 110.604 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -116.73 88.65 2.94 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.595 0.758 . . . . 74.319999999999993 109.171 -172.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.73 -42.28 83.54 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.894 1.277 . . . . 52.130000000000003 112.215 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -47.82 -26.49 1.66 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.728 1.211 . . . . 44.439999999999998 112.996 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.92 91.01 16.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.117 0.967 . . . . 72.219999999999999 110.24 171.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.16 148.8 35.15 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.818 2.346 . . . . 64.530000000000001 112.503 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 m -83.67 158.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 120.869 0.366 . . . . 44.329999999999998 111.24 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -129.77 128.32 42.18 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.111 0.964 . . . . 73.049999999999997 110.214 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -87.19 142.52 27.85 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.456 0.702 . . . . 75.040000000000006 110.8 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -136.18 137.4 40.86 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.519 1.128 . . . . 74.040000000000006 109.498 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -160.96 135.26 7.14 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.602 -0.518 . . . . 70.439999999999998 109.602 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 63.77 18.98 11.5 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.859 1.264 . . . . 74.400000000000006 112.585 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -1.52 83.84 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 116.62 -0.263 . . . . 72.25 113.713 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -90.66 156.35 18.17 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.781 0.833 . . . . 75.510000000000005 110.652 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -73.21 -7.66 52.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 113.635 0.976 . . . . 72.439999999999998 113.635 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 HG11 ' A' ' 51' ' ' VAL . 69.1 t 63.7 99.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.115 0.966 . . . . 74.200000000000003 111.988 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.38 153.33 31.22 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.886 0.874 . . . . 74.409999999999997 110.188 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -77.4 118.21 19.63 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.408 0.623 . . . . 72.209999999999994 111.737 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 t -142.93 -157.54 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.797 1.239 . . . . 70.430000000000007 109.06 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -56.24 -59.11 5.42 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.037 0.935 . . . . 63.310000000000002 112.739 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -87.67 -15.34 37.46 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.798 0.666 . . . . 73.040000000000006 112.798 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG11 HG13 ' A' ' 45' ' ' VAL . 23.3 t -121.42 123.07 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 122.861 0.465 . . . . 54.329999999999998 110.864 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG23 ' HB ' ' A' ' 63' ' ' VAL . 13.1 m -135.86 141.08 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.105 0.562 . . . . 72.340000000000003 110.366 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.71 137.66 49.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.649 0.78 . . . . 72.319999999999993 110.252 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -123.09 147.91 46.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.419 0.688 . . . . 74.120000000000005 111.038 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -135.88 120.84 18.69 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 123.996 0.918 . . . . 70.049999999999997 111.548 -175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -119.89 82.04 1.83 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.876 0.87 . . . . 75.120000000000005 109.384 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.83 -129.19 41.39 Favored Glycine 0 CA--C 1.541 1.681 0 CA-C-O 119.235 -0.758 . . . . 71.540000000000006 111.657 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.62 -0.13 8.93 Favored 'Trans proline' 0 CA--C 1.563 1.96 0 C-N-CA 122.592 2.195 . . . . 61.299999999999997 113.706 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -84.37 99.64 10.77 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.582 0.753 . . . . 75.25 109.29 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -111.83 106.01 14.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.94 0.496 . . . . 70.010000000000005 110.757 -175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -119.03 145.39 45.91 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.054 0.761 . . . . 63.130000000000003 113.054 -171.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 tt -99.86 121.83 41.9 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.944 0.897 . . . . 64.329999999999998 109.11 173.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' VAL . 45.0 t -106.84 125.59 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 123.767 0.827 . . . . 62.0 109.946 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.02 110.99 37.48 Favored Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 109.116 -0.698 . . . . 72.319999999999993 109.116 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.93 -70.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.39 2.727 . . . . 73.299999999999997 114.195 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.81 100.24 8.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.082 0.553 . . . . 65.140000000000001 109.831 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 90' ' ' ILE . 8.9 m -78.87 87.86 4.71 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.646 0.736 . . . . 73.420000000000002 111.864 -171.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.403 ' HA ' HG22 ' A' ' 19' ' ' THR . 83.0 mt-30 -76.47 162.39 71.06 Favored Pre-proline 0 CA--C 1.565 1.541 0 C-N-CA 124.043 0.937 . . . . 74.349999999999994 110.543 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -51.2 -28.14 24.94 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.991 2.461 . . . . 74.530000000000001 114.343 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.4 m -67.1 -42.2 84.96 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.398 0.679 . . . . 64.340000000000003 111.205 174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -69.55 -20.1 63.68 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.855 0.862 . . . . 74.239999999999995 112.568 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.7 -175.16 50.7 Favored Glycine 0 N--CA 1.474 1.193 0 N-CA-C 113.798 0.279 . . . . 52.140000000000001 113.798 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.34 -110.92 2.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 122.964 0.316 . . . . 63.140000000000001 112.768 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.52 125.03 28.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.54 0.736 . . . . 75.329999999999998 111.355 -177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 28.7 m-85 -105.16 115.49 30.35 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.815 0.846 . . . . 74.099999999999994 109.079 172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.36 127.05 53.54 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 108.526 -0.916 . . . . 72.319999999999993 108.526 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.8 t -126.27 101.49 6.75 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.324 0.491 . . . . 63.549999999999997 112.324 -169.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.4 t -85.18 117.28 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.696 0.798 . . . . 64.510000000000005 112.084 -174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.89 11.53 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.185 0.594 . . . . 73.439999999999998 111.417 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.12 -63.17 0.22 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.72 -0.673 . . . . 72.430000000000007 112.265 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -85.25 -33.29 22.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.585 0.754 . . . . 65.299999999999997 111.027 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.44 -176.82 4.47 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.179 0.992 . . . . 64.010000000000005 110.868 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.7 p -153.06 138.26 17.41 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.14 0.576 . . . . 62.119999999999997 112.344 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.78 36.06 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.194 0.998 . . . . 71.349999999999994 111.126 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 33.7 m-85 -106.46 142.28 36.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.501 0.721 . . . . 75.230000000000004 110.933 -174.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 85.8 m-85 -134.52 137.61 43.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.854 0.862 . . . . 73.109999999999999 109.447 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.3 m -124.0 105.59 9.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.371 0.668 . . . . 72.530000000000001 109.547 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 15' ' ' VAL . 89.6 t -104.53 121.47 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.53 0.732 . . . . 70.310000000000002 110.306 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.2 m -105.47 123.99 48.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.0 0.92 . . . . 72.549999999999997 110.965 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 67' ' ' THR . 33.2 mt . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 123.829 0.851 . . . . 74.219999999999999 110.603 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.328 0.122 . . . . 73.030000000000001 111.328 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.36 141.89 97.46 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.032 0.533 . . . . 71.040000000000006 111.789 -175.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.76 141.11 58.29 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.638 2.225 . . . . 74.099999999999994 112.701 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p -78.92 134.93 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.028 0.531 . . . . 75.5 112.286 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.478 ' HA ' ' HG3' ' A' ' 82' ' ' GLU . 14.6 p-80 -124.8 144.78 50.1 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.402 0.681 . . . . 73.129999999999995 110.971 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.99 104.45 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 121.231 0.538 . . . . 74.120000000000005 109.69 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -76.91 -29.12 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.611 0.764 . . . . 73.329999999999998 111.521 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 38.7 t70 -143.98 117.31 5.81 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 123.47 0.708 . . . . 65.25 109.501 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ASP . 62.7 Cg_endo -84.32 122.74 7.83 Favored 'Cis proline' 0 C--N 1.376 1.975 0 CA-C-N 120.584 1.244 . . . . 60.32 112.449 -1.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -63.02 -24.52 67.95 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.012 0.925 . . . . 75.140000000000001 111.239 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.58 155.87 21.74 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.17 1.388 . . . . 73.099999999999994 110.063 175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -83.91 106.72 15.81 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.329 0.585 . . . . 74.439999999999998 110.237 177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -87.13 124.64 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.465 0.706 . . . . 74.049999999999997 112.232 -169.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -81.43 133.85 35.46 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.178 0.591 . . . . 74.129999999999995 110.15 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 88' ' ' VAL . 52.0 t -122.41 127.31 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.094 0.958 . . . . 74.540000000000006 109.502 174.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -105.95 106.94 17.68 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.549 -0.537 . . . . 64.439999999999998 109.549 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.45 162.23 14.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.411 0.624 . . . . 63.219999999999999 111.922 -177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.0 mm -110.41 163.97 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.391 1.077 . . . . 70.140000000000001 108.454 171.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.466 HG22 ' HG3' ' A' ' 69' ' ' PRO . 74.6 p -56.15 121.26 9.02 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.296 0.638 . . . . 73.519999999999996 111.181 174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.534 ' H ' ' HA ' ' A' ' 68' ' ' GLN . 45.8 m 70.68 8.13 6.46 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 125.552 1.541 . . . . 53.119999999999997 114.058 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.63 148.97 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.218 0.607 . . . . 63.119999999999997 110.88 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.4 p -84.09 116.68 23.0 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.666 0.786 . . . . 73.299999999999997 112.369 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.52 113.47 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 124.035 0.934 . . . . 35.420000000000002 110.319 172.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 27.8 ttt -99.88 105.01 16.7 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 173.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 52.4 mt -77.08 103.93 7.29 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.9 0.88 . . . . 74.040000000000006 109.86 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.86 111.69 21.02 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.543 -0.753 . . . . 53.439999999999998 111.466 -169.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.7 m -129.84 143.52 50.85 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.718 0.807 . . . . 74.25 111.705 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -147.94 124.35 10.97 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.987 1.315 . . . . 63.340000000000003 109.14 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.27 146.38 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.959 0.904 . . . . 74.140000000000001 111.171 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -67.11 -29.05 68.68 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.621 0.768 . . . . 75.319999999999993 111.947 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -113.68 118.16 33.58 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.918 0.887 . . . . 71.409999999999997 110.525 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -70.65 83.71 0.62 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.682 0.793 . . . . 75.319999999999993 109.129 176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 177.88 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 75.430000000000007 110.868 -169.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -58.72 110.75 2.86 Favored Pre-proline 0 N--CA 1.486 1.367 0 N-CA-C 114.354 1.242 . . . . 54.520000000000003 114.354 -170.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 34' ' ' ALA . 4.3 Cg_exo -76.93 101.15 1.47 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 123.161 2.574 . . . . 70.329999999999998 111.464 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' HB ' ' SG ' ' A' ' 77' ' ' CYS . 26.4 m -73.9 149.39 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-O 121.255 0.55 . . . . 73.049999999999997 111.741 -176.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -129.9 108.07 9.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.217 1.007 . . . . 75.430000000000007 108.67 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -83.77 141.84 31.11 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.67 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 75.4 m-85 -126.92 130.04 49.36 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.508 0.723 . . . . 74.25 110.537 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -84.08 -122.87 0.03 OUTLIER 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 108.686 -0.857 . . . . 72.310000000000002 108.686 172.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -89.67 44.93 1.24 Allowed 'General case' 0 CA--C 1.56 1.348 0 O-C-N 121.279 -0.888 . . . . 71.510000000000005 110.658 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.09 -9.69 61.54 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 115.647 -0.706 . . . . 52.329999999999998 113.691 -174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.48 -33.47 62.87 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 113.916 1.08 . . . . 61.200000000000003 113.916 -173.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 36.6 tt0 71.08 121.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.523 1.129 . . . . 75.420000000000002 111.649 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.503 HG11 HD11 ' A' ' 62' ' ' LEU . 19.4 t -91.32 115.29 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.692 0.797 . . . . 75.109999999999999 111.029 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -114.32 171.47 7.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.292 1.037 . . . . 74.430000000000007 109.509 171.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.64 129.6 40.42 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.627 0.371 . . . . 72.430000000000007 110.598 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 t -141.47 -175.94 4.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.013 0.925 . . . . 64.450000000000003 110.448 -172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.48 -32.26 72.26 Favored 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 123.769 0.828 . . . . 74.209999999999994 111.858 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.76 14.89 17.55 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.768 0.827 . . . . 75.329999999999998 111.978 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.96 126.76 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.861 -0.525 . . . . 75.409999999999997 111.1 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.84 147.51 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.413 0.685 . . . . 72.230000000000004 109.871 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.89 135.83 53.21 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.349 0.66 . . . . 65.219999999999999 110.644 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -97.64 111.02 23.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.764 0.825 . . . . 63.200000000000003 110.066 173.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -128.37 112.65 14.65 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.328 0.651 . . . . 63.409999999999997 110.214 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 59' ' ' HIS . 9.0 pt-20 -161.35 113.44 1.83 Allowed 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.9 0.88 . . . . 73.519999999999996 110.669 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.99 -112.35 4.75 Favored Glycine 0 CA--C 1.549 2.163 0 CA-C-O 119.481 -0.622 . . . . 72.340000000000003 114.413 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.62 -11.69 4.8 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.643 2.228 . . . . 71.540000000000006 113.412 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 18.1 m-70 -78.47 114.81 17.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.613 0.765 . . . . 75.340000000000003 112.132 -176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.51 70.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.106 0.962 . . . . 72.239999999999995 110.148 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.5 mtt-85 -102.93 127.03 50.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 122.814 0.446 . . . . 74.219999999999999 111.296 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 8.9 tt -77.41 134.93 38.29 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 71.540000000000006 110.154 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.96 114.82 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.305 0.642 . . . . 34.299999999999997 109.676 173.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.414 HD23 HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -109.83 94.01 16.13 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 123.647 0.779 . . . . 54.100000000000001 109.062 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.81 -41.87 42.65 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.432 2.755 . . . . 62.32 114.199 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.38 2.63 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.834 0.454 . . . . 63.420000000000002 110.458 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.3 m -69.45 -29.61 67.33 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.557 0.743 . . . . 53.299999999999997 112.552 -175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.534 ' HA ' ' H ' ' A' ' 20' ' ' SER . 48.3 mt-30 60.3 -178.07 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.09 0 N-CA-C 112.355 0.502 . . . . 73.299999999999997 112.355 170.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' A' ' 19' ' ' THR . 22.8 Cg_exo -68.42 -33.99 21.72 Favored 'Trans proline' 0 C--N 1.381 2.277 0 CA-C-N 121.101 1.429 . . . . 64.329999999999998 112.129 164.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.4 p -74.74 -57.34 3.98 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 124.434 1.094 . . . . 74.140000000000001 113.536 -173.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.75 17.71 0.29 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.872 1.064 . . . . 71.099999999999994 113.872 -170.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.84 -154.57 16.04 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 123.05 0.357 . . . . 74.219999999999999 113.36 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 107.94 -177.22 20.99 Favored Glycine 0 N--CA 1.477 1.403 0 O-C-N 122.486 -0.42 . . . . 62.0 112.544 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 87' ' ' THR . 38.2 mt-10 -88.48 125.47 34.77 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 122.264 -0.551 . . . . 75.099999999999994 110.647 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 39' ' ' TYR . 95.4 m-85 -109.33 115.68 30.43 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.113 0.565 . . . . 72.25 111.882 -176.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -111.19 120.01 40.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.862 0.865 . . . . 73.450000000000003 110.634 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.554 ' SG ' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t -100.72 96.32 7.25 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.704 0.802 . . . . 72.140000000000001 111.105 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -90.08 105.13 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.743 0.817 . . . . 62.520000000000003 111.143 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.591 ' HB1' ' HB1' ' A' ' 34' ' ' ALA . . . -86.05 -50.6 6.92 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.501 0.72 . . . . 72.019999999999996 111.601 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.73 111.46 0.27 Allowed Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.592 -1.003 . . . . 74.540000000000006 110.592 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.38 -66.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.893 1.277 . . . . 71.329999999999998 110.693 -167.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' HG3' ' HA ' ' A' ' 5' ' ' HIS . 11.2 mm-40 -84.73 155.79 21.73 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.52 1.128 . . . . 72.510000000000005 111.985 178.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.5 p -152.78 146.33 24.99 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.654 -1.157 . . . . 63.109999999999999 111.062 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 77' ' ' CYS . . . -94.75 153.14 17.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.19 0.996 . . . . 73.25 110.634 176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -128.26 132.72 48.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.491 0.716 . . . . 73.25 111.425 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.17 151.2 50.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.789 1.236 . . . . 75.329999999999998 109.08 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 74' ' ' GLU . 58.9 m -129.54 100.97 5.73 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.752 -0.833 . . . . 72.439999999999998 108.752 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 15' ' ' VAL . 57.2 t -97.43 100.85 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.161 0.505 . . . . 63.219999999999999 109.914 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.5 m -98.58 128.21 44.81 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.837 -0.801 . . . . 75.0 108.837 174.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.454 HG21 ' HA ' ' A' ' 69' ' ' PRO . 24.6 mm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 121.771 0.796 . . . . 75.239999999999995 112.064 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.529 ' HB3' ' SD ' ' A' ' 2' ' ' MET . 65.2 m80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.702 0.286 . . . . 72.120000000000005 111.365 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 1' ' ' HIS . 1.3 mpt? 56.96 72.82 0.88 Allowed Pre-proline 0 CA--C 1.568 1.639 0 C-N-CA 125.599 1.56 . . . . 64.450000000000003 113.925 177.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HG2' HH21 ' A' ' 31' ' ' ARG . 66.6 Cg_endo -84.31 172.73 9.25 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.754 2.303 . . . . 73.420000000000002 112.183 167.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.6 p -163.13 136.6 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 121.395 0.617 . . . . 64.239999999999995 111.881 178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -147.19 117.57 7.41 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 124.81 1.244 . . . . 72.019999999999996 110.406 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.5 mt -60.89 116.3 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 C-N-CA 123.266 0.626 . . . . 70.129999999999995 111.07 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.37 -16.58 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.55 0.74 . . . . 71.319999999999993 112.571 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -161.79 128.48 2.49 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.227 0.611 . . . . 52.450000000000003 109.873 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.04 163.38 72.81 Favored 'Cis proline' 0 C--N 1.372 1.767 0 CA-C-N 120.854 1.341 . . . . 73.239999999999995 112.906 -7.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -109.09 16.68 22.35 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.543 0.737 . . . . 52.310000000000002 111.946 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.42 -175.3 5.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.845 0.683 . . . . 75.219999999999999 112.845 -175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -77.34 105.24 8.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.288 1.035 . . . . 73.25 109.805 171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.95 108.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.777 0.431 . . . . 74.420000000000002 111.063 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -80.36 112.28 17.55 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.323 0.649 . . . . 73.530000000000001 110.759 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -105.77 105.11 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.168 0.987 . . . . 72.439999999999998 110.407 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -76.99 110.59 11.75 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.74 0.416 . . . . 75.420000000000002 110.263 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.47 146.25 51.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.333 0.653 . . . . 75.409999999999997 112.629 -171.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 50.9 mt -87.0 154.95 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 123.611 0.764 . . . . 72.549999999999997 109.68 174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.402 HG22 ' HG3' ' A' ' 69' ' ' PRO . 68.7 p -54.8 -25.15 26.34 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.363 1.065 . . . . 74.510000000000005 113.803 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.1 t -106.68 2.87 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.07 0.948 . . . . 63.119999999999997 112.947 -174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 18' ' ' ILE . 30.8 mm-40 -95.55 156.3 16.38 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.032 0.753 . . . . 70.420000000000002 113.032 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.5 p -91.77 124.53 35.97 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.328 -0.851 . . . . 70.409999999999997 111.044 175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.54 120.19 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.052 0.541 . . . . 64.340000000000003 110.725 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 85.7 mtp -110.08 95.11 5.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.894 0.878 . . . . 73.340000000000003 110.29 177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -85.03 127.21 34.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.634 0.774 . . . . 74.109999999999999 110.35 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -122.06 139.87 53.19 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.238 0.458 . . . . 72.200000000000003 112.238 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.69 116.92 11.85 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.011 0.924 . . . . 44.149999999999999 110.594 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.85 134.57 36.08 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.483 0.659 . . . . 72.209999999999994 111.022 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.67 151.96 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 124.315 1.046 . . . . 70.109999999999999 110.924 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -75.15 -35.71 61.61 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.961 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.502 HH21 ' HG2' ' A' ' 3' ' ' PRO . 3.4 mpt_? -101.04 92.44 5.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.823 -1.177 . . . . 74.420000000000002 107.823 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.94 -18.5 65.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.349 0.66 . . . . 71.25 112.431 -177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.71 -27.95 64.38 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.949 0.899 . . . . 75.129999999999995 112.173 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.89 119.38 74.25 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.697 0.799 . . . . 74.140000000000001 111.071 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -75.51 173.13 15.03 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.763 2.308 . . . . 65.439999999999998 112.864 174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.43 152.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.767 0.794 . . . . 70.329999999999998 111.747 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -107.96 108.98 20.34 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.315 -1.311 . . . . 63.140000000000001 107.475 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -84.88 132.15 34.42 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.203 0.525 . . . . 72.0 110.396 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' GLU . 97.6 m-85 -126.34 163.13 23.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.389 1.076 . . . . 64.140000000000001 110.793 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -143.87 169.01 18.6 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.258 -1.337 . . . . 75.140000000000001 107.609 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -49.5 101.84 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.361 0.664 . . . . 74.340000000000003 112.343 177.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.8 -31.7 6.04 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 115.544 0.977 . . . . 71.239999999999995 115.544 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -137.06 137.98 39.93 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.49 0.716 . . . . 64.129999999999995 110.861 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 39' ' ' TYR . 14.7 pt-20 -72.5 152.04 42.14 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 111.705 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 62' ' ' LEU . 14.0 t -100.42 102.16 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.05 0.54 . . . . 73.150000000000006 111.19 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.46 168.0 9.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.131 0.972 . . . . 73.549999999999997 109.693 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.94 85.85 0.7 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.316 0.579 . . . . 63.149999999999999 111.485 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' H ' ' HB ' ' A' ' 51' ' ' VAL . 22.8 t -95.17 -167.45 1.63 Allowed 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.373 1.069 . . . . 65.439999999999998 109.94 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.51 -37.21 77.71 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.311 0.644 . . . . 54.409999999999997 112.648 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.495 ' O ' ' HD2' ' A' ' 65' ' ' PRO . 49.0 m-85 -102.55 10.55 38.75 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.376 0.67 . . . . 73.310000000000002 112.248 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HB ' ' H ' ' A' ' 48' ' ' SER . 22.6 t -129.18 135.25 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-N 119.225 0.921 . . . . 60.229999999999997 112.394 -175.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 63' ' ' VAL . 22.5 m -132.22 143.08 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 123.972 0.909 . . . . 32.109999999999999 109.719 166.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -119.75 124.28 45.81 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.274 0.63 . . . . 73.209999999999994 110.821 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 15.4 mm-40 -108.29 115.77 30.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.731 0.812 . . . . 72.340000000000003 111.227 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.506 ' HB3' HH11 ' A' ' 60' ' ' ARG . 13.8 m120 -120.65 117.94 28.83 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.363 0.665 . . . . 71.209999999999994 110.406 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.33 96.17 2.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.71 0.804 . . . . 63.219999999999999 110.129 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.75 -128.3 37.63 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 119.55 -0.583 . . . . 53.32 112.957 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HG2' ' HD2' ' A' ' 59' ' ' HIS . 57.1 Cg_endo -70.9 -23.19 25.91 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.196 1.93 . . . . 71.430000000000007 112.804 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.437 ' HD2' ' HG2' ' A' ' 58' ' ' PRO . 18.8 m-70 -79.09 100.05 7.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.474 0.654 . . . . 72.340000000000003 111.564 -176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.506 HH11 ' HB3' ' A' ' 55' ' ' ASN . 36.0 mmt180 -108.49 104.6 13.97 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.607 1.163 . . . . 75.150000000000006 109.563 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HB2' ' A' ' 54' ' ' GLU . 10.9 ptp180 -126.7 140.25 52.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.167 1.173 . . . . 75.120000000000005 114.167 -174.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 45' ' ' VAL . 6.9 tt -91.78 127.78 37.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.578 1.551 . . . . 63.310000000000002 108.397 170.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 52' ' ' VAL . 56.0 t -117.44 112.05 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.509 -0.552 . . . . 62.420000000000002 109.509 176.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 104.76 44.9 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-O 118.699 -0.667 . . . . 70.439999999999998 109.632 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 50' ' ' PHE . 79.3 Cg_exo -45.09 -56.85 2.43 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 124.37 3.38 . . . . 72.310000000000002 115.628 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.47 92.21 3.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.554 0.742 . . . . 64.430000000000007 109.533 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 m -75.11 94.28 2.89 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-O 121.666 0.745 . . . . 72.120000000000005 111.24 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -70.55 153.63 94.89 Favored Pre-proline 0 CA--C 1.559 1.293 0 CA-C-N 114.621 -1.172 . . . . 72.439999999999998 110.83 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.402 ' HG3' HG22 ' A' ' 19' ' ' THR . 51.0 Cg_exo -54.62 -37.07 90.97 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.045 2.497 . . . . 64.230000000000004 113.553 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -75.25 -29.68 60.28 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.418 1.087 . . . . 62.32 112.278 177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -98.26 7.14 46.66 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.793 0.837 . . . . 51.43 112.069 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -105.84 -145.12 12.84 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.31 0.481 . . . . 61.130000000000003 112.24 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.64 -143.21 25.45 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 117.069 0.435 . . . . 71.230000000000004 113.344 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -82.07 125.6 31.03 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.444 0.698 . . . . 75.409999999999997 112.049 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 56.4 m-85 -117.68 162.62 17.74 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.647 1.179 . . . . 63.200000000000003 111.254 176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 26.9 tt0 -146.11 125.36 13.0 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.768 0.827 . . . . 71.409999999999997 110.593 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.3 t -108.28 110.34 21.92 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.723 0.809 . . . . 74.109999999999999 110.498 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.12 104.08 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 122.925 0.49 . . . . 74.219999999999999 111.917 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.71 97.08 9.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 110.035 -0.358 . . . . 61.240000000000002 110.035 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.6 -80.84 0.31 Allowed Glycine 0 C--N 1.349 1.263 0 O-C-N 123.66 0.6 . . . . 74.340000000000003 113.23 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -128.02 -20.39 3.82 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.713 0.805 . . . . 75.049999999999997 111.969 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -91.56 147.4 23.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.863 -0.523 . . . . 62.329999999999998 110.496 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 24.4 p -132.2 124.36 28.85 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.844 0.683 . . . . 74.439999999999998 112.844 -175.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.85 158.61 15.41 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.284 1.034 . . . . 52.350000000000001 109.968 169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.1 146.18 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.371 0.508 . . . . 60.109999999999999 112.371 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 91.8 m-85 -136.89 148.97 47.35 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 124.291 1.036 . . . . 71.5 110.331 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 50.9 m -135.55 101.45 4.8 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.195 0.598 . . . . 71.120000000000005 109.596 174.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 66.3 t -90.19 105.51 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.763 0.825 . . . . 63.140000000000001 110.142 -174.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.9 m -82.49 99.98 9.8 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.048 0.939 . . . . 75.099999999999994 111.235 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 122.267 1.032 . . . . 71.510000000000005 110.06 -179.815 . . . . . . . . 0 0 . 1 stop_ save_